date generated: 2023-08-29
Mitch performs unidimensional and multidimensional gene set enrichment analysis. The concept behind this dates to work by Cox and Mann (https://doi.org/10.1186/1471-2105-13-S16-S12). This implementation is suited to R based workflows of multi-omics datasets. This software was developed by Antony Kaspi and Mark Ziemann. Learn more about Mitch at the website: https://github.com/markziemann/Mitch
Here is the first few lines of the input profile.
| x | |
|---|---|
| 0610009B22Rik | -3.3814425 |
| 0610009E02Rik | -0.3557659 |
| 0610009L18Rik | -0.8507498 |
| 0610010K14Rik | 1.2510787 |
| 0610012G03Rik | 3.9729326 |
| 0610030E20Rik | 0.1581737 |
Here are some metrics about the input data profile:
| Profile metrics | |
|---|---|
| num_genesets | 1604 |
| num_genes_in_profile | 16911 |
| duplicated_genes_present | 0 |
| num_profile_genes_in_sets | 8289 |
| num_profile_genes_not_in_sets | 8622 |
Here is a plot of the input profiles. Note the dynamic ranges.
Here is the contour plot of the profile including all detected genes.
Here are some metrics about the gene sets used:
GMT file of genesets: mouse_msigdb_reactome_2022-02-16.gmt| Gene sets metrics | |
|---|---|
| num_genesets | 1604 |
| num_genesets_excluded | 434 |
| num_genesets_included | 1170 |
Significance is calculated by -log10(p-value). All points shown are FDR<0.05.
Significance is calculated by -log10(p-value). Top N sets shown irrespective of FDR.
Top N= 50 gene sets
## Warning in kable_styling(., "hover", full_width = FALSE): Please specify format
## in kable. kableExtra can customize either HTML or LaTeX outputs. See
## https://haozhu233.github.io/kableExtra/ for details.
| set | setSize | pANOVA | s.dist | p.adjustANOVA |
|---|---|---|---|---|
| COHESIN LOADING ONTO CHROMATIN | 10 | 3.53e-03 | -0.533 | 0.05990 |
| SYNTHESIS SECRETION AND INACTIVATION OF GLUCAGON LIKE PEPTIDE 1 GLP 1 | 12 | 1.40e-03 | -0.533 | 0.03760 |
| INCRETIN SYNTHESIS SECRETION AND INACTIVATION | 13 | 1.18e-03 | -0.520 | 0.03710 |
| TERMINATION OF O GLYCAN BIOSYNTHESIS | 11 | 3.28e-03 | 0.512 | 0.05900 |
| POST CHAPERONIN TUBULIN FOLDING PATHWAY | 17 | 2.65e-04 | 0.511 | 0.01740 |
| CROSSLINKING OF COLLAGEN FIBRILS | 15 | 9.38e-04 | 0.493 | 0.03710 |
| PROCESSING AND ACTIVATION OF SUMO | 10 | 8.22e-03 | -0.483 | 0.10100 |
| APOPTOSIS INDUCED DNA FRAGMENTATION | 10 | 8.22e-03 | -0.483 | 0.10100 |
| ADENYLATE CYCLASE ACTIVATING PATHWAY | 10 | 1.06e-02 | 0.467 | 0.11100 |
| CYTOSOLIC IRON SULFUR CLUSTER ASSEMBLY | 13 | 3.73e-03 | 0.465 | 0.06230 |
| TRANSPORT OF CONNEXONS TO THE PLASMA MEMBRANE | 13 | 4.42e-03 | 0.456 | 0.06710 |
| SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | 12 | 6.28e-03 | -0.456 | 0.08640 |
| CD28 DEPENDENT VAV1 PATHWAY | 11 | 1.14e-02 | -0.441 | 0.11200 |
| ACTIVATION OF SMO | 16 | 2.80e-03 | 0.432 | 0.05560 |
| MITOTIC TELOPHASE CYTOKINESIS | 13 | 1.12e-02 | -0.406 | 0.11200 |
| SYNTHESIS OF ACTIVE UBIQUITIN ROLES OF E1 AND E2 ENZYMES | 29 | 1.73e-04 | -0.403 | 0.01450 |
| MET ACTIVATES RAP1 AND RAC1 | 11 | 2.26e-02 | -0.397 | 0.16500 |
| REPRESSION OF WNT TARGET GENES | 14 | 1.17e-02 | 0.389 | 0.11400 |
| CREB1 PHOSPHORYLATION THROUGH THE ACTIVATION OF ADENYLATE CYCLASE | 11 | 2.67e-02 | -0.386 | 0.18100 |
| CHK1 CHK2 CDS1 MEDIATED INACTIVATION OF CYCLIN B CDK1 COMPLEX | 10 | 3.53e-02 | -0.384 | 0.21900 |
| CELLULAR HEXOSE TRANSPORT | 11 | 2.92e-02 | 0.380 | 0.19300 |
| ACTIVATION OF RAC1 | 13 | 1.82e-02 | -0.378 | 0.14400 |
| ACTIVATION OF AMPK DOWNSTREAM OF NMDARS | 20 | 4.32e-03 | 0.369 | 0.06710 |
| SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | 14 | 1.81e-02 | 0.365 | 0.14400 |
| SYNAPTIC ADHESION LIKE MOLECULES | 21 | 4.09e-03 | 0.362 | 0.06550 |
| ASSEMBLY AND CELL SURFACE PRESENTATION OF NMDA RECEPTORS | 35 | 2.82e-04 | 0.355 | 0.01740 |
| FOXO MEDIATED TRANSCRIPTION OF CELL DEATH GENES | 15 | 1.87e-02 | 0.351 | 0.14700 |
| NRAGE SIGNALS DEATH THROUGH JNK | 55 | 8.30e-06 | 0.347 | 0.00203 |
| SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | 20 | 7.28e-03 | -0.347 | 0.09800 |
| A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | 26 | 2.32e-03 | 0.345 | 0.04970 |
| MATURATION OF NUCLEOPROTEIN | 10 | 5.99e-02 | -0.344 | 0.28800 |
| EARLY PHASE OF HIV LIFE CYCLE | 13 | 3.38e-02 | -0.340 | 0.21400 |
| SIGNALING BY FGFR4 IN DISEASE | 10 | 6.56e-02 | -0.336 | 0.30600 |
| PRE NOTCH PROCESSING IN GOLGI | 18 | 1.39e-02 | 0.335 | 0.12800 |
| SIGNALING BY FGFR3 FUSIONS IN CANCER | 10 | 6.99e-02 | -0.331 | 0.31000 |
| E2F MEDIATED REGULATION OF DNA REPLICATION | 19 | 1.37e-02 | -0.327 | 0.12800 |
| COLLAGEN BIOSYNTHESIS AND MODIFYING ENZYMES | 62 | 9.27e-06 | 0.326 | 0.00203 |
| SYNTHESIS OF LEUKOTRIENES LT AND EOXINS EX | 12 | 5.23e-02 | 0.324 | 0.27800 |
| CARBOXYTERMINAL POST TRANSLATIONAL MODIFICATIONS OF TUBULIN | 35 | 9.83e-04 | 0.322 | 0.03710 |
| SEALING OF THE NUCLEAR ENVELOPE NE BY ESCRT III | 23 | 7.59e-03 | 0.322 | 0.09860 |
| NOTCH4 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | 20 | 1.30e-02 | 0.321 | 0.12100 |
| CRMPS IN SEMA3A SIGNALING | 16 | 2.66e-02 | 0.320 | 0.18100 |
| ADP SIGNALLING THROUGH P2Y PURINOCEPTOR 12 | 19 | 1.72e-02 | -0.316 | 0.14300 |
| NCAM1 INTERACTIONS | 40 | 6.39e-04 | 0.312 | 0.03120 |
| PEXOPHAGY | 11 | 8.02e-02 | 0.305 | 0.33300 |
| REGULATION OF TP53 ACTIVITY THROUGH ASSOCIATION WITH CO FACTORS | 13 | 5.75e-02 | 0.304 | 0.28600 |
| INSULIN PROCESSING | 24 | 9.90e-03 | -0.304 | 0.10900 |
| PRESYNAPTIC DEPOLARIZATION AND CALCIUM CHANNEL OPENING | 11 | 8.23e-02 | 0.303 | 0.33700 |
| G BETA GAMMA SIGNALLING THROUGH CDC42 | 18 | 2.63e-02 | -0.303 | 0.18100 |
| NF KB IS ACTIVATED AND SIGNALS SURVIVAL | 13 | 5.91e-02 | 0.302 | 0.28800 |
| set | setSize | pANOVA | s.dist | p.adjustANOVA |
|---|---|---|---|---|
| COHESIN LOADING ONTO CHROMATIN | 10 | 3.53e-03 | -5.33e-01 | 0.059900 |
| SYNTHESIS SECRETION AND INACTIVATION OF GLUCAGON LIKE PEPTIDE 1 GLP 1 | 12 | 1.40e-03 | -5.33e-01 | 0.037600 |
| INCRETIN SYNTHESIS SECRETION AND INACTIVATION | 13 | 1.18e-03 | -5.20e-01 | 0.037100 |
| TERMINATION OF O GLYCAN BIOSYNTHESIS | 11 | 3.28e-03 | 5.12e-01 | 0.059000 |
| POST CHAPERONIN TUBULIN FOLDING PATHWAY | 17 | 2.65e-04 | 5.11e-01 | 0.017400 |
| CROSSLINKING OF COLLAGEN FIBRILS | 15 | 9.38e-04 | 4.93e-01 | 0.037100 |
| PROCESSING AND ACTIVATION OF SUMO | 10 | 8.22e-03 | -4.83e-01 | 0.101000 |
| APOPTOSIS INDUCED DNA FRAGMENTATION | 10 | 8.22e-03 | -4.83e-01 | 0.101000 |
| ADENYLATE CYCLASE ACTIVATING PATHWAY | 10 | 1.06e-02 | 4.67e-01 | 0.111000 |
| CYTOSOLIC IRON SULFUR CLUSTER ASSEMBLY | 13 | 3.73e-03 | 4.65e-01 | 0.062300 |
| TRANSPORT OF CONNEXONS TO THE PLASMA MEMBRANE | 13 | 4.42e-03 | 4.56e-01 | 0.067100 |
| SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | 12 | 6.28e-03 | -4.56e-01 | 0.086400 |
| CD28 DEPENDENT VAV1 PATHWAY | 11 | 1.14e-02 | -4.41e-01 | 0.112000 |
| ACTIVATION OF SMO | 16 | 2.80e-03 | 4.32e-01 | 0.055600 |
| MITOTIC TELOPHASE CYTOKINESIS | 13 | 1.12e-02 | -4.06e-01 | 0.112000 |
| SYNTHESIS OF ACTIVE UBIQUITIN ROLES OF E1 AND E2 ENZYMES | 29 | 1.73e-04 | -4.03e-01 | 0.014500 |
| MET ACTIVATES RAP1 AND RAC1 | 11 | 2.26e-02 | -3.97e-01 | 0.165000 |
| REPRESSION OF WNT TARGET GENES | 14 | 1.17e-02 | 3.89e-01 | 0.114000 |
| CREB1 PHOSPHORYLATION THROUGH THE ACTIVATION OF ADENYLATE CYCLASE | 11 | 2.67e-02 | -3.86e-01 | 0.181000 |
| CHK1 CHK2 CDS1 MEDIATED INACTIVATION OF CYCLIN B CDK1 COMPLEX | 10 | 3.53e-02 | -3.84e-01 | 0.219000 |
| CELLULAR HEXOSE TRANSPORT | 11 | 2.92e-02 | 3.80e-01 | 0.193000 |
| ACTIVATION OF RAC1 | 13 | 1.82e-02 | -3.78e-01 | 0.144000 |
| ACTIVATION OF AMPK DOWNSTREAM OF NMDARS | 20 | 4.32e-03 | 3.69e-01 | 0.067100 |
| SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | 14 | 1.81e-02 | 3.65e-01 | 0.144000 |
| SYNAPTIC ADHESION LIKE MOLECULES | 21 | 4.09e-03 | 3.62e-01 | 0.065500 |
| ASSEMBLY AND CELL SURFACE PRESENTATION OF NMDA RECEPTORS | 35 | 2.82e-04 | 3.55e-01 | 0.017400 |
| FOXO MEDIATED TRANSCRIPTION OF CELL DEATH GENES | 15 | 1.87e-02 | 3.51e-01 | 0.147000 |
| NRAGE SIGNALS DEATH THROUGH JNK | 55 | 8.30e-06 | 3.47e-01 | 0.002030 |
| SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | 20 | 7.28e-03 | -3.47e-01 | 0.098000 |
| A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | 26 | 2.32e-03 | 3.45e-01 | 0.049700 |
| MATURATION OF NUCLEOPROTEIN | 10 | 5.99e-02 | -3.44e-01 | 0.288000 |
| EARLY PHASE OF HIV LIFE CYCLE | 13 | 3.38e-02 | -3.40e-01 | 0.214000 |
| SIGNALING BY FGFR4 IN DISEASE | 10 | 6.56e-02 | -3.36e-01 | 0.306000 |
| PRE NOTCH PROCESSING IN GOLGI | 18 | 1.39e-02 | 3.35e-01 | 0.128000 |
| SIGNALING BY FGFR3 FUSIONS IN CANCER | 10 | 6.99e-02 | -3.31e-01 | 0.310000 |
| E2F MEDIATED REGULATION OF DNA REPLICATION | 19 | 1.37e-02 | -3.27e-01 | 0.128000 |
| COLLAGEN BIOSYNTHESIS AND MODIFYING ENZYMES | 62 | 9.27e-06 | 3.26e-01 | 0.002030 |
| SYNTHESIS OF LEUKOTRIENES LT AND EOXINS EX | 12 | 5.23e-02 | 3.24e-01 | 0.278000 |
| CARBOXYTERMINAL POST TRANSLATIONAL MODIFICATIONS OF TUBULIN | 35 | 9.83e-04 | 3.22e-01 | 0.037100 |
| SEALING OF THE NUCLEAR ENVELOPE NE BY ESCRT III | 23 | 7.59e-03 | 3.22e-01 | 0.098600 |
| NOTCH4 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | 20 | 1.30e-02 | 3.21e-01 | 0.121000 |
| CRMPS IN SEMA3A SIGNALING | 16 | 2.66e-02 | 3.20e-01 | 0.181000 |
| ADP SIGNALLING THROUGH P2Y PURINOCEPTOR 12 | 19 | 1.72e-02 | -3.16e-01 | 0.143000 |
| NCAM1 INTERACTIONS | 40 | 6.39e-04 | 3.12e-01 | 0.031200 |
| PEXOPHAGY | 11 | 8.02e-02 | 3.05e-01 | 0.333000 |
| REGULATION OF TP53 ACTIVITY THROUGH ASSOCIATION WITH CO FACTORS | 13 | 5.75e-02 | 3.04e-01 | 0.286000 |
| INSULIN PROCESSING | 24 | 9.90e-03 | -3.04e-01 | 0.109000 |
| PRESYNAPTIC DEPOLARIZATION AND CALCIUM CHANNEL OPENING | 11 | 8.23e-02 | 3.03e-01 | 0.337000 |
| G BETA GAMMA SIGNALLING THROUGH CDC42 | 18 | 2.63e-02 | -3.03e-01 | 0.181000 |
| NF KB IS ACTIVATED AND SIGNALS SURVIVAL | 13 | 5.91e-02 | 3.02e-01 | 0.288000 |
| SYNTHESIS OF IP3 AND IP4 IN THE CYTOSOL | 26 | 7.63e-03 | 3.02e-01 | 0.098600 |
| MET ACTIVATES RAS SIGNALING | 10 | 9.87e-02 | -3.02e-01 | 0.372000 |
| CLEC7A DECTIN 1 INDUCES NFAT ACTIVATION | 11 | 8.35e-02 | -3.01e-01 | 0.339000 |
| SIGNALING BY PDGFRA TRANSMEMBRANE JUXTAMEMBRANE AND KINASE DOMAIN MUTANTS | 12 | 7.41e-02 | -2.98e-01 | 0.314000 |
| PROTEIN UBIQUITINATION | 69 | 2.04e-05 | -2.97e-01 | 0.002390 |
| GENE AND PROTEIN EXPRESSION BY JAK STAT SIGNALING AFTER INTERLEUKIN 12 STIMULATION | 31 | 4.31e-03 | -2.96e-01 | 0.067100 |
| DEFECTIVE B4GALT7 CAUSES EDS PROGEROID TYPE | 20 | 2.23e-02 | 2.95e-01 | 0.164000 |
| TNF RECEPTOR SUPERFAMILY TNFSF MEMBERS MEDIATING NON CANONICAL NF KB PATHWAY | 13 | 6.69e-02 | 2.94e-01 | 0.306000 |
| REGULATION OF COMMISSURAL AXON PATHFINDING BY SLIT AND ROBO | 10 | 1.08e-01 | 2.93e-01 | 0.383000 |
| RUNX3 REGULATES NOTCH SIGNALING | 13 | 6.73e-02 | 2.93e-01 | 0.306000 |
| RHO GTPASES ACTIVATE IQGAPS | 23 | 1.50e-02 | 2.93e-01 | 0.135000 |
| GAP JUNCTION ASSEMBLY | 22 | 1.76e-02 | 2.92e-01 | 0.144000 |
| LGI ADAM INTERACTIONS | 14 | 6.09e-02 | 2.89e-01 | 0.290000 |
| RETROGRADE NEUROTROPHIN SIGNALLING | 13 | 7.10e-02 | 2.89e-01 | 0.311000 |
| COLLAGEN FORMATION | 78 | 1.04e-05 | 2.89e-01 | 0.002030 |
| REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | 15 | 5.35e-02 | -2.88e-01 | 0.278000 |
| SIGNALING BY NOTCH1 HD DOMAIN MUTANTS IN CANCER | 15 | 5.37e-02 | 2.88e-01 | 0.278000 |
| ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | 23 | 1.70e-02 | -2.87e-01 | 0.143000 |
| SIGNALING BY FLT3 FUSION PROTEINS | 18 | 3.54e-02 | -2.86e-01 | 0.219000 |
| RMTS METHYLATE HISTONE ARGININES | 43 | 1.18e-03 | 2.86e-01 | 0.037100 |
| NOTCH HLH TRANSCRIPTION PATHWAY | 28 | 9.69e-03 | 2.82e-01 | 0.109000 |
| REGULATION OF RUNX1 EXPRESSION AND ACTIVITY | 17 | 4.61e-02 | 2.79e-01 | 0.262000 |
| RHOBTB1 GTPASE CYCLE | 23 | 2.09e-02 | -2.78e-01 | 0.157000 |
| REGULATION OF GENE EXPRESSION IN LATE STAGE BRANCHING MORPHOGENESIS PANCREATIC BUD PRECURSOR CELLS | 13 | 8.29e-02 | 2.78e-01 | 0.338000 |
| INTERLEUKIN 37 SIGNALING | 17 | 4.85e-02 | 2.76e-01 | 0.267000 |
| SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | 20 | 3.26e-02 | 2.76e-01 | 0.210000 |
| DISEASES ASSOCIATED WITH O GLYCOSYLATION OF PROTEINS | 54 | 5.04e-04 | 2.74e-01 | 0.029500 |
| RECYCLING PATHWAY OF L1 | 40 | 2.87e-03 | 2.72e-01 | 0.055900 |
| DISEASES ASSOCIATED WITH GLYCOSYLATION PRECURSOR BIOSYNTHESIS | 18 | 4.56e-02 | 2.72e-01 | 0.262000 |
| KINESINS | 48 | 1.11e-03 | 2.72e-01 | 0.037100 |
| ADENYLATE CYCLASE INHIBITORY PATHWAY | 13 | 9.00e-02 | 2.72e-01 | 0.354000 |
| PROTEIN METHYLATION | 17 | 5.42e-02 | -2.70e-01 | 0.278000 |
| E3 UBIQUITIN LIGASES UBIQUITINATE TARGET PROTEINS | 50 | 9.79e-04 | -2.70e-01 | 0.037100 |
| PHASE 2 PLATEAU PHASE | 13 | 9.31e-02 | 2.69e-01 | 0.356000 |
| REGULATION OF INNATE IMMUNE RESPONSES TO CYTOSOLIC DNA | 13 | 9.32e-02 | 2.69e-01 | 0.356000 |
| IRE1ALPHA ACTIVATES CHAPERONES | 49 | 1.21e-03 | 2.67e-01 | 0.037100 |
| COLLAGEN CHAIN TRIMERIZATION | 39 | 4.03e-03 | 2.66e-01 | 0.065500 |
| CARNITINE METABOLISM | 14 | 8.92e-02 | 2.62e-01 | 0.353000 |
| METHYLATION | 11 | 1.35e-01 | -2.60e-01 | 0.432000 |
| COOPERATION OF PDCL PHLP1 AND TRIC CCT IN G PROTEIN BETA FOLDING | 35 | 7.75e-03 | -2.60e-01 | 0.098600 |
| TP53 REGULATES TRANSCRIPTION OF GENES INVOLVED IN G2 CELL CYCLE ARREST | 15 | 8.13e-02 | 2.60e-01 | 0.335000 |
| TRIGLYCERIDE CATABOLISM | 14 | 9.32e-02 | -2.59e-01 | 0.356000 |
| CELL EXTRACELLULAR MATRIX INTERACTIONS | 18 | 5.86e-02 | 2.58e-01 | 0.287000 |
| DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | 13 | 1.11e-01 | 2.55e-01 | 0.387000 |
| GLUCONEOGENESIS | 27 | 2.22e-02 | 2.54e-01 | 0.164000 |
| GAP JUNCTION TRAFFICKING AND REGULATION | 34 | 1.07e-02 | 2.53e-01 | 0.111000 |
| REGULATION OF TLR BY ENDOGENOUS LIGAND | 12 | 1.30e-01 | -2.52e-01 | 0.422000 |
| ANCHORING FIBRIL FORMATION | 14 | 1.03e-01 | 2.52e-01 | 0.376000 |
| CLASS I PEROXISOMAL MEMBRANE PROTEIN IMPORT | 20 | 5.22e-02 | -2.51e-01 | 0.278000 |
| CELL DEATH SIGNALLING VIA NRAGE NRIF AND NADE | 73 | 2.29e-04 | 2.49e-01 | 0.017400 |
| VLDLR INTERNALISATION AND DEGRADATION | 12 | 1.35e-01 | 2.49e-01 | 0.432000 |
| PEPTIDE HORMONE METABOLISM | 58 | 1.06e-03 | -2.49e-01 | 0.037100 |
| HSF1 DEPENDENT TRANSACTIVATION | 35 | 1.11e-02 | 2.48e-01 | 0.112000 |
| SIGNALING BY LEPTIN | 10 | 1.78e-01 | 2.46e-01 | 0.483000 |
| NEGATIVE REGULATION OF TCF DEPENDENT SIGNALING BY WNT LIGAND ANTAGONISTS | 10 | 1.80e-01 | 2.45e-01 | 0.484000 |
| PYRUVATE METABOLISM | 27 | 2.86e-02 | -2.43e-01 | 0.191000 |
| INTERLEUKIN 12 SIGNALING | 37 | 1.07e-02 | -2.43e-01 | 0.111000 |
| SIGNALING BY BMP | 24 | 4.10e-02 | -2.41e-01 | 0.243000 |
| CYTOCHROME C MEDIATED APOPTOTIC RESPONSE | 12 | 1.49e-01 | -2.41e-01 | 0.452000 |
| CONSTITUTIVE SIGNALING BY OVEREXPRESSED ERBB2 | 11 | 1.68e-01 | -2.40e-01 | 0.475000 |
| ASSEMBLY OF COLLAGEN FIBRILS AND OTHER MULTIMERIC STRUCTURES | 51 | 3.09e-03 | 2.40e-01 | 0.058000 |
| BIOTIN TRANSPORT AND METABOLISM | 11 | 1.71e-01 | 2.38e-01 | 0.475000 |
| RHOBTB3 ATPASE CYCLE | 10 | 1.96e-01 | -2.36e-01 | 0.505000 |
| RESOLUTION OF D LOOP STRUCTURES THROUGH SYNTHESIS DEPENDENT STRAND ANNEALING SDSA | 24 | 4.51e-02 | -2.36e-01 | 0.261000 |
| BRANCHED CHAIN AMINO ACID CATABOLISM | 21 | 6.09e-02 | -2.36e-01 | 0.290000 |
| NCAM SIGNALING FOR NEURITE OUT GROWTH | 60 | 1.68e-03 | 2.35e-01 | 0.042700 |
| SHC MEDIATED CASCADE FGFR4 | 11 | 1.79e-01 | -2.34e-01 | 0.484000 |
| ZBP1 DAI MEDIATED INDUCTION OF TYPE I IFNS | 18 | 8.61e-02 | 2.34e-01 | 0.344000 |
| REGULATION OF BETA CELL DEVELOPMENT | 24 | 4.78e-02 | 2.33e-01 | 0.266000 |
| KERATAN SULFATE BIOSYNTHESIS | 23 | 5.32e-02 | 2.33e-01 | 0.278000 |
| REGULATION OF IFNG SIGNALING | 13 | 1.48e-01 | -2.32e-01 | 0.452000 |
| ELEVATION OF CYTOSOLIC CA2 LEVELS | 15 | 1.21e-01 | 2.31e-01 | 0.410000 |
| NOTCH3 ACTIVATION AND TRANSMISSION OF SIGNAL TO THE NUCLEUS | 26 | 4.23e-02 | 2.30e-01 | 0.249000 |
| CDC42 GTPASE CYCLE | 152 | 1.01e-06 | 2.30e-01 | 0.000589 |
| WNT5A DEPENDENT INTERNALIZATION OF FZD4 | 15 | 1.23e-01 | 2.30e-01 | 0.414000 |
| THE PHOTOTRANSDUCTION CASCADE | 21 | 6.86e-02 | -2.30e-01 | 0.308000 |
| NOTCH2 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | 11 | 1.88e-01 | 2.29e-01 | 0.493000 |
| O GLYCOSYLATION OF TSR DOMAIN CONTAINING PROTEINS | 37 | 1.59e-02 | 2.29e-01 | 0.139000 |
| ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | 32 | 2.49e-02 | 2.29e-01 | 0.174000 |
| P75NTR SIGNALS VIA NF KB | 16 | 1.13e-01 | 2.29e-01 | 0.391000 |
| AKT PHOSPHORYLATES TARGETS IN THE NUCLEUS | 10 | 2.11e-01 | 2.29e-01 | 0.523000 |
| CGMP EFFECTS | 15 | 1.25e-01 | -2.29e-01 | 0.415000 |
| INTERACTION BETWEEN L1 AND ANKYRINS | 27 | 4.01e-02 | 2.28e-01 | 0.242000 |
| P75 NTR RECEPTOR MEDIATED SIGNALLING | 94 | 1.40e-04 | 2.27e-01 | 0.012600 |
| AGGREPHAGY | 34 | 2.21e-02 | 2.27e-01 | 0.164000 |
| CONSTITUTIVE SIGNALING BY AKT1 E17K IN CANCER | 26 | 4.60e-02 | 2.26e-01 | 0.262000 |
| DARPP 32 EVENTS | 23 | 6.05e-02 | -2.26e-01 | 0.290000 |
| TIE2 SIGNALING | 17 | 1.07e-01 | -2.26e-01 | 0.383000 |
| PHOSPHORYLATION OF THE APC C | 17 | 1.09e-01 | -2.25e-01 | 0.383000 |
| ACTIVATED NTRK2 SIGNALS THROUGH FRS2 AND FRS3 | 10 | 2.20e-01 | -2.24e-01 | 0.534000 |
| IRF3 MEDIATED INDUCTION OF TYPE I IFN | 11 | 2.00e-01 | 2.23e-01 | 0.511000 |
| ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | 11 | 2.00e-01 | -2.23e-01 | 0.511000 |
| ROLE OF PHOSPHOLIPIDS IN PHAGOCYTOSIS | 22 | 7.12e-02 | 2.22e-01 | 0.311000 |
| METABOLISM OF POLYAMINES | 58 | 3.47e-03 | -2.22e-01 | 0.059900 |
| DEADENYLATION OF MRNA | 25 | 5.50e-02 | -2.22e-01 | 0.279000 |
| PI 3K CASCADE FGFR4 | 11 | 2.03e-01 | -2.22e-01 | 0.514000 |
| TRISTETRAPROLIN TTP ZFP36 BINDS AND DESTABILIZES MRNA | 16 | 1.25e-01 | -2.21e-01 | 0.415000 |
| DISEASES OF GLYCOSYLATION | 127 | 1.76e-05 | 2.21e-01 | 0.002280 |
| DEFECTIVE EXT2 CAUSES EXOSTOSES 2 | 14 | 1.54e-01 | 2.20e-01 | 0.460000 |
| SIGNALLING TO RAS | 18 | 1.07e-01 | 2.20e-01 | 0.382000 |
| IRAK4 DEFICIENCY TLR2 4 | 13 | 1.71e-01 | -2.19e-01 | 0.475000 |
| SEMA4D IN SEMAPHORIN SIGNALING | 24 | 6.56e-02 | 2.17e-01 | 0.306000 |
| HOMOLOGOUS DNA PAIRING AND STRAND EXCHANGE | 40 | 1.75e-02 | -2.17e-01 | 0.144000 |
| INHIBITION OF THE PROTEOLYTIC ACTIVITY OF APC C REQUIRED FOR THE ONSET OF ANAPHASE BY MITOTIC SPINDLE CHECKPOINT COMPONENTS | 19 | 1.03e-01 | -2.16e-01 | 0.376000 |
| G ALPHA 12 13 SIGNALLING EVENTS | 74 | 1.37e-03 | 2.15e-01 | 0.037600 |
| ABERRANT REGULATION OF MITOTIC EXIT IN CANCER DUE TO RB1 DEFECTS | 19 | 1.06e-01 | -2.14e-01 | 0.382000 |
| SIGNALING BY PDGFR IN DISEASE | 20 | 9.82e-02 | -2.14e-01 | 0.372000 |
| ECM PROTEOGLYCANS | 66 | 2.75e-03 | 2.13e-01 | 0.055500 |
| DEFECTIVE CFTR CAUSES CYSTIC FIBROSIS | 59 | 4.71e-03 | -2.13e-01 | 0.070700 |
| REGULATION OF BACH1 ACTIVITY | 11 | 2.22e-01 | -2.13e-01 | 0.535000 |
| KERATAN SULFATE KERATIN METABOLISM | 29 | 4.82e-02 | 2.12e-01 | 0.266000 |
| OLFACTORY SIGNALING PATHWAY | 30 | 4.47e-02 | -2.12e-01 | 0.260000 |
| ACTIVATION OF BAD AND TRANSLOCATION TO MITOCHONDRIA | 15 | 1.56e-01 | -2.12e-01 | 0.461000 |
| REGULATION OF TP53 ACTIVITY THROUGH METHYLATION | 18 | 1.21e-01 | 2.11e-01 | 0.410000 |
| RAB GERANYLGERANYLATION | 59 | 5.05e-03 | -2.11e-01 | 0.074800 |
| CHONDROITIN SULFATE BIOSYNTHESIS | 19 | 1.11e-01 | 2.11e-01 | 0.387000 |
| LAMININ INTERACTIONS | 28 | 5.35e-02 | 2.11e-01 | 0.278000 |
| INTERLEUKIN 10 SIGNALING | 20 | 1.03e-01 | -2.11e-01 | 0.376000 |
| INTERLEUKIN 20 FAMILY SIGNALING | 13 | 1.89e-01 | 2.11e-01 | 0.494000 |
| INITIAL TRIGGERING OF COMPLEMENT | 11 | 2.28e-01 | 2.10e-01 | 0.546000 |
| TICAM1 RIP1 MEDIATED IKK COMPLEX RECRUITMENT | 18 | 1.23e-01 | -2.10e-01 | 0.414000 |
| NEGATIVE REGULATION OF NMDA RECEPTOR MEDIATED NEURONAL TRANSMISSION | 21 | 9.65e-02 | 2.10e-01 | 0.368000 |
| PURINE CATABOLISM | 16 | 1.49e-01 | -2.09e-01 | 0.452000 |
| ACTIVATION OF THE MRNA UPON BINDING OF THE CAP BINDING COMPLEX AND EIFS AND SUBSEQUENT BINDING TO 43S | 59 | 5.60e-03 | -2.09e-01 | 0.080900 |
| RHOBTB GTPASE CYCLE | 35 | 3.28e-02 | -2.08e-01 | 0.210000 |
| SIGNALING BY CTNNB1 PHOSPHO SITE MUTANTS | 15 | 1.63e-01 | -2.08e-01 | 0.468000 |
| RHOBTB2 GTPASE CYCLE | 23 | 8.47e-02 | -2.08e-01 | 0.342000 |
| BBSOME MEDIATED CARGO TARGETING TO CILIUM | 23 | 8.55e-02 | -2.07e-01 | 0.343000 |
| SYNTHESIS OF PE | 13 | 1.99e-01 | 2.06e-01 | 0.511000 |
| ORC1 REMOVAL FROM CHROMATIN | 68 | 3.52e-03 | -2.05e-01 | 0.059900 |
| ELASTIC FIBRE FORMATION | 36 | 3.43e-02 | 2.04e-01 | 0.216000 |
| DEGRADATION OF THE EXTRACELLULAR MATRIX | 107 | 2.73e-04 | 2.04e-01 | 0.017400 |
| ANTIGEN PROCESSING CROSS PRESENTATION | 95 | 6.38e-04 | -2.03e-01 | 0.031200 |
| NEGATIVE REGULATION OF NOTCH4 SIGNALING | 54 | 1.01e-02 | -2.02e-01 | 0.110000 |
| PYROPTOSIS | 21 | 1.09e-01 | -2.02e-01 | 0.384000 |
| SWITCHING OF ORIGINS TO A POST REPLICATIVE STATE | 87 | 1.18e-03 | -2.01e-01 | 0.037100 |
| SUMOYLATION OF INTRACELLULAR RECEPTORS | 25 | 8.17e-02 | -2.01e-01 | 0.336000 |
| S PHASE | 155 | 1.60e-05 | -2.01e-01 | 0.002280 |
| INTRINSIC PATHWAY OF FIBRIN CLOT FORMATION | 12 | 2.29e-01 | -2.01e-01 | 0.548000 |
| CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | 47 | 1.79e-02 | -2.00e-01 | 0.144000 |
| REGULATION OF RUNX2 EXPRESSION AND ACTIVITY | 70 | 3.90e-03 | -2.00e-01 | 0.064300 |
| INTERFERON ALPHA BETA SIGNALING | 52 | 1.29e-02 | -1.99e-01 | 0.121000 |
| PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | 16 | 1.68e-01 | -1.99e-01 | 0.475000 |
| SEROTONIN NEUROTRANSMITTER RELEASE CYCLE | 18 | 1.44e-01 | 1.99e-01 | 0.444000 |
| PLATELET AGGREGATION PLUG FORMATION | 32 | 5.15e-02 | 1.99e-01 | 0.278000 |
| DOWNSTREAM SIGNALING EVENTS OF B CELL RECEPTOR BCR | 79 | 2.34e-03 | -1.98e-01 | 0.049700 |
| NOTCH2 ACTIVATION AND TRANSMISSION OF SIGNAL TO THE NUCLEUS | 23 | 1.00e-01 | 1.98e-01 | 0.375000 |
| PRE NOTCH EXPRESSION AND PROCESSING | 64 | 6.20e-03 | 1.98e-01 | 0.086300 |
| TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | 11 | 2.57e-01 | -1.97e-01 | 0.580000 |
| NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | 20 | 1.27e-01 | -1.97e-01 | 0.417000 |
| FORMATION OF FIBRIN CLOT CLOTTING CASCADE | 20 | 1.28e-01 | -1.97e-01 | 0.418000 |
| O LINKED GLYCOSYLATION | 89 | 1.40e-03 | 1.96e-01 | 0.037600 |
| NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | 11 | 2.61e-01 | -1.96e-01 | 0.585000 |
| INTERLEUKIN 12 FAMILY SIGNALING | 44 | 2.47e-02 | -1.96e-01 | 0.174000 |
| CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM | 49 | 1.82e-02 | 1.95e-01 | 0.144000 |
| FATTY ACYL COA BIOSYNTHESIS | 32 | 5.76e-02 | -1.94e-01 | 0.286000 |
| DISEASES ASSOCIATED WITH GLYCOSAMINOGLYCAN METABOLISM | 39 | 3.70e-02 | 1.93e-01 | 0.227000 |
| PROCESSING OF SMDT1 | 16 | 1.82e-01 | -1.93e-01 | 0.486000 |
| FORMATION OF THE BETA CATENIN TCF TRANSACTIVATING COMPLEX | 46 | 2.40e-02 | 1.92e-01 | 0.171000 |
| SCF SKP2 MEDIATED DEGRADATION OF P27 P21 | 59 | 1.08e-02 | -1.92e-01 | 0.111000 |
| CHOLESTEROL BIOSYNTHESIS | 24 | 1.04e-01 | -1.92e-01 | 0.378000 |
| GLYCOGEN SYNTHESIS | 14 | 2.14e-01 | -1.92e-01 | 0.527000 |
| EXTRACELLULAR MATRIX ORGANIZATION | 241 | 3.14e-07 | 1.92e-01 | 0.000367 |
| INTEGRIN SIGNALING | 24 | 1.05e-01 | 1.91e-01 | 0.381000 |
| SIGNALING BY NOTCH2 | 33 | 5.81e-02 | 1.91e-01 | 0.287000 |
| NEGATIVE REGULATORS OF DDX58 IFIH1 SIGNALING | 32 | 6.24e-02 | -1.90e-01 | 0.296000 |
| APC C MEDIATED DEGRADATION OF CELL CYCLE PROTEINS | 81 | 3.08e-03 | -1.90e-01 | 0.058000 |
| HYALURONAN METABOLISM | 15 | 2.03e-01 | 1.90e-01 | 0.514000 |
| TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | 31 | 6.79e-02 | 1.90e-01 | 0.308000 |
| GLUTAMATE AND GLUTAMINE METABOLISM | 13 | 2.39e-01 | 1.89e-01 | 0.561000 |
| SIGNALING BY FLT3 ITD AND TKD MUTANTS | 15 | 2.06e-01 | -1.89e-01 | 0.519000 |
| DNA DAMAGE BYPASS | 47 | 2.56e-02 | -1.88e-01 | 0.177000 |
| RAF INDEPENDENT MAPK1 3 ACTIVATION | 21 | 1.36e-01 | 1.88e-01 | 0.434000 |
| HDACS DEACETYLATE HISTONES | 46 | 2.77e-02 | 1.88e-01 | 0.186000 |
| COLLAGEN DEGRADATION | 51 | 2.05e-02 | 1.88e-01 | 0.157000 |
| ABORTIVE ELONGATION OF HIV 1 TRANSCRIPT IN THE ABSENCE OF TAT | 23 | 1.20e-01 | 1.87e-01 | 0.409000 |
| STABILIZATION OF P53 | 55 | 1.68e-02 | -1.87e-01 | 0.143000 |
| TRANSLESION SYNTHESIS BY POLH | 19 | 1.60e-01 | -1.86e-01 | 0.465000 |
| ASPARTATE AND ASPARAGINE METABOLISM | 10 | 3.07e-01 | -1.86e-01 | 0.646000 |
| FRS MEDIATED FGFR4 SIGNALING | 13 | 2.45e-01 | -1.86e-01 | 0.566000 |
| RIP MEDIATED NFKB ACTIVATION VIA ZBP1 | 15 | 2.12e-01 | 1.86e-01 | 0.525000 |
| SIGNALING BY FGFR1 IN DISEASE | 32 | 6.92e-02 | -1.86e-01 | 0.309000 |
| ASSEMBLY OF THE PRE REPLICATIVE COMPLEX | 65 | 9.82e-03 | -1.85e-01 | 0.109000 |
| PKA ACTIVATION IN GLUCAGON SIGNALLING | 16 | 2.00e-01 | 1.85e-01 | 0.511000 |
| GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | 31 | 7.45e-02 | 1.85e-01 | 0.314000 |
| TRP CHANNELS | 18 | 1.76e-01 | 1.84e-01 | 0.480000 |
| SIGNALING BY KIT IN DISEASE | 20 | 1.55e-01 | -1.83e-01 | 0.461000 |
| SIGNALING BY ERBB2 ECD MUTANTS | 16 | 2.04e-01 | -1.83e-01 | 0.515000 |
| INTERFERON GAMMA SIGNALING | 73 | 6.82e-03 | -1.83e-01 | 0.092800 |
| G2 M DNA DAMAGE CHECKPOINT | 65 | 1.07e-02 | -1.83e-01 | 0.111000 |
| NR1H3 NR1H2 REGULATE GENE EXPRESSION LINKED TO CHOLESTEROL TRANSPORT AND EFFLUX | 32 | 7.32e-02 | 1.83e-01 | 0.312000 |
| INOSITOL PHOSPHATE METABOLISM | 47 | 3.04e-02 | 1.83e-01 | 0.198000 |
| P75NTR RECRUITS SIGNALLING COMPLEXES | 13 | 2.54e-01 | 1.83e-01 | 0.579000 |
| RET SIGNALING | 36 | 5.85e-02 | 1.82e-01 | 0.287000 |
| ACTIVATION OF THE PRE REPLICATIVE COMPLEX | 30 | 8.50e-02 | -1.82e-01 | 0.342000 |
| AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | 26 | 1.10e-01 | 1.81e-01 | 0.385000 |
| GP1B IX V ACTIVATION SIGNALLING | 10 | 3.22e-01 | 1.81e-01 | 0.660000 |
| FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | 120 | 6.40e-04 | 1.81e-01 | 0.031200 |
| RHOB GTPASE CYCLE | 67 | 1.09e-02 | 1.80e-01 | 0.111000 |
| DEGRADATION OF CYSTEINE AND HOMOCYSTEINE | 12 | 2.82e-01 | 1.79e-01 | 0.617000 |
| SIGNALING BY HIPPO | 20 | 1.65e-01 | -1.79e-01 | 0.472000 |
| TRANSLESION SYNTHESIS BY POLK | 17 | 2.01e-01 | -1.79e-01 | 0.512000 |
| MITOTIC SPINDLE CHECKPOINT | 96 | 2.45e-03 | -1.79e-01 | 0.051300 |
| DISEASES OF METABOLISM | 201 | 1.26e-05 | 1.79e-01 | 0.002110 |
| RECOGNITION OF DNA DAMAGE BY PCNA CONTAINING REPLICATION COMPLEX | 30 | 9.01e-02 | -1.79e-01 | 0.354000 |
| ORGANIC CATION ANION ZWITTERION TRANSPORT | 10 | 3.29e-01 | 1.78e-01 | 0.667000 |
| ACTIVATION OF ATR IN RESPONSE TO REPLICATION STRESS | 34 | 7.19e-02 | -1.78e-01 | 0.312000 |
| MITOCHONDRIAL TRNA AMINOACYLATION | 21 | 1.62e-01 | 1.76e-01 | 0.467000 |
| FGFR1 MUTANT RECEPTOR ACTIVATION | 25 | 1.27e-01 | -1.76e-01 | 0.417000 |
| INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | 29 | 1.01e-01 | -1.76e-01 | 0.376000 |
| REGULATION OF HMOX1 EXPRESSION AND ACTIVITY | 64 | 1.52e-02 | -1.76e-01 | 0.136000 |
| COMMON PATHWAY OF FIBRIN CLOT FORMATION | 11 | 3.15e-01 | -1.75e-01 | 0.653000 |
| MATURATION OF SARS COV 2 SPIKE PROTEIN | 29 | 1.03e-01 | 1.75e-01 | 0.376000 |
| ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | 15 | 2.41e-01 | 1.75e-01 | 0.561000 |
| RUNX1 REGULATES GENES INVOLVED IN MEGAKARYOCYTE DIFFERENTIATION AND PLATELET FUNCTION | 50 | 3.25e-02 | 1.75e-01 | 0.210000 |
| SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | 106 | 1.89e-03 | -1.75e-01 | 0.043300 |
| APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | 70 | 1.19e-02 | -1.74e-01 | 0.114000 |
| DISEASES OF CARBOHYDRATE METABOLISM | 29 | 1.07e-01 | 1.73e-01 | 0.383000 |
| REGULATION OF TP53 ACTIVITY THROUGH ACETYLATION | 30 | 1.02e-01 | 1.73e-01 | 0.376000 |
| DNA METHYLATION | 20 | 1.82e-01 | 1.73e-01 | 0.486000 |
| CASPASE ACTIVATION VIA DEPENDENCE RECEPTORS IN THE ABSENCE OF LIGAND | 10 | 3.45e-01 | 1.72e-01 | 0.678000 |
| APOPTOTIC EXECUTION PHASE | 45 | 4.57e-02 | -1.72e-01 | 0.262000 |
| MET ACTIVATES PTK2 SIGNALING | 29 | 1.10e-01 | 1.72e-01 | 0.384000 |
| GABA RECEPTOR ACTIVATION | 53 | 3.07e-02 | -1.72e-01 | 0.200000 |
| SIGNAL REGULATORY PROTEIN FAMILY INTERACTIONS | 11 | 3.25e-01 | 1.72e-01 | 0.664000 |
| NEUREXINS AND NEUROLIGINS | 54 | 2.93e-02 | 1.72e-01 | 0.193000 |
| PHASE 4 RESTING MEMBRANE POTENTIAL | 14 | 2.67e-01 | 1.71e-01 | 0.596000 |
| DNA REPLICATION PRE INITIATION | 81 | 7.73e-03 | -1.71e-01 | 0.098600 |
| CELL CYCLE CHECKPOINTS | 243 | 4.44e-06 | -1.71e-01 | 0.001730 |
| PI 3K CASCADE FGFR2 | 16 | 2.37e-01 | -1.71e-01 | 0.560000 |
| SYNTHESIS OF PA | 29 | 1.12e-01 | 1.71e-01 | 0.388000 |
| DNA REPLICATION | 123 | 1.16e-03 | -1.70e-01 | 0.037100 |
| GASTRIN CREB SIGNALLING PATHWAY VIA PKC AND MAPK | 16 | 2.40e-01 | -1.70e-01 | 0.561000 |
| HIV TRANSCRIPTION INITIATION | 45 | 4.97e-02 | -1.69e-01 | 0.271000 |
| EUKARYOTIC TRANSLATION INITIATION | 114 | 1.84e-03 | -1.69e-01 | 0.043300 |
| DEATH RECEPTOR SIGNALLING | 133 | 7.93e-04 | 1.69e-01 | 0.034400 |
| SUMOYLATION OF DNA METHYLATION PROTEINS | 16 | 2.45e-01 | 1.68e-01 | 0.566000 |
| G PROTEIN ACTIVATION | 22 | 1.73e-01 | -1.68e-01 | 0.476000 |
| REGULATED NECROSIS | 46 | 4.94e-02 | -1.68e-01 | 0.270000 |
| BETA CATENIN PHOSPHORYLATION CASCADE | 16 | 2.47e-01 | -1.67e-01 | 0.568000 |
| NEPHRIN FAMILY INTERACTIONS | 22 | 1.75e-01 | 1.67e-01 | 0.479000 |
| ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | 23 | 1.67e-01 | 1.66e-01 | 0.475000 |
| DOWNSTREAM SIGNALING OF ACTIVATED FGFR1 | 24 | 1.60e-01 | -1.66e-01 | 0.465000 |
| SENSORY PROCESSING OF SOUND BY OUTER HAIR CELLS OF THE COCHLEA | 41 | 6.68e-02 | 1.65e-01 | 0.306000 |
| DEGRADATION OF GLI1 BY THE PROTEASOME | 58 | 2.94e-02 | -1.65e-01 | 0.193000 |
| SIGNALING BY NOTCH3 | 48 | 4.80e-02 | 1.65e-01 | 0.266000 |
| GAB1 SIGNALOSOME | 13 | 3.03e-01 | 1.65e-01 | 0.644000 |
| G2 M CHECKPOINTS | 135 | 9.61e-04 | -1.65e-01 | 0.037100 |
| FORMATION OF THE CORNIFIED ENVELOPE | 29 | 1.25e-01 | 1.65e-01 | 0.415000 |
| KERATINIZATION | 29 | 1.25e-01 | 1.65e-01 | 0.415000 |
| EFFECTS OF PIP2 HYDROLYSIS | 27 | 1.39e-01 | 1.65e-01 | 0.437000 |
| G1 S DNA DAMAGE CHECKPOINTS | 66 | 2.09e-02 | -1.65e-01 | 0.157000 |
| GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | 23 | 1.72e-01 | 1.64e-01 | 0.476000 |
| P38MAPK EVENTS | 12 | 3.32e-01 | 1.62e-01 | 0.667000 |
| INTERLEUKIN 6 SIGNALING | 10 | 3.75e-01 | 1.62e-01 | 0.694000 |
| METABOLISM OF FOLATE AND PTERINES | 15 | 2.78e-01 | 1.62e-01 | 0.612000 |
| FORMATION OF INCISION COMPLEX IN GG NER | 43 | 6.72e-02 | -1.61e-01 | 0.306000 |
| MTORC1 MEDIATED SIGNALLING | 24 | 1.72e-01 | -1.61e-01 | 0.476000 |
| ATTENUATION PHASE | 25 | 1.64e-01 | 1.61e-01 | 0.470000 |
| DEGRADATION OF AXIN | 54 | 4.15e-02 | -1.60e-01 | 0.245000 |
| COPI MEDIATED ANTEROGRADE TRANSPORT | 90 | 8.72e-03 | 1.60e-01 | 0.103000 |
| MITOCHONDRIAL CALCIUM ION TRANSPORT | 23 | 1.84e-01 | -1.60e-01 | 0.488000 |
| FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | 19 | 2.28e-01 | 1.60e-01 | 0.546000 |
| CS DS DEGRADATION | 14 | 3.01e-01 | 1.60e-01 | 0.644000 |
| FC EPSILON RECEPTOR FCERI SIGNALING | 124 | 2.17e-03 | -1.60e-01 | 0.047900 |
| TRANSCRIPTIONAL REGULATION BY E2F6 | 34 | 1.08e-01 | -1.59e-01 | 0.383000 |
| MUCOPOLYSACCHARIDOSES | 11 | 3.61e-01 | 1.59e-01 | 0.694000 |
| TP53 REGULATES TRANSCRIPTION OF ADDITIONAL CELL CYCLE GENES WHOSE EXACT ROLE IN THE P53 PATHWAY REMAIN UNCERTAIN | 20 | 2.19e-01 | -1.59e-01 | 0.532000 |
| FCERI MEDIATED NF KB ACTIVATION | 77 | 1.60e-02 | -1.59e-01 | 0.139000 |
| CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | 12 | 3.42e-01 | 1.58e-01 | 0.676000 |
| CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | 19 | 2.33e-01 | -1.58e-01 | 0.555000 |
| NR1H2 AND NR1H3 MEDIATED SIGNALING | 38 | 9.22e-02 | 1.58e-01 | 0.356000 |
| INTERFERON SIGNALING | 161 | 5.56e-04 | -1.58e-01 | 0.031000 |
| KILLING MECHANISMS | 10 | 3.89e-01 | 1.57e-01 | 0.707000 |
| SIGNALING BY THE B CELL RECEPTOR BCR | 104 | 5.72e-03 | -1.57e-01 | 0.081600 |
| TBC RABGAPS | 43 | 7.56e-02 | 1.57e-01 | 0.317000 |
| DEGRADATION OF DVL | 56 | 4.29e-02 | -1.56e-01 | 0.251000 |
| HS GAG DEGRADATION | 21 | 2.18e-01 | 1.55e-01 | 0.532000 |
| AMINE LIGAND BINDING RECEPTORS | 29 | 1.49e-01 | 1.55e-01 | 0.452000 |
| DERMATAN SULFATE BIOSYNTHESIS | 11 | 3.75e-01 | 1.55e-01 | 0.694000 |
| GLUTATHIONE SYNTHESIS AND RECYCLING | 11 | 3.76e-01 | 1.54e-01 | 0.694000 |
| ER QUALITY CONTROL COMPARTMENT ERQC | 21 | 2.22e-01 | -1.54e-01 | 0.535000 |
| INTERLEUKIN 6 FAMILY SIGNALING | 20 | 2.34e-01 | 1.54e-01 | 0.555000 |
| APC CDC20 MEDIATED DEGRADATION OF NEK2A | 24 | 1.93e-01 | -1.54e-01 | 0.501000 |
| ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | 73 | 2.36e-02 | -1.53e-01 | 0.169000 |
| RESPONSE OF EIF2AK4 GCN2 TO AMINO ACID DEFICIENCY | 94 | 1.07e-02 | -1.52e-01 | 0.111000 |
| PLATELET ADHESION TO EXPOSED COLLAGEN | 11 | 3.81e-01 | -1.52e-01 | 0.698000 |
| TP53 REGULATES TRANSCRIPTION OF GENES INVOLVED IN G1 CELL CYCLE ARREST | 13 | 3.42e-01 | 1.52e-01 | 0.676000 |
| MOLECULES ASSOCIATED WITH ELASTIC FIBRES | 31 | 1.43e-01 | 1.52e-01 | 0.443000 |
| MITOTIC G1 PHASE AND G1 S TRANSITION | 142 | 1.82e-03 | -1.52e-01 | 0.043300 |
| SHC MEDIATED CASCADE FGFR1 | 14 | 3.28e-01 | -1.51e-01 | 0.666000 |
| FRS MEDIATED FGFR2 SIGNALING | 18 | 2.68e-01 | -1.51e-01 | 0.597000 |
| WNT5A DEPENDENT INTERNALIZATION OF FZD2 FZD5 AND ROR2 | 13 | 3.47e-01 | 1.51e-01 | 0.679000 |
| REGULATION OF PTEN STABILITY AND ACTIVITY | 67 | 3.31e-02 | -1.51e-01 | 0.211000 |
| CYCLIN A CDK2 ASSOCIATED EVENTS AT S PHASE ENTRY | 84 | 1.72e-02 | -1.51e-01 | 0.143000 |
| PRESYNAPTIC FUNCTION OF KAINATE RECEPTORS | 19 | 2.57e-01 | -1.50e-01 | 0.580000 |
| AUF1 HNRNP D0 BINDS AND DESTABILIZES MRNA | 54 | 5.62e-02 | -1.50e-01 | 0.283000 |
| HEDGEHOG LIGAND BIOGENESIS | 62 | 4.08e-02 | -1.50e-01 | 0.243000 |
| COMPLEX I BIOGENESIS | 56 | 5.26e-02 | -1.50e-01 | 0.278000 |
| NON INTEGRIN MEMBRANE ECM INTERACTIONS | 56 | 5.30e-02 | 1.50e-01 | 0.278000 |
| BUTYRATE RESPONSE FACTOR 1 BRF1 BINDS AND DESTABILIZES MRNA | 16 | 3.00e-01 | -1.50e-01 | 0.644000 |
| LYSOSPHINGOLIPID AND LPA RECEPTORS | 11 | 3.91e-01 | -1.50e-01 | 0.707000 |
| CONSTITUTIVE SIGNALING BY EGFRVIII | 15 | 3.16e-01 | -1.49e-01 | 0.654000 |
| ACTIVATION OF KAINATE RECEPTORS UPON GLUTAMATE BINDING | 28 | 1.72e-01 | -1.49e-01 | 0.476000 |
| COPI DEPENDENT GOLGI TO ER RETROGRADE TRAFFIC | 86 | 1.70e-02 | 1.49e-01 | 0.143000 |
| GLYCEROPHOSPHOLIPID BIOSYNTHESIS | 107 | 8.09e-03 | 1.48e-01 | 0.101000 |
| PLASMA LIPOPROTEIN CLEARANCE | 26 | 1.92e-01 | 1.48e-01 | 0.501000 |
| TNFR1 INDUCED NFKAPPAB SIGNALING PATHWAY | 29 | 1.69e-01 | 1.47e-01 | 0.475000 |
| GRB2 EVENTS IN ERBB2 SIGNALING | 14 | 3.40e-01 | -1.47e-01 | 0.676000 |
| REGULATION OF EXPRESSION OF SLITS AND ROBOS | 161 | 1.27e-03 | -1.47e-01 | 0.037600 |
| NEGATIVE REGULATION OF FLT3 | 15 | 3.26e-01 | 1.46e-01 | 0.666000 |
| REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | 85 | 2.07e-02 | -1.45e-01 | 0.157000 |
| PROTEIN PROTEIN INTERACTIONS AT SYNAPSES | 85 | 2.08e-02 | 1.45e-01 | 0.157000 |
| REDUCTION OF CYTOSOLIC CA LEVELS | 12 | 3.85e-01 | -1.45e-01 | 0.703000 |
| RORA ACTIVATES GENE EXPRESSION | 18 | 2.88e-01 | 1.45e-01 | 0.627000 |
| FORMATION OF APOPTOSOME | 10 | 4.28e-01 | -1.45e-01 | 0.737000 |
| ACTIVATION OF IRF3 IRF7 MEDIATED BY TBK1 IKK EPSILON | 17 | 3.03e-01 | 1.44e-01 | 0.644000 |
| PCNA DEPENDENT LONG PATCH BASE EXCISION REPAIR | 21 | 2.53e-01 | -1.44e-01 | 0.578000 |
| METABOLISM OF FAT SOLUBLE VITAMINS | 32 | 1.60e-01 | 1.44e-01 | 0.465000 |
| SEPARATION OF SISTER CHROMATIDS | 165 | 1.57e-03 | -1.43e-01 | 0.040800 |
| RUNX1 INTERACTS WITH CO FACTORS WHOSE PRECISE EFFECT ON RUNX1 TARGETS IS NOT KNOWN | 37 | 1.33e-01 | 1.43e-01 | 0.430000 |
| REGULATION OF RUNX3 EXPRESSION AND ACTIVITY | 53 | 7.29e-02 | -1.42e-01 | 0.312000 |
| CALNEXIN CALRETICULIN CYCLE | 26 | 2.09e-01 | -1.42e-01 | 0.522000 |
| TERMINATION OF TRANSLESION DNA SYNTHESIS | 31 | 1.70e-01 | -1.42e-01 | 0.475000 |
| HEME BIOSYNTHESIS | 13 | 3.74e-01 | 1.42e-01 | 0.694000 |
| BLOOD GROUP SYSTEMS BIOSYNTHESIS | 12 | 3.93e-01 | -1.42e-01 | 0.708000 |
| HDR THROUGH SINGLE STRAND ANNEALING SSA | 36 | 1.40e-01 | -1.42e-01 | 0.439000 |
| SHC1 EVENTS IN ERBB4 SIGNALING | 12 | 3.95e-01 | -1.42e-01 | 0.709000 |
| CD28 CO STIMULATION | 30 | 1.80e-01 | -1.42e-01 | 0.484000 |
| PI 3K CASCADE FGFR1 | 14 | 3.60e-01 | -1.41e-01 | 0.694000 |
| LONG TERM POTENTIATION | 23 | 2.41e-01 | 1.41e-01 | 0.561000 |
| CELLULAR RESPONSE TO HYPOXIA | 72 | 3.85e-02 | -1.41e-01 | 0.233000 |
| REGULATION OF RAS BY GAPS | 67 | 4.63e-02 | -1.41e-01 | 0.262000 |
| TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | 85 | 2.51e-02 | 1.41e-01 | 0.175000 |
| RAC1 GTPASE CYCLE | 176 | 1.40e-03 | 1.40e-01 | 0.037600 |
| PYRIMIDINE SALVAGE | 10 | 4.44e-01 | 1.40e-01 | 0.750000 |
| ROLE OF LAT2 NTAL LAB ON CALCIUM MOBILIZATION | 14 | 3.69e-01 | -1.39e-01 | 0.694000 |
| MICRORNA MIRNA BIOGENESIS | 24 | 2.40e-01 | 1.39e-01 | 0.561000 |
| SIGNALING BY NOTCH1 | 75 | 3.84e-02 | 1.38e-01 | 0.233000 |
| RIPK1 MEDIATED REGULATED NECROSIS | 25 | 2.32e-01 | -1.38e-01 | 0.553000 |
| SIGNALING BY CYTOSOLIC FGFR1 FUSION MUTANTS | 18 | 3.11e-01 | -1.38e-01 | 0.650000 |
| TRANSLESION SYNTHESIS BY Y FAMILY DNA POLYMERASES BYPASSES LESIONS ON DNA TEMPLATE | 38 | 1.42e-01 | -1.38e-01 | 0.441000 |
| FGFR2 LIGAND BINDING AND ACTIVATION | 11 | 4.29e-01 | -1.38e-01 | 0.738000 |
| SENSORY PROCESSING OF SOUND | 61 | 6.30e-02 | 1.38e-01 | 0.297000 |
| G BETA GAMMA SIGNALLING THROUGH PI3KGAMMA | 23 | 2.55e-01 | -1.37e-01 | 0.579000 |
| MITOTIC METAPHASE AND ANAPHASE | 206 | 7.01e-04 | -1.37e-01 | 0.031500 |
| SODIUM CALCIUM EXCHANGERS | 10 | 4.53e-01 | -1.37e-01 | 0.757000 |
| INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | 13 | 3.93e-01 | -1.37e-01 | 0.708000 |
| HIV ELONGATION ARREST AND RECOVERY | 32 | 1.82e-01 | 1.36e-01 | 0.486000 |
| SEMAPHORIN INTERACTIONS | 64 | 5.95e-02 | 1.36e-01 | 0.288000 |
| PHOSPHOLIPID METABOLISM | 185 | 1.41e-03 | 1.36e-01 | 0.037600 |
| SELENOAMINO ACID METABOLISM | 109 | 1.41e-02 | -1.36e-01 | 0.128000 |
| FANCONI ANEMIA PATHWAY | 36 | 1.58e-01 | 1.36e-01 | 0.465000 |
| ONCOGENE INDUCED SENESCENCE | 32 | 1.84e-01 | 1.36e-01 | 0.488000 |
| TCR SIGNALING | 102 | 1.83e-02 | -1.35e-01 | 0.144000 |
| ADHERENS JUNCTIONS INTERACTIONS | 29 | 2.08e-01 | -1.35e-01 | 0.522000 |
| VOLTAGE GATED POTASSIUM CHANNELS | 40 | 1.39e-01 | 1.35e-01 | 0.437000 |
| NONSENSE MEDIATED DECAY NMD | 109 | 1.53e-02 | -1.35e-01 | 0.136000 |
| PROLONGED ERK ACTIVATION EVENTS | 13 | 4.02e-01 | -1.34e-01 | 0.716000 |
| G PROTEIN BETA GAMMA SIGNALLING | 30 | 2.05e-01 | -1.34e-01 | 0.517000 |
| INLB MEDIATED ENTRY OF LISTERIA MONOCYTOGENES INTO HOST CELL | 15 | 3.70e-01 | -1.34e-01 | 0.694000 |
| CHROMATIN MODIFYING ENZYMES | 218 | 6.84e-04 | 1.34e-01 | 0.031500 |
| MEIOTIC RECOMBINATION | 38 | 1.54e-01 | -1.34e-01 | 0.460000 |
| CLEC7A DECTIN 1 SIGNALING | 95 | 2.45e-02 | -1.34e-01 | 0.174000 |
| C TYPE LECTIN RECEPTORS CLRS | 114 | 1.41e-02 | -1.33e-01 | 0.128000 |
| GOLGI ASSOCIATED VESICLE BIOGENESIS | 54 | 9.32e-02 | -1.32e-01 | 0.356000 |
| AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | 14 | 3.94e-01 | 1.32e-01 | 0.708000 |
| PROCESSING OF INTRONLESS PRE MRNAS | 19 | 3.21e-01 | -1.32e-01 | 0.658000 |
| DAP12 INTERACTIONS | 29 | 2.20e-01 | -1.32e-01 | 0.534000 |
| DECTIN 1 MEDIATED NONCANONICAL NF KB SIGNALING | 60 | 7.83e-02 | -1.31e-01 | 0.327000 |
| GLYCOSAMINOGLYCAN METABOLISM | 114 | 1.56e-02 | 1.31e-01 | 0.137000 |
| RHOC GTPASE CYCLE | 73 | 5.26e-02 | 1.31e-01 | 0.278000 |
| N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | 35 | 1.80e-01 | -1.31e-01 | 0.484000 |
| SHC MEDIATED CASCADE FGFR3 | 13 | 4.14e-01 | -1.31e-01 | 0.726000 |
| CA2 PATHWAY | 56 | 9.03e-02 | -1.31e-01 | 0.354000 |
| PROCESSING OF DNA DOUBLE STRAND BREAK ENDS | 71 | 5.69e-02 | -1.31e-01 | 0.286000 |
| DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | 23 | 2.78e-01 | 1.31e-01 | 0.612000 |
| HOST INTERACTIONS OF HIV FACTORS | 124 | 1.21e-02 | -1.31e-01 | 0.115000 |
| EXTRA NUCLEAR ESTROGEN SIGNALING | 65 | 6.87e-02 | -1.31e-01 | 0.308000 |
| RAS ACTIVATION UPON CA2 INFLUX THROUGH NMDA RECEPTOR | 20 | 3.13e-01 | 1.30e-01 | 0.652000 |
| EUKARYOTIC TRANSLATION ELONGATION | 87 | 3.69e-02 | -1.29e-01 | 0.227000 |
| FOXO MEDIATED TRANSCRIPTION OF OXIDATIVE STRESS METABOLIC AND NEURONAL GENES | 23 | 2.83e-01 | -1.29e-01 | 0.618000 |
| DSCAM INTERACTIONS | 10 | 4.83e-01 | 1.28e-01 | 0.781000 |
| HCMV EARLY EVENTS | 80 | 4.77e-02 | 1.28e-01 | 0.266000 |
| SPRY REGULATION OF FGF SIGNALING | 16 | 3.75e-01 | 1.28e-01 | 0.694000 |
| JOSEPHIN DOMAIN DUBS | 11 | 4.63e-01 | 1.28e-01 | 0.766000 |
| STIMULI SENSING CHANNELS | 74 | 5.76e-02 | 1.28e-01 | 0.286000 |
| L1CAM INTERACTIONS | 107 | 2.27e-02 | 1.28e-01 | 0.165000 |
| RHOA GTPASE CYCLE | 141 | 9.15e-03 | 1.27e-01 | 0.106000 |
| COSTIMULATION BY THE CD28 FAMILY | 49 | 1.24e-01 | -1.27e-01 | 0.415000 |
| ASSEMBLY OF THE HIV VIRION | 16 | 3.79e-01 | 1.27e-01 | 0.698000 |
| SIGNALING BY MODERATE KINASE ACTIVITY BRAF MUTANTS | 41 | 1.61e-01 | 1.26e-01 | 0.467000 |
| INFLUENZA INFECTION | 145 | 8.79e-03 | -1.26e-01 | 0.103000 |
| PLASMA LIPOPROTEIN REMODELING | 15 | 3.99e-01 | 1.26e-01 | 0.711000 |
| ER TO GOLGI ANTEROGRADE TRANSPORT | 139 | 1.05e-02 | 1.26e-01 | 0.111000 |
| METABOLISM OF PORPHYRINS | 19 | 3.44e-01 | 1.26e-01 | 0.677000 |
| NOTCH3 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | 23 | 2.98e-01 | 1.25e-01 | 0.640000 |
| ACETYLCHOLINE REGULATES INSULIN SECRETION | 10 | 4.94e-01 | 1.25e-01 | 0.783000 |
| STING MEDIATED INDUCTION OF HOST IMMUNE RESPONSES | 14 | 4.19e-01 | 1.25e-01 | 0.727000 |
| GLUCOSE METABOLISM | 80 | 5.48e-02 | 1.24e-01 | 0.279000 |
| G ALPHA S SIGNALLING EVENTS | 98 | 3.50e-02 | 1.23e-01 | 0.219000 |
| METABOLISM OF COFACTORS | 18 | 3.66e-01 | -1.23e-01 | 0.694000 |
| IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | 22 | 3.18e-01 | -1.23e-01 | 0.656000 |
| ACYL CHAIN REMODELLING OF PS | 14 | 4.27e-01 | 1.23e-01 | 0.737000 |
| EPH EPHRIN MEDIATED REPULSION OF CELLS | 51 | 1.30e-01 | 1.23e-01 | 0.422000 |
| CYCLIN A B1 B2 ASSOCIATED EVENTS DURING G2 M TRANSITION | 22 | 3.20e-01 | -1.23e-01 | 0.658000 |
| FRS MEDIATED FGFR1 SIGNALING | 16 | 3.96e-01 | -1.23e-01 | 0.709000 |
| APC C CDC20 MEDIATED DEGRADATION OF CYCLIN B | 21 | 3.33e-01 | -1.22e-01 | 0.667000 |
| TRANSCRIPTION OF E2F TARGETS UNDER NEGATIVE CONTROL BY DREAM COMPLEX | 18 | 3.70e-01 | -1.22e-01 | 0.694000 |
| INTERLEUKIN 4 AND INTERLEUKIN 13 SIGNALING | 80 | 5.92e-02 | -1.22e-01 | 0.288000 |
| METABOLISM OF ANGIOTENSINOGEN TO ANGIOTENSINS | 10 | 5.05e-01 | -1.22e-01 | 0.787000 |
| SIGNALING BY NOTCH1 PEST DOMAIN MUTANTS IN CANCER | 59 | 1.06e-01 | 1.22e-01 | 0.382000 |
| NF KB ACTIVATION THROUGH FADD RIP 1 PATHWAY MEDIATED BY CASPASE 8 AND 10 | 11 | 4.86e-01 | -1.21e-01 | 0.782000 |
| TRAFFICKING OF AMPA RECEPTORS | 31 | 2.43e-01 | 1.21e-01 | 0.565000 |
| N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI | 24 | 3.05e-01 | 1.21e-01 | 0.644000 |
| TRANSCRIPTIONAL REGULATION OF GRANULOPOIESIS | 44 | 1.66e-01 | 1.21e-01 | 0.473000 |
| SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | 15 | 4.18e-01 | 1.21e-01 | 0.727000 |
| DOWNSTREAM SIGNALING OF ACTIVATED FGFR4 | 18 | 3.76e-01 | -1.21e-01 | 0.694000 |
| CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | 11 | 4.89e-01 | 1.21e-01 | 0.782000 |
| MISMATCH REPAIR | 14 | 4.35e-01 | -1.20e-01 | 0.743000 |
| PI 3K CASCADE FGFR3 | 13 | 4.52e-01 | -1.20e-01 | 0.757000 |
| ERCC6 CSB AND EHMT2 G9A POSITIVELY REGULATE RRNA EXPRESSION | 32 | 2.39e-01 | 1.20e-01 | 0.561000 |
| ENOS ACTIVATION | 11 | 4.91e-01 | -1.20e-01 | 0.782000 |
| TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | 77 | 6.87e-02 | 1.20e-01 | 0.308000 |
| TP53 REGULATES TRANSCRIPTION OF SEVERAL ADDITIONAL CELL DEATH GENES WHOSE SPECIFIC ROLES IN P53 DEPENDENT APOPTOSIS REMAIN UNCERTAIN | 12 | 4.72e-01 | 1.20e-01 | 0.772000 |
| IRON UPTAKE AND TRANSPORT | 51 | 1.41e-01 | -1.19e-01 | 0.441000 |
| O LINKED GLYCOSYLATION OF MUCINS | 42 | 1.82e-01 | 1.19e-01 | 0.486000 |
| P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | 12 | 4.76e-01 | 1.19e-01 | 0.776000 |
| TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | 17 | 3.97e-01 | 1.19e-01 | 0.709000 |
| OXIDATIVE STRESS INDUCED SENESCENCE | 78 | 7.02e-02 | 1.19e-01 | 0.310000 |
| LISTERIA MONOCYTOGENES ENTRY INTO HOST CELLS | 19 | 3.71e-01 | -1.19e-01 | 0.694000 |
| PYRUVATE METABOLISM AND CITRIC ACID TCA CYCLE | 51 | 1.44e-01 | -1.18e-01 | 0.444000 |
| CRISTAE FORMATION | 31 | 2.56e-01 | -1.18e-01 | 0.580000 |
| MITOCHONDRIAL IRON SULFUR CLUSTER BIOGENESIS | 13 | 4.63e-01 | 1.18e-01 | 0.766000 |
| TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | 16 | 4.15e-01 | 1.18e-01 | 0.727000 |
| SYNTHESIS OF IP2 IP AND INS IN THE CYTOSOL | 13 | 4.65e-01 | 1.17e-01 | 0.766000 |
| UPTAKE AND FUNCTION OF ANTHRAX TOXINS | 11 | 5.02e-01 | 1.17e-01 | 0.787000 |
| OTHER SEMAPHORIN INTERACTIONS | 19 | 3.81e-01 | 1.16e-01 | 0.698000 |
| MEIOSIS | 64 | 1.09e-01 | -1.16e-01 | 0.383000 |
| CASPASE ACTIVATION VIA DEATH RECEPTORS IN THE PRESENCE OF LIGAND | 14 | 4.53e-01 | -1.16e-01 | 0.757000 |
| SIGNALING BY ERBB2 IN CANCER | 24 | 3.27e-01 | -1.16e-01 | 0.666000 |
| ASSEMBLY OF ACTIVE LPL AND LIPC LIPASE COMPLEXES | 10 | 5.27e-01 | 1.16e-01 | 0.805000 |
| TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | 168 | 9.86e-03 | 1.16e-01 | 0.109000 |
| REGULATION OF TNFR1 SIGNALING | 34 | 2.44e-01 | 1.15e-01 | 0.566000 |
| PEROXISOMAL LIPID METABOLISM | 26 | 3.10e-01 | -1.15e-01 | 0.649000 |
| HIV INFECTION | 220 | 3.36e-03 | -1.15e-01 | 0.059600 |
| NETRIN 1 SIGNALING | 48 | 1.70e-01 | 1.14e-01 | 0.475000 |
| HDMS DEMETHYLATE HISTONES | 27 | 3.04e-01 | 1.14e-01 | 0.644000 |
| SIGNALING BY ERBB4 | 56 | 1.39e-01 | -1.14e-01 | 0.437000 |
| FCERI MEDIATED MAPK ACTIVATION | 28 | 2.95e-01 | -1.14e-01 | 0.638000 |
| SUMOYLATION OF DNA DAMAGE RESPONSE AND REPAIR PROTEINS | 73 | 9.23e-02 | -1.14e-01 | 0.356000 |
| IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | 45 | 1.87e-01 | -1.14e-01 | 0.493000 |
| POSTMITOTIC NUCLEAR PORE COMPLEX NPC REFORMATION | 26 | 3.16e-01 | -1.14e-01 | 0.654000 |
| CARGO TRAFFICKING TO THE PERICILIARY MEMBRANE | 49 | 1.69e-01 | -1.14e-01 | 0.475000 |
| DISEASES OF DNA REPAIR | 11 | 5.16e-01 | -1.13e-01 | 0.795000 |
| METABOLISM OF CARBOHYDRATES | 257 | 1.94e-03 | 1.12e-01 | 0.043800 |
| DEADENYLATION DEPENDENT MRNA DECAY | 55 | 1.49e-01 | -1.12e-01 | 0.452000 |
| INFLAMMASOMES | 19 | 3.97e-01 | -1.12e-01 | 0.709000 |
| SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | 13 | 4.83e-01 | 1.12e-01 | 0.781000 |
| TRAF6 MEDIATED INDUCTION OF TAK1 COMPLEX WITHIN TLR4 COMPLEX | 16 | 4.39e-01 | 1.12e-01 | 0.744000 |
| RESPIRATORY ELECTRON TRANSPORT | 102 | 5.13e-02 | -1.12e-01 | 0.278000 |
| SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | 11 | 5.22e-01 | -1.12e-01 | 0.801000 |
| SULFUR AMINO ACID METABOLISM | 22 | 3.65e-01 | 1.12e-01 | 0.694000 |
| SLC MEDIATED TRANSMEMBRANE TRANSPORT | 186 | 8.77e-03 | 1.12e-01 | 0.103000 |
| HEPARAN SULFATE HEPARIN HS GAG METABOLISM | 52 | 1.65e-01 | 1.11e-01 | 0.471000 |
| SIGNALING BY ROBO RECEPTORS | 206 | 6.05e-03 | -1.11e-01 | 0.085300 |
| RESOLUTION OF SISTER CHROMATID COHESION | 101 | 5.40e-02 | -1.11e-01 | 0.278000 |
| SHC1 EVENTS IN EGFR SIGNALING | 10 | 5.47e-01 | -1.10e-01 | 0.812000 |
| ABC TRANSPORTER DISORDERS | 69 | 1.15e-01 | -1.10e-01 | 0.397000 |
| HATS ACETYLATE HISTONES | 92 | 6.94e-02 | 1.10e-01 | 0.309000 |
| PROGRAMMED CELL DEATH | 188 | 9.87e-03 | -1.09e-01 | 0.109000 |
| MAP2K AND MAPK ACTIVATION | 36 | 2.58e-01 | 1.09e-01 | 0.582000 |
| DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | 37 | 2.56e-01 | -1.08e-01 | 0.580000 |
| PENTOSE PHOSPHATE PATHWAY | 13 | 5.02e-01 | -1.07e-01 | 0.787000 |
| DOWNSTREAM SIGNALING OF ACTIVATED FGFR2 | 23 | 3.74e-01 | -1.07e-01 | 0.694000 |
| ERKS ARE INACTIVATED | 13 | 5.04e-01 | 1.07e-01 | 0.787000 |
| PI METABOLISM | 79 | 1.01e-01 | 1.07e-01 | 0.376000 |
| BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN GENE EXPRESSION | 26 | 3.47e-01 | 1.06e-01 | 0.679000 |
| IL 6 TYPE CYTOKINE RECEPTOR LIGAND INTERACTIONS | 14 | 4.92e-01 | 1.06e-01 | 0.782000 |
| PROCESSIVE SYNTHESIS ON THE C STRAND OF THE TELOMERE | 19 | 4.23e-01 | -1.06e-01 | 0.733000 |
| THE CITRIC ACID TCA CYCLE AND RESPIRATORY ELECTRON TRANSPORT | 172 | 1.69e-02 | -1.06e-01 | 0.143000 |
| INTEGRATION OF ENERGY METABOLISM | 97 | 7.26e-02 | 1.06e-01 | 0.312000 |
| UNFOLDED PROTEIN RESPONSE UPR | 85 | 9.31e-02 | 1.05e-01 | 0.356000 |
| RHO GTPASES ACTIVATE NADPH OXIDASES | 18 | 4.43e-01 | 1.04e-01 | 0.750000 |
| DEGRADATION OF BETA CATENIN BY THE DESTRUCTION COMPLEX | 83 | 1.00e-01 | -1.04e-01 | 0.375000 |
| SYNTHESIS OF PROSTAGLANDINS PG AND THROMBOXANES TX | 13 | 5.15e-01 | -1.04e-01 | 0.795000 |
| PERK REGULATES GENE EXPRESSION | 28 | 3.40e-01 | -1.04e-01 | 0.676000 |
| PKMTS METHYLATE HISTONE LYSINES | 48 | 2.13e-01 | 1.04e-01 | 0.525000 |
| FREE FATTY ACIDS REGULATE INSULIN SECRETION | 10 | 5.70e-01 | -1.04e-01 | 0.829000 |
| DDX58 IFIH1 MEDIATED INDUCTION OF INTERFERON ALPHA BETA | 62 | 1.59e-01 | -1.04e-01 | 0.465000 |
| PHASE II CONJUGATION OF COMPOUNDS | 61 | 1.62e-01 | -1.04e-01 | 0.467000 |
| G0 AND EARLY G1 | 25 | 3.71e-01 | -1.03e-01 | 0.694000 |
| FRS MEDIATED FGFR3 SIGNALING | 15 | 4.89e-01 | -1.03e-01 | 0.782000 |
| GLYCOGEN STORAGE DISEASES | 12 | 5.37e-01 | 1.03e-01 | 0.811000 |
| ACTIVATION OF MATRIX METALLOPROTEINASES | 15 | 4.90e-01 | 1.03e-01 | 0.782000 |
| REGULATED PROTEOLYSIS OF P75NTR | 12 | 5.37e-01 | 1.03e-01 | 0.811000 |
| METALLOPROTEASE DUBS | 26 | 3.66e-01 | -1.02e-01 | 0.694000 |
| ACTIVATION OF ANTERIOR HOX GENES IN HINDBRAIN DEVELOPMENT DURING EARLY EMBRYOGENESIS | 66 | 1.50e-01 | 1.02e-01 | 0.454000 |
| HCMV INFECTION | 103 | 7.34e-02 | 1.02e-01 | 0.312000 |
| APOPTOSIS | 166 | 2.33e-02 | -1.02e-01 | 0.168000 |
| IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | 10 | 5.77e-01 | -1.02e-01 | 0.831000 |
| FCERI MEDIATED CA 2 MOBILIZATION | 26 | 3.69e-01 | -1.02e-01 | 0.694000 |
| TRANSLATION | 286 | 3.25e-03 | -1.01e-01 | 0.059000 |
| TRANSCRIPTIONAL REGULATION BY RUNX2 | 111 | 6.58e-02 | -1.01e-01 | 0.306000 |
| REPRODUCTION | 76 | 1.28e-01 | -1.01e-01 | 0.418000 |
| DETOXIFICATION OF REACTIVE OXYGEN SPECIES | 31 | 3.32e-01 | -1.01e-01 | 0.667000 |
| EPHRIN SIGNALING | 19 | 4.49e-01 | 1.00e-01 | 0.755000 |
| CARDIAC CONDUCTION | 108 | 7.23e-02 | 1.00e-01 | 0.312000 |
| RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | 125 | 5.45e-02 | -9.96e-02 | 0.279000 |
| RND3 GTPASE CYCLE | 38 | 2.89e-01 | 9.95e-02 | 0.628000 |
| TNFS BIND THEIR PHYSIOLOGICAL RECEPTORS | 15 | 5.05e-01 | 9.94e-02 | 0.787000 |
| NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | 48 | 2.35e-01 | 9.91e-02 | 0.557000 |
| LYSINE CATABOLISM | 10 | 5.88e-01 | 9.91e-02 | 0.835000 |
| SIGNALING BY FGFR2 IN DISEASE | 36 | 3.05e-01 | -9.88e-02 | 0.644000 |
| NEGATIVE REGULATION OF MAPK PATHWAY | 42 | 2.68e-01 | 9.88e-02 | 0.597000 |
| INACTIVATION OF CSF3 G CSF SIGNALING | 24 | 4.02e-01 | -9.87e-02 | 0.716000 |
| TNF SIGNALING | 43 | 2.64e-01 | 9.84e-02 | 0.593000 |
| LAGGING STRAND SYNTHESIS | 20 | 4.47e-01 | -9.82e-02 | 0.754000 |
| ABC TRANSPORTERS IN LIPID HOMEOSTASIS | 13 | 5.40e-01 | 9.81e-02 | 0.811000 |
| MRNA SPLICING | 188 | 2.09e-02 | -9.78e-02 | 0.157000 |
| RND2 GTPASE CYCLE | 38 | 2.97e-01 | 9.77e-02 | 0.640000 |
| SYNTHESIS OF PYROPHOSPHATES IN THE CYTOSOL | 10 | 5.94e-01 | 9.74e-02 | 0.838000 |
| RHOH GTPASE CYCLE | 37 | 3.06e-01 | -9.72e-02 | 0.645000 |
| PLASMA LIPOPROTEIN ASSEMBLY | 11 | 5.77e-01 | -9.71e-02 | 0.831000 |
| REGULATION OF MECP2 EXPRESSION AND ACTIVITY | 30 | 3.57e-01 | 9.71e-02 | 0.694000 |
| RRNA PROCESSING | 194 | 2.00e-02 | -9.70e-02 | 0.156000 |
| COPI INDEPENDENT GOLGI TO ER RETROGRADE TRAFFIC | 44 | 2.70e-01 | 9.61e-02 | 0.600000 |
| DISEASES OF MITOTIC CELL CYCLE | 37 | 3.13e-01 | -9.58e-02 | 0.653000 |
| TRANS GOLGI NETWORK VESICLE BUDDING | 69 | 1.69e-01 | -9.57e-02 | 0.475000 |
| CELLULAR RESPONSE TO STARVATION | 145 | 4.70e-02 | -9.56e-02 | 0.265000 |
| PROCESSING OF CAPPED INTRON CONTAINING PRE MRNA | 237 | 1.13e-02 | -9.56e-02 | 0.112000 |
| ACTIVATION OF NMDA RECEPTORS AND POSTSYNAPTIC EVENTS | 83 | 1.33e-01 | 9.55e-02 | 0.429000 |
| THROMBOXANE SIGNALLING THROUGH TP RECEPTOR | 22 | 4.38e-01 | -9.55e-02 | 0.744000 |
| SIGNAL AMPLIFICATION | 30 | 3.66e-01 | -9.54e-02 | 0.694000 |
| TRANSCRIPTION OF THE HIV GENOME | 67 | 1.78e-01 | -9.53e-02 | 0.483000 |
| SIGNALING BY CSF3 G CSF | 29 | 3.75e-01 | -9.52e-02 | 0.694000 |
| CLASS I MHC MEDIATED ANTIGEN PROCESSING PRESENTATION | 344 | 2.53e-03 | -9.50e-02 | 0.052000 |
| TRANSLATION OF SARS COV 1 STRUCTURAL PROTEINS | 28 | 3.85e-01 | 9.49e-02 | 0.703000 |
| TP53 REGULATES TRANSCRIPTION OF CASPASE ACTIVATORS AND CASPASES | 11 | 5.86e-01 | -9.48e-02 | 0.835000 |
| DEACTIVATION OF THE BETA CATENIN TRANSACTIVATING COMPLEX | 41 | 2.94e-01 | 9.47e-02 | 0.636000 |
| TAK1 ACTIVATES NFKB BY PHOSPHORYLATION AND ACTIVATION OF IKKS COMPLEX | 30 | 3.69e-01 | 9.47e-02 | 0.694000 |
| SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | 16 | 5.13e-01 | -9.44e-02 | 0.795000 |
| HDR THROUGH HOMOLOGOUS RECOMBINATION HRR | 63 | 1.95e-01 | -9.44e-02 | 0.505000 |
| DEREGULATED CDK5 TRIGGERS MULTIPLE NEURODEGENERATIVE PATHWAYS IN ALZHEIMER S DISEASE MODELS | 19 | 4.76e-01 | 9.44e-02 | 0.776000 |
| ZINC TRANSPORTERS | 16 | 5.18e-01 | -9.34e-02 | 0.797000 |
| MAPK6 MAPK4 SIGNALING | 84 | 1.39e-01 | -9.34e-02 | 0.437000 |
| SIGNALING BY PDGF | 57 | 2.23e-01 | 9.34e-02 | 0.536000 |
| INTRA GOLGI TRAFFIC | 43 | 2.90e-01 | 9.33e-02 | 0.628000 |
| PREGNENOLONE BIOSYNTHESIS | 12 | 5.77e-01 | 9.30e-02 | 0.831000 |
| DEPOLYMERISATION OF THE NUCLEAR LAMINA | 13 | 5.63e-01 | 9.28e-02 | 0.827000 |
| ABC FAMILY PROTEINS MEDIATED TRANSPORT | 93 | 1.23e-01 | -9.25e-02 | 0.414000 |
| FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | 18 | 4.97e-01 | -9.24e-02 | 0.784000 |
| RUNX2 REGULATES BONE DEVELOPMENT | 29 | 3.91e-01 | 9.21e-02 | 0.707000 |
| PLASMA LIPOPROTEIN ASSEMBLY REMODELING AND CLEARANCE | 49 | 2.65e-01 | 9.21e-02 | 0.593000 |
| FCGAMMA RECEPTOR FCGR DEPENDENT PHAGOCYTOSIS | 81 | 1.53e-01 | 9.19e-02 | 0.460000 |
| ION CHANNEL TRANSPORT | 139 | 6.32e-02 | 9.14e-02 | 0.297000 |
| SENESCENCE ASSOCIATED SECRETORY PHENOTYPE SASP | 63 | 2.11e-01 | 9.13e-02 | 0.523000 |
| GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | 19 | 4.92e-01 | -9.11e-02 | 0.782000 |
| NS1 MEDIATED EFFECTS ON HOST PATHWAYS | 37 | 3.39e-01 | -9.09e-02 | 0.675000 |
| SELECTIVE AUTOPHAGY | 71 | 1.88e-01 | 9.05e-02 | 0.493000 |
| METAL ION SLC TRANSPORTERS | 25 | 4.34e-01 | -9.04e-02 | 0.743000 |
| DNA DAMAGE RECOGNITION IN GG NER | 38 | 3.35e-01 | 9.04e-02 | 0.669000 |
| M PHASE | 339 | 4.38e-03 | -9.02e-02 | 0.067100 |
| DISASSEMBLY OF THE DESTRUCTION COMPLEX AND RECRUITMENT OF AXIN TO THE MEMBRANE | 27 | 4.18e-01 | 9.01e-02 | 0.727000 |
| CYCLIN D ASSOCIATED EVENTS IN G1 | 45 | 2.97e-01 | -9.00e-02 | 0.639000 |
| METABOLISM OF RNA | 644 | 1.07e-04 | -8.99e-02 | 0.010400 |
| METABOLISM OF WATER SOLUBLE VITAMINS AND COFACTORS | 101 | 1.19e-01 | 8.98e-02 | 0.409000 |
| PINK1 PRKN MEDIATED MITOPHAGY | 22 | 4.66e-01 | -8.97e-02 | 0.768000 |
| SIGNALING BY PTK6 | 50 | 2.73e-01 | 8.97e-02 | 0.603000 |
| TELOMERE C STRAND LAGGING STRAND SYNTHESIS | 33 | 3.74e-01 | -8.94e-02 | 0.694000 |
| ION HOMEOSTASIS | 49 | 2.80e-01 | 8.92e-02 | 0.614000 |
| UNBLOCKING OF NMDA RECEPTORS GLUTAMATE BINDING AND ACTIVATION | 21 | 4.80e-01 | 8.91e-02 | 0.779000 |
| CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | 31 | 3.91e-01 | 8.90e-02 | 0.707000 |
| PROLACTIN RECEPTOR SIGNALING | 11 | 6.11e-01 | -8.86e-02 | 0.845000 |
| FLT3 SIGNALING IN DISEASE | 27 | 4.27e-01 | -8.84e-02 | 0.737000 |
| PHASE 0 RAPID DEPOLARISATION | 29 | 4.11e-01 | 8.83e-02 | 0.724000 |
| IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX | 10 | 6.30e-01 | 8.81e-02 | 0.860000 |
| INTERLEUKIN 7 SIGNALING | 20 | 4.96e-01 | 8.80e-02 | 0.784000 |
| CELL CYCLE | 593 | 2.74e-04 | -8.78e-02 | 0.017400 |
| PURINE SALVAGE | 12 | 5.99e-01 | -8.78e-02 | 0.838000 |
| METABOLISM OF AMINO ACIDS AND DERIVATIVES | 314 | 7.76e-03 | -8.76e-02 | 0.098600 |
| SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | 52 | 2.77e-01 | 8.72e-02 | 0.611000 |
| OTHER INTERLEUKIN SIGNALING | 19 | 5.13e-01 | 8.66e-02 | 0.795000 |
| AMYLOID FIBER FORMATION | 57 | 2.60e-01 | 8.63e-02 | 0.585000 |
| SIGNALING BY BRAF AND RAF FUSIONS | 60 | 2.52e-01 | 8.55e-02 | 0.578000 |
| SIGNALING BY TGFB FAMILY MEMBERS | 96 | 1.49e-01 | -8.52e-02 | 0.452000 |
| DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | 23 | 4.80e-01 | -8.50e-02 | 0.779000 |
| TELOMERE C STRAND SYNTHESIS INITIATION | 13 | 5.96e-01 | -8.49e-02 | 0.838000 |
| G1 S SPECIFIC TRANSCRIPTION | 26 | 4.55e-01 | -8.47e-02 | 0.758000 |
| ONCOGENIC MAPK SIGNALING | 77 | 1.99e-01 | 8.46e-02 | 0.511000 |
| INITIATION OF NUCLEAR ENVELOPE NE REFORMATION | 17 | 5.46e-01 | -8.46e-02 | 0.811000 |
| SIGNALING BY NTRKS | 129 | 9.75e-02 | 8.46e-02 | 0.370000 |
| RNA POLYMERASE II TRANSCRIPTION TERMINATION | 65 | 2.40e-01 | -8.44e-02 | 0.561000 |
| TP53 REGULATES TRANSCRIPTION OF GENES INVOLVED IN CYTOCHROME C RELEASE | 19 | 5.27e-01 | 8.39e-02 | 0.805000 |
| CELL CYCLE MITOTIC | 475 | 1.86e-03 | -8.36e-02 | 0.043300 |
| FORMATION OF THE EARLY ELONGATION COMPLEX | 33 | 4.06e-01 | 8.36e-02 | 0.719000 |
| GAP JUNCTION DEGRADATION | 11 | 6.31e-01 | 8.35e-02 | 0.860000 |
| DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | 26 | 4.62e-01 | -8.34e-02 | 0.766000 |
| DAP12 SIGNALING | 24 | 4.80e-01 | -8.33e-02 | 0.779000 |
| NUCLEOBASE CATABOLISM | 31 | 4.23e-01 | -8.31e-02 | 0.733000 |
| SPHINGOLIPID DE NOVO BIOSYNTHESIS | 42 | 3.52e-01 | -8.31e-02 | 0.686000 |
| RESOLUTION OF D LOOP STRUCTURES | 30 | 4.32e-01 | -8.30e-02 | 0.741000 |
| DEFECTS IN VITAMIN AND COFACTOR METABOLISM | 20 | 5.24e-01 | 8.24e-02 | 0.803000 |
| APOPTOTIC FACTOR MEDIATED RESPONSE | 18 | 5.46e-01 | -8.22e-02 | 0.811000 |
| INTEGRIN CELL SURFACE INTERACTIONS | 71 | 2.35e-01 | 8.16e-02 | 0.557000 |
| DISEASES ASSOCIATED WITH N GLYCOSYLATION OF PROTEINS | 17 | 5.60e-01 | 8.16e-02 | 0.827000 |
| TNFR1 INDUCED PROAPOPTOTIC SIGNALING | 12 | 6.25e-01 | 8.16e-02 | 0.858000 |
| VEGFR2 MEDIATED CELL PROLIFERATION | 19 | 5.39e-01 | -8.15e-02 | 0.811000 |
| RHO GTPASES ACTIVATE CIT | 18 | 5.51e-01 | 8.12e-02 | 0.815000 |
| TRANSCRIPTIONAL REGULATION BY VENTX | 35 | 4.06e-01 | 8.12e-02 | 0.719000 |
| MUSCLE CONTRACTION | 163 | 7.43e-02 | 8.11e-02 | 0.314000 |
| REGULATION OF TP53 ACTIVITY THROUGH PHOSPHORYLATION | 87 | 1.92e-01 | -8.10e-02 | 0.501000 |
| TRANSCRIPTION OF E2F TARGETS UNDER NEGATIVE CONTROL BY P107 RBL1 AND P130 RBL2 IN COMPLEX WITH HDAC1 | 15 | 5.87e-01 | -8.10e-02 | 0.835000 |
| INWARDLY RECTIFYING K CHANNELS | 31 | 4.35e-01 | -8.09e-02 | 0.743000 |
| ACYL CHAIN REMODELLING OF PG | 10 | 6.58e-01 | -8.08e-02 | 0.877000 |
| GLUCAGON TYPE LIGAND RECEPTORS | 25 | 4.85e-01 | -8.07e-02 | 0.782000 |
| METABOLISM OF VITAMINS AND COFACTORS | 150 | 8.87e-02 | 8.06e-02 | 0.353000 |
| DAG AND IP3 SIGNALING | 40 | 3.79e-01 | 8.04e-02 | 0.698000 |
| INTERLEUKIN 1 SIGNALING | 96 | 1.75e-01 | -8.02e-02 | 0.479000 |
| PECAM1 INTERACTIONS | 12 | 6.31e-01 | 8.02e-02 | 0.860000 |
| RECOGNITION AND ASSOCIATION OF DNA GLYCOSYLASE WITH SITE CONTAINING AN AFFECTED PURINE | 22 | 5.15e-01 | 8.01e-02 | 0.795000 |
| LDL CLEARANCE | 16 | 5.80e-01 | 8.00e-02 | 0.831000 |
| GLYOXYLATE METABOLISM AND GLYCINE DEGRADATION | 25 | 4.89e-01 | -8.00e-02 | 0.782000 |
| GLYCOSPHINGOLIPID METABOLISM | 39 | 3.89e-01 | 7.98e-02 | 0.707000 |
| INSULIN RECEPTOR RECYCLING | 20 | 5.37e-01 | -7.97e-02 | 0.811000 |
| PROCESSING OF CAPPED INTRONLESS PRE MRNA | 28 | 4.69e-01 | -7.91e-02 | 0.770000 |
| REGULATION OF LIPID METABOLISM BY PPARALPHA | 107 | 1.58e-01 | 7.90e-02 | 0.465000 |
| GOLGI TO ER RETROGRADE TRANSPORT | 119 | 1.37e-01 | 7.89e-02 | 0.436000 |
| RAP1 SIGNALLING | 15 | 5.97e-01 | -7.89e-02 | 0.838000 |
| HIV LIFE CYCLE | 142 | 1.05e-01 | -7.89e-02 | 0.381000 |
| CYTOKINE SIGNALING IN IMMUNE SYSTEM | 544 | 1.77e-03 | -7.87e-02 | 0.043300 |
| CD209 DC SIGN SIGNALING | 18 | 5.64e-01 | -7.86e-02 | 0.827000 |
| RUNX1 REGULATES TRANSCRIPTION OF GENES INVOLVED IN DIFFERENTIATION OF HSCS | 84 | 2.14e-01 | -7.85e-02 | 0.526000 |
| CELL CELL COMMUNICATION | 107 | 1.62e-01 | 7.84e-02 | 0.467000 |
| RNA POLYMERASE II TRANSCRIBES SNRNA GENES | 74 | 2.47e-01 | -7.79e-02 | 0.568000 |
| ADP SIGNALLING THROUGH P2Y PURINOCEPTOR 1 | 23 | 5.18e-01 | -7.78e-02 | 0.797000 |
| REGULATION OF LOCALIZATION OF FOXO TRANSCRIPTION FACTORS | 12 | 6.41e-01 | 7.78e-02 | 0.869000 |
| RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | 85 | 2.17e-01 | 7.76e-02 | 0.530000 |
| INTERLEUKIN 35 SIGNALLING | 10 | 6.74e-01 | -7.68e-02 | 0.879000 |
| CONSTITUTIVE SIGNALING BY LIGAND RESPONSIVE EGFR CANCER VARIANTS | 19 | 5.64e-01 | -7.64e-02 | 0.827000 |
| SIGNALING BY GPCR | 462 | 5.28e-03 | 7.60e-02 | 0.077200 |
| FOXO MEDIATED TRANSCRIPTION OF CELL CYCLE GENES | 16 | 6.00e-01 | -7.57e-02 | 0.838000 |
| ERK MAPK TARGETS | 22 | 5.39e-01 | 7.56e-02 | 0.811000 |
| NONHOMOLOGOUS END JOINING NHEJ | 43 | 3.91e-01 | -7.56e-02 | 0.707000 |
| SHC1 EVENTS IN ERBB2 SIGNALING | 20 | 5.61e-01 | -7.51e-02 | 0.827000 |
| RHO GTPASE CYCLE | 422 | 8.63e-03 | 7.48e-02 | 0.103000 |
| RNA POLYMERASE II TRANSCRIPTION | 1085 | 3.93e-05 | -7.45e-02 | 0.004180 |
| MITOTIC PROMETAPHASE | 176 | 8.91e-02 | -7.44e-02 | 0.353000 |
| RRNA PROCESSING IN THE MITOCHONDRION | 10 | 6.84e-01 | -7.44e-02 | 0.883000 |
| SIGNALING BY NTRK3 TRKC | 17 | 5.98e-01 | 7.38e-02 | 0.838000 |
| BETA OXIDATION OF VERY LONG CHAIN FATTY ACIDS | 11 | 6.73e-01 | 7.36e-02 | 0.879000 |
| GLYCOLYSIS | 66 | 3.02e-01 | 7.35e-02 | 0.644000 |
| HCMV LATE EVENTS | 65 | 3.08e-01 | 7.32e-02 | 0.646000 |
| CYTOSOLIC SENSORS OF PATHOGEN ASSOCIATED DNA | 59 | 3.33e-01 | 7.29e-02 | 0.667000 |
| RHO GTPASES ACTIVATE KTN1 | 11 | 6.76e-01 | -7.27e-02 | 0.879000 |
| RRNA MODIFICATION IN THE NUCLEUS AND CYTOSOL | 59 | 3.35e-01 | -7.26e-02 | 0.669000 |
| CONDENSATION OF PROPHASE CHROMOSOMES | 27 | 5.14e-01 | -7.25e-02 | 0.795000 |
| NEGATIVE REGULATION OF MET ACTIVITY | 21 | 5.66e-01 | -7.24e-02 | 0.827000 |
| TGF BETA RECEPTOR SIGNALING ACTIVATES SMADS | 32 | 4.80e-01 | -7.22e-02 | 0.779000 |
| GENERATION OF SECOND MESSENGER MOLECULES | 19 | 5.86e-01 | -7.21e-02 | 0.835000 |
| REGULATION OF PTEN GENE TRANSCRIPTION | 58 | 3.43e-01 | 7.21e-02 | 0.676000 |
| TRANSCRIPTIONAL REGULATION BY SMALL RNAS | 61 | 3.31e-01 | 7.20e-02 | 0.667000 |
| KERATAN SULFATE DEGRADATION | 11 | 6.80e-01 | 7.18e-02 | 0.880000 |
| NUCLEAR EVENTS KINASE AND TRANSCRIPTION FACTOR ACTIVATION | 59 | 3.41e-01 | 7.17e-02 | 0.676000 |
| ACTIVATION OF BH3 ONLY PROTEINS | 30 | 4.97e-01 | -7.16e-02 | 0.784000 |
| NGF STIMULATED TRANSCRIPTION | 37 | 4.54e-01 | 7.11e-02 | 0.758000 |
| EPH EPHRIN SIGNALING | 92 | 2.40e-01 | 7.10e-02 | 0.561000 |
| ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | 286 | 4.04e-02 | -7.06e-02 | 0.242000 |
| SIGNALING BY HEDGEHOG | 142 | 1.49e-01 | 7.02e-02 | 0.452000 |
| SYNTHESIS OF PC | 25 | 5.46e-01 | 6.97e-02 | 0.811000 |
| PLATELET HOMEOSTASIS | 78 | 2.89e-01 | -6.94e-02 | 0.628000 |
| BINDING AND UPTAKE OF LIGANDS BY SCAVENGER RECEPTORS | 31 | 5.04e-01 | 6.94e-02 | 0.787000 |
| PURINERGIC SIGNALING IN LEISHMANIASIS INFECTION | 23 | 5.65e-01 | -6.93e-02 | 0.827000 |
| SIGNALING BY SCF KIT | 41 | 4.44e-01 | -6.91e-02 | 0.750000 |
| TRNA AMINOACYLATION | 42 | 4.39e-01 | 6.91e-02 | 0.744000 |
| INTERLEUKIN RECEPTOR SHC SIGNALING | 20 | 5.93e-01 | 6.90e-02 | 0.838000 |
| SIGNALING BY EGFR | 46 | 4.19e-01 | 6.90e-02 | 0.727000 |
| ACTIVATION OF THE AP 1 FAMILY OF TRANSCRIPTION FACTORS | 10 | 7.06e-01 | -6.89e-02 | 0.893000 |
| PEROXISOMAL PROTEIN IMPORT | 57 | 3.69e-01 | -6.89e-02 | 0.694000 |
| CELLULAR SENESCENCE | 141 | 1.59e-01 | 6.88e-02 | 0.465000 |
| ASYMMETRIC LOCALIZATION OF PCP PROTEINS | 63 | 3.46e-01 | -6.87e-02 | 0.678000 |
| NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | 17 | 6.24e-01 | 6.86e-02 | 0.858000 |
| SYNTHESIS OF BILE ACIDS AND BILE SALTS | 22 | 5.79e-01 | 6.84e-02 | 0.831000 |
| SUMOYLATION | 161 | 1.37e-01 | -6.80e-02 | 0.436000 |
| UB SPECIFIC PROCESSING PROTEASES | 169 | 1.27e-01 | -6.80e-02 | 0.418000 |
| RNA POLYMERASE III TRANSCRIPTION TERMINATION | 23 | 5.73e-01 | -6.79e-02 | 0.830000 |
| CELLULAR RESPONSE TO CHEMICAL STRESS | 150 | 1.53e-01 | -6.76e-02 | 0.460000 |
| NEURONAL SYSTEM | 366 | 2.68e-02 | 6.76e-02 | 0.181000 |
| SIGNALING BY ERYTHROPOIETIN | 24 | 5.67e-01 | 6.74e-02 | 0.827000 |
| RESPONSE OF MTB TO PHAGOCYTOSIS | 21 | 5.94e-01 | 6.71e-02 | 0.838000 |
| MET PROMOTES CELL MOTILITY | 39 | 4.70e-01 | 6.69e-02 | 0.771000 |
| RAS PROCESSING | 24 | 5.71e-01 | -6.68e-02 | 0.829000 |
| MAP3K8 TPL2 DEPENDENT MAPK1 3 ACTIVATION | 16 | 6.44e-01 | 6.68e-02 | 0.869000 |
| CYTOPROTECTION BY HMOX1 | 120 | 2.09e-01 | -6.64e-02 | 0.522000 |
| INTRAFLAGELLAR TRANSPORT | 50 | 4.19e-01 | 6.61e-02 | 0.727000 |
| SUMOYLATION OF TRANSCRIPTION COFACTORS | 42 | 4.60e-01 | 6.59e-02 | 0.765000 |
| RHOJ GTPASE CYCLE | 54 | 4.03e-01 | -6.58e-02 | 0.716000 |
| POLYMERASE SWITCHING | 14 | 6.70e-01 | -6.57e-02 | 0.879000 |
| TRIGLYCERIDE METABOLISM | 23 | 5.87e-01 | -6.54e-02 | 0.835000 |
| DOWNSTREAM SIGNALING OF ACTIVATED FGFR3 | 20 | 6.15e-01 | -6.49e-02 | 0.850000 |
| BIOSYNTHESIS OF SPECIALIZED PRORESOLVING MEDIATORS SPMS | 12 | 6.99e-01 | -6.45e-02 | 0.891000 |
| SIGNALING BY FGFR IN DISEASE | 55 | 4.08e-01 | -6.45e-02 | 0.720000 |
| ACETYLCHOLINE BINDING AND DOWNSTREAM EVENTS | 10 | 7.24e-01 | -6.45e-02 | 0.895000 |
| HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | 10 | 7.24e-01 | -6.45e-02 | 0.895000 |
| ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | 30 | 5.42e-01 | -6.44e-02 | 0.811000 |
| ERBB2 ACTIVATES PTK6 SIGNALING | 10 | 7.25e-01 | 6.43e-02 | 0.895000 |
| AUTOPHAGY | 137 | 1.95e-01 | 6.42e-02 | 0.505000 |
| PLATELET CALCIUM HOMEOSTASIS | 27 | 5.64e-01 | 6.41e-02 | 0.827000 |
| SIGNALING BY NOTCH4 | 83 | 3.14e-01 | -6.39e-02 | 0.653000 |
| LATE ENDOSOMAL MICROAUTOPHAGY | 30 | 5.46e-01 | 6.38e-02 | 0.811000 |
| N GLYCAN ANTENNAE ELONGATION | 15 | 6.69e-01 | 6.37e-02 | 0.879000 |
| CHROMOSOME MAINTENANCE | 101 | 2.71e-01 | -6.34e-02 | 0.600000 |
| METABOLISM OF NITRIC OXIDE NOS3 ACTIVATION AND REGULATION | 15 | 6.76e-01 | -6.24e-02 | 0.879000 |
| TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | 13 | 6.98e-01 | 6.21e-02 | 0.891000 |
| PI3K EVENTS IN ERBB2 SIGNALING | 14 | 6.88e-01 | -6.19e-02 | 0.884000 |
| SIGNALING BY RHO GTPASES MIRO GTPASES AND RHOBTB3 | 622 | 8.69e-03 | 6.19e-02 | 0.103000 |
| YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | 11 | 7.23e-01 | 6.17e-02 | 0.895000 |
| ANTIMICROBIAL PEPTIDES | 12 | 7.12e-01 | 6.16e-02 | 0.895000 |
| RESOLUTION OF AP SITES VIA THE MULTIPLE NUCLEOTIDE PATCH REPLACEMENT PATHWAY | 25 | 5.94e-01 | -6.15e-02 | 0.838000 |
| ANTIGEN ACTIVATES B CELL RECEPTOR BCR LEADING TO GENERATION OF SECOND MESSENGERS | 26 | 5.88e-01 | -6.14e-02 | 0.835000 |
| EGFR DOWNREGULATION | 27 | 5.81e-01 | 6.14e-02 | 0.832000 |
| DEVELOPMENTAL BIOLOGY | 813 | 3.12e-03 | 6.13e-02 | 0.058000 |
| NEDDYLATION | 218 | 1.20e-01 | -6.12e-02 | 0.409000 |
| TRANSCRIPTIONAL ACTIVITY OF SMAD2 SMAD3 SMAD4 HETEROTRIMER | 43 | 4.89e-01 | -6.10e-02 | 0.782000 |
| DISORDERS OF TRANSMEMBRANE TRANSPORTERS | 143 | 2.11e-01 | -6.06e-02 | 0.523000 |
| ADAPTIVE IMMUNE SYSTEM | 599 | 1.18e-02 | -6.05e-02 | 0.114000 |
| SUMOYLATION OF TRANSCRIPTION FACTORS | 16 | 6.76e-01 | -6.04e-02 | 0.879000 |
| ASPARAGINE N LINKED GLYCOSYLATION | 282 | 8.51e-02 | 5.97e-02 | 0.342000 |
| FOXO MEDIATED TRANSCRIPTION | 57 | 4.36e-01 | -5.96e-02 | 0.743000 |
| REGULATION OF INSULIN LIKE GROWTH FACTOR IGF TRANSPORT AND UPTAKE BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | 89 | 3.32e-01 | 5.95e-02 | 0.667000 |
| POSITIVE EPIGENETIC REGULATION OF RRNA EXPRESSION | 62 | 4.18e-01 | 5.95e-02 | 0.727000 |
| IRAK1 RECRUITS IKK COMPLEX | 14 | 7.01e-01 | 5.94e-02 | 0.892000 |
| INTERACTIONS OF REV WITH HOST CELLULAR PROTEINS | 35 | 5.43e-01 | -5.94e-02 | 0.811000 |
| POTENTIAL THERAPEUTICS FOR SARS | 77 | 3.73e-01 | 5.88e-02 | 0.694000 |
| PROTEIN LOCALIZATION | 156 | 2.09e-01 | -5.84e-02 | 0.522000 |
| SIGNALING BY NODAL | 16 | 6.86e-01 | 5.84e-02 | 0.884000 |
| APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | 34 | 5.56e-01 | -5.83e-02 | 0.822000 |
| ERYTHROPOIETIN ACTIVATES RAS | 13 | 7.17e-01 | -5.81e-02 | 0.895000 |
| REGULATION OF IFNA SIGNALING | 12 | 7.29e-01 | 5.79e-02 | 0.897000 |
| ERBB2 REGULATES CELL MOTILITY | 13 | 7.20e-01 | -5.75e-02 | 0.895000 |
| TP53 REGULATES METABOLIC GENES | 85 | 3.64e-01 | -5.70e-02 | 0.694000 |
| RHOD GTPASE CYCLE | 50 | 4.87e-01 | -5.68e-02 | 0.782000 |
| NEUROTOXICITY OF CLOSTRIDIUM TOXINS | 10 | 7.56e-01 | -5.68e-02 | 0.909000 |
| TICAM1 DEPENDENT ACTIVATION OF IRF3 IRF7 | 12 | 7.34e-01 | 5.67e-02 | 0.900000 |
| CLASS B 2 SECRETIN FAMILY RECEPTORS | 70 | 4.13e-01 | 5.67e-02 | 0.726000 |
| PTK6 REGULATES RHO GTPASES RAS GTPASE AND MAP KINASES | 13 | 7.24e-01 | -5.66e-02 | 0.895000 |
| TNFR2 NON CANONICAL NF KB PATHWAY | 83 | 3.74e-01 | -5.65e-02 | 0.694000 |
| GOLGI CISTERNAE PERICENTRIOLAR STACK REORGANIZATION | 12 | 7.35e-01 | -5.64e-02 | 0.900000 |
| MTOR SIGNALLING | 40 | 5.38e-01 | -5.62e-02 | 0.811000 |
| SIGNALING BY FGFR1 | 42 | 5.29e-01 | -5.62e-02 | 0.806000 |
| DNA STRAND ELONGATION | 32 | 5.85e-01 | -5.59e-02 | 0.835000 |
| METABOLISM OF NUCLEOTIDES | 92 | 3.55e-01 | -5.58e-02 | 0.691000 |
| TRANSCRIPTIONAL REGULATION OF PLURIPOTENT STEM CELLS | 16 | 6.99e-01 | -5.58e-02 | 0.891000 |
| INTRINSIC PATHWAY FOR APOPTOSIS | 52 | 4.87e-01 | -5.57e-02 | 0.782000 |
| TRAF6 MEDIATED NF KB ACTIVATION | 22 | 6.51e-01 | 5.57e-02 | 0.872000 |
| ESTROGEN DEPENDENT NUCLEAR EVENTS DOWNSTREAM OF ESR MEMBRANE SIGNALING | 20 | 6.67e-01 | -5.56e-02 | 0.879000 |
| SIGNALING BY ACTIVIN | 12 | 7.39e-01 | -5.56e-02 | 0.901000 |
| SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | 62 | 4.49e-01 | 5.56e-02 | 0.755000 |
| VIRAL MESSENGER RNA SYNTHESIS | 42 | 5.34e-01 | 5.55e-02 | 0.811000 |
| ION TRANSPORT BY P TYPE ATPASES | 48 | 5.06e-01 | 5.55e-02 | 0.787000 |
| POTASSIUM CHANNELS | 90 | 3.64e-01 | 5.54e-02 | 0.694000 |
| OPIOID SIGNALLING | 86 | 3.76e-01 | -5.53e-02 | 0.694000 |
| RHOF GTPASE CYCLE | 40 | 5.46e-01 | -5.52e-02 | 0.811000 |
| ERYTHROPOIETIN ACTIVATES PHOSPHOINOSITIDE 3 KINASE PI3K | 11 | 7.52e-01 | 5.51e-02 | 0.905000 |
| PI3K AKT SIGNALING IN CANCER | 87 | 3.76e-01 | 5.49e-02 | 0.694000 |
| THE NLRP3 INFLAMMASOME | 15 | 7.17e-01 | -5.41e-02 | 0.895000 |
| RNA POLYMERASE I TRANSCRIPTION TERMINATION | 31 | 6.02e-01 | -5.41e-02 | 0.838000 |
| SIGNALING BY NOTCH | 189 | 2.01e-01 | 5.40e-02 | 0.512000 |
| RHOV GTPASE CYCLE | 32 | 5.98e-01 | -5.39e-02 | 0.838000 |
| PARASITE INFECTION | 54 | 4.94e-01 | 5.39e-02 | 0.783000 |
| NEGATIVE REGULATION OF FGFR3 SIGNALING | 24 | 6.48e-01 | 5.39e-02 | 0.870000 |
| NEUTROPHIL DEGRANULATION | 384 | 7.12e-02 | -5.38e-02 | 0.311000 |
| ANTI INFLAMMATORY RESPONSE FAVOURING LEISHMANIA PARASITE INFECTION | 110 | 3.33e-01 | 5.35e-02 | 0.667000 |
| ALPHA LINOLENIC OMEGA3 AND LINOLEIC OMEGA6 ACID METABOLISM | 12 | 7.49e-01 | 5.34e-02 | 0.904000 |
| SIGNALING BY INSULIN RECEPTOR | 61 | 4.71e-01 | -5.33e-02 | 0.772000 |
| OVARIAN TUMOR DOMAIN PROTEASES | 36 | 5.80e-01 | -5.33e-02 | 0.831000 |
| MRNA SPLICING MINOR PATHWAY | 52 | 5.06e-01 | 5.33e-02 | 0.787000 |
| INTERLEUKIN 2 FAMILY SIGNALING | 32 | 6.02e-01 | 5.33e-02 | 0.838000 |
| MAPK FAMILY SIGNALING CASCADES | 286 | 1.22e-01 | 5.32e-02 | 0.414000 |
| NUCLEOTIDE SALVAGE | 21 | 6.75e-01 | 5.29e-02 | 0.879000 |
| RAB REGULATION OF TRAFFICKING | 119 | 3.20e-01 | 5.28e-02 | 0.658000 |
| CTLA4 INHIBITORY SIGNALING | 20 | 6.83e-01 | -5.28e-02 | 0.883000 |
| MHC CLASS II ANTIGEN PRESENTATION | 102 | 3.58e-01 | 5.27e-02 | 0.694000 |
| MITOCHONDRIAL TRANSLATION | 93 | 3.81e-01 | -5.26e-02 | 0.698000 |
| MITOTIC G2 G2 M PHASES | 186 | 2.18e-01 | -5.25e-02 | 0.532000 |
| CHEMOKINE RECEPTORS BIND CHEMOKINES | 17 | 7.08e-01 | -5.24e-02 | 0.894000 |
| MITOPHAGY | 29 | 6.27e-01 | -5.22e-02 | 0.859000 |
| GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | 14 | 7.37e-01 | -5.18e-02 | 0.900000 |
| HEME SIGNALING | 45 | 5.48e-01 | -5.17e-02 | 0.812000 |
| MITOTIC PROPHASE | 94 | 3.88e-01 | -5.16e-02 | 0.707000 |
| COPII MEDIATED VESICLE TRANSPORT | 64 | 4.76e-01 | 5.15e-02 | 0.776000 |
| SIGNALING BY ERBB2 | 47 | 5.43e-01 | -5.14e-02 | 0.811000 |
| IRS MEDIATED SIGNALLING | 37 | 5.90e-01 | -5.12e-02 | 0.836000 |
| HEDGEHOG OFF STATE | 107 | 3.62e-01 | 5.10e-02 | 0.694000 |
| SNRNP ASSEMBLY | 51 | 5.30e-01 | -5.09e-02 | 0.807000 |
| DOWNREGULATION OF ERBB2 SIGNALING | 27 | 6.48e-01 | 5.07e-02 | 0.870000 |
| CELL JUNCTION ORGANIZATION | 75 | 4.52e-01 | 5.02e-02 | 0.757000 |
| DCC MEDIATED ATTRACTIVE SIGNALING | 14 | 7.46e-01 | 5.00e-02 | 0.902000 |
| GLOBAL GENOME NUCLEOTIDE EXCISION REPAIR GG NER | 84 | 4.32e-01 | -4.96e-02 | 0.741000 |
| INTERLEUKIN 1 FAMILY SIGNALING | 122 | 3.45e-01 | -4.96e-02 | 0.678000 |
| DEUBIQUITINATION | 243 | 1.88e-01 | -4.91e-02 | 0.493000 |
| PROCESSIVE SYNTHESIS ON THE LAGGING STRAND | 15 | 7.42e-01 | -4.91e-02 | 0.902000 |
| TRANSFERRIN ENDOCYTOSIS AND RECYCLING | 26 | 6.66e-01 | -4.90e-02 | 0.879000 |
| INTRA GOLGI AND RETROGRADE GOLGI TO ER TRAFFIC | 185 | 2.51e-01 | 4.89e-02 | 0.577000 |
| SIGNAL TRANSDUCTION BY L1 | 21 | 6.98e-01 | 4.89e-02 | 0.891000 |
| SIGNALING BY NTRK2 TRKB | 24 | 6.79e-01 | -4.88e-02 | 0.880000 |
| RECEPTOR TYPE TYROSINE PROTEIN PHOSPHATASES | 20 | 7.06e-01 | 4.87e-02 | 0.893000 |
| SIGNALING BY RETINOIC ACID | 34 | 6.25e-01 | -4.84e-02 | 0.858000 |
| REGULATION OF HSF1 MEDIATED HEAT SHOCK RESPONSE | 77 | 4.65e-01 | -4.82e-02 | 0.766000 |
| BETA CATENIN INDEPENDENT WNT SIGNALING | 139 | 3.28e-01 | -4.81e-02 | 0.666000 |
| THE ROLE OF NEF IN HIV 1 REPLICATION AND DISEASE PATHOGENESIS | 25 | 6.77e-01 | -4.81e-02 | 0.879000 |
| SIGNALING BY RECEPTOR TYROSINE KINASES | 459 | 8.11e-02 | 4.77e-02 | 0.335000 |
| GPVI MEDIATED ACTIVATION CASCADE | 31 | 6.46e-01 | 4.76e-02 | 0.870000 |
| HDR THROUGH MMEJ ALT NHEJ | 10 | 7.96e-01 | -4.73e-02 | 0.931000 |
| CHAPERONE MEDIATED AUTOPHAGY | 19 | 7.21e-01 | -4.73e-02 | 0.895000 |
| HEMOSTASIS | 474 | 7.93e-02 | 4.72e-02 | 0.330000 |
| INTERLEUKIN 3 INTERLEUKIN 5 AND GM CSF SIGNALING | 41 | 6.02e-01 | 4.71e-02 | 0.838000 |
| GLYCOGEN METABOLISM | 25 | 6.84e-01 | -4.70e-02 | 0.883000 |
| TRANSCRIPTIONAL REGULATION BY RUNX1 | 179 | 2.80e-01 | 4.69e-02 | 0.614000 |
| CA DEPENDENT EVENTS | 36 | 6.28e-01 | 4.67e-02 | 0.859000 |
| CLATHRIN MEDIATED ENDOCYTOSIS | 130 | 3.60e-01 | 4.65e-02 | 0.694000 |
| SIGNALING BY TGF BETA RECEPTOR COMPLEX | 72 | 4.95e-01 | -4.65e-02 | 0.784000 |
| SUMOYLATION OF DNA REPLICATION PROTEINS | 43 | 5.98e-01 | -4.65e-02 | 0.838000 |
| HYALURONAN UPTAKE AND DEGRADATION | 11 | 7.90e-01 | 4.64e-02 | 0.931000 |
| EXTENSION OF TELOMERES | 49 | 5.77e-01 | -4.61e-02 | 0.831000 |
| HIV TRANSCRIPTION ELONGATION | 42 | 6.06e-01 | 4.60e-02 | 0.841000 |
| RESPONSE OF EIF2AK1 HRI TO HEME DEFICIENCY | 14 | 7.66e-01 | -4.59e-02 | 0.916000 |
| EGR2 AND SOX10 MEDIATED INITIATION OF SCHWANN CELL MYELINATION | 27 | 6.80e-01 | 4.58e-02 | 0.880000 |
| SIGNALING BY INTERLEUKINS | 348 | 1.44e-01 | -4.57e-02 | 0.444000 |
| INSULIN RECEPTOR SIGNALLING CASCADE | 42 | 6.09e-01 | -4.56e-02 | 0.845000 |
| ACTIVATED PKN1 STIMULATES TRANSCRIPTION OF AR ANDROGEN RECEPTOR REGULATED GENES KLK2 AND KLK3 | 21 | 7.18e-01 | 4.55e-02 | 0.895000 |
| TIGHT JUNCTION INTERACTIONS | 20 | 7.26e-01 | 4.52e-02 | 0.896000 |
| NERVOUS SYSTEM DEVELOPMENT | 547 | 7.21e-02 | 4.51e-02 | 0.312000 |
| INHIBITION OF DNA RECOMBINATION AT TELOMERE | 35 | 6.44e-01 | 4.51e-02 | 0.869000 |
| INTERLEUKIN 27 SIGNALING | 10 | 8.05e-01 | 4.50e-02 | 0.937000 |
| SIGNALING BY MET | 75 | 5.02e-01 | 4.49e-02 | 0.787000 |
| RHO GTPASES ACTIVATE ROCKS | 19 | 7.35e-01 | 4.48e-02 | 0.900000 |
| MAPK TARGETS NUCLEAR EVENTS MEDIATED BY MAP KINASES | 31 | 6.69e-01 | -4.44e-02 | 0.879000 |
| NUCLEAR SIGNALING BY ERBB4 | 30 | 6.74e-01 | 4.43e-02 | 0.879000 |
| SUMOYLATION OF SUMOYLATION PROTEINS | 33 | 6.60e-01 | -4.42e-02 | 0.878000 |
| RHO GTPASES ACTIVATE PKNS | 47 | 6.01e-01 | -4.41e-02 | 0.838000 |
| EPHB MEDIATED FORWARD SIGNALING | 42 | 6.22e-01 | 4.39e-02 | 0.857000 |
| AQUAPORIN MEDIATED TRANSPORT | 40 | 6.32e-01 | -4.37e-02 | 0.860000 |
| LEISHMANIA INFECTION | 189 | 3.04e-01 | 4.34e-02 | 0.644000 |
| SUPPRESSION OF PHAGOSOMAL MATURATION | 12 | 7.95e-01 | -4.33e-02 | 0.931000 |
| THE CANONICAL RETINOID CYCLE IN RODS TWILIGHT VISION | 14 | 7.81e-01 | 4.28e-02 | 0.930000 |
| VASOPRESSIN REGULATES RENAL WATER HOMEOSTASIS VIA AQUAPORINS | 37 | 6.53e-01 | -4.27e-02 | 0.872000 |
| SIGNALING BY VEGF | 101 | 4.60e-01 | 4.26e-02 | 0.765000 |
| VEGFR2 MEDIATED VASCULAR PERMEABILITY | 26 | 7.08e-01 | -4.25e-02 | 0.894000 |
| NUCLEOBASE BIOSYNTHESIS | 15 | 7.76e-01 | 4.24e-02 | 0.926000 |
| GLUCAGON LIKE PEPTIDE 1 GLP1 REGULATES INSULIN SECRETION | 38 | 6.55e-01 | -4.20e-02 | 0.873000 |
| SIGNALING BY EGFR IN CANCER | 21 | 7.40e-01 | -4.18e-02 | 0.901000 |
| MECP2 REGULATES NEURONAL RECEPTORS AND CHANNELS | 18 | 7.59e-01 | -4.18e-02 | 0.911000 |
| RHOG GTPASE CYCLE | 73 | 5.43e-01 | 4.12e-02 | 0.811000 |
| FCGR3A MEDIATED IL10 SYNTHESIS | 32 | 6.87e-01 | 4.12e-02 | 0.884000 |
| COMPLEMENT CASCADE | 24 | 7.31e-01 | -4.06e-02 | 0.898000 |
| DNA DAMAGE TELOMERE STRESS INDUCED SENESCENCE | 43 | 6.46e-01 | -4.06e-02 | 0.870000 |
| TRANSPORT OF BILE SALTS AND ORGANIC ACIDS METAL IONS AND AMINE COMPOUNDS | 63 | 5.80e-01 | -4.04e-02 | 0.831000 |
| THE ROLE OF GTSE1 IN G2 M PROGRESSION AFTER G2 CHECKPOINT | 68 | 5.67e-01 | -4.01e-02 | 0.827000 |
| DUAL INCISION IN TC NER | 65 | 5.77e-01 | -4.00e-02 | 0.831000 |
| ACYL CHAIN REMODELLING OF PC | 17 | 7.76e-01 | 3.98e-02 | 0.926000 |
| SIGNALLING TO ERKS | 32 | 6.99e-01 | 3.95e-02 | 0.891000 |
| GLUCAGON SIGNALING IN METABOLIC REGULATION | 29 | 7.13e-01 | -3.94e-02 | 0.895000 |
| INSERTION OF TAIL ANCHORED PROTEINS INTO THE ENDOPLASMIC RETICULUM MEMBRANE | 22 | 7.50e-01 | 3.92e-02 | 0.904000 |
| RNA POLYMERASE III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | 28 | 7.20e-01 | -3.92e-02 | 0.895000 |
| SIRT1 NEGATIVELY REGULATES RRNA EXPRESSION | 24 | 7.41e-01 | -3.90e-02 | 0.901000 |
| INNATE IMMUNE SYSTEM | 773 | 6.73e-02 | -3.89e-02 | 0.306000 |
| NICOTINAMIDE SALVAGING | 15 | 7.97e-01 | -3.84e-02 | 0.931000 |
| PLATELET SENSITIZATION BY LDL | 15 | 7.99e-01 | -3.80e-02 | 0.932000 |
| HSF1 ACTIVATION | 27 | 7.34e-01 | 3.78e-02 | 0.900000 |
| ESR MEDIATED SIGNALING | 163 | 4.07e-01 | -3.77e-02 | 0.719000 |
| GPCR LIGAND BINDING | 247 | 3.10e-01 | 3.76e-02 | 0.649000 |
| PHASE I FUNCTIONALIZATION OF COMPOUNDS | 58 | 6.22e-01 | 3.74e-02 | 0.857000 |
| SUMOYLATION OF RNA BINDING PROTEINS | 45 | 6.65e-01 | -3.73e-02 | 0.879000 |
| REGULATION OF FOXO TRANSCRIPTIONAL ACTIVITY BY ACETYLATION | 10 | 8.38e-01 | -3.73e-02 | 0.948000 |
| ROLE OF SECOND MESSENGERS IN NETRIN 1 SIGNALING | 10 | 8.38e-01 | -3.73e-02 | 0.948000 |
| TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | 13 | 8.19e-01 | 3.67e-02 | 0.946000 |
| TRANSPORT OF SMALL MOLECULES | 569 | 1.39e-01 | 3.64e-02 | 0.437000 |
| HSP90 CHAPERONE CYCLE FOR STEROID HORMONE RECEPTORS SHR | 48 | 6.63e-01 | 3.63e-02 | 0.879000 |
| RNA POLYMERASE I TRANSCRIPTION INITIATION | 47 | 6.67e-01 | 3.63e-02 | 0.879000 |
| CREB1 PHOSPHORYLATION THROUGH NMDA RECEPTOR MEDIATED ACTIVATION OF RAS SIGNALING | 28 | 7.40e-01 | 3.63e-02 | 0.901000 |
| INFECTIOUS DISEASE | 722 | 9.97e-02 | -3.62e-02 | 0.375000 |
| G PROTEIN MEDIATED EVENTS | 52 | 6.52e-01 | 3.61e-02 | 0.872000 |
| NUCLEAR ENVELOPE NE REASSEMBLY | 64 | 6.22e-01 | 3.56e-02 | 0.857000 |
| NOD1 2 SIGNALING PATHWAY | 34 | 7.20e-01 | 3.56e-02 | 0.895000 |
| RHO GTPASES ACTIVATE WASPS AND WAVES | 36 | 7.14e-01 | -3.53e-02 | 0.895000 |
| NEGATIVE REGULATION OF FGFR1 SIGNALING | 25 | 7.61e-01 | 3.52e-02 | 0.912000 |
| RECEPTOR MEDIATED MITOPHAGY | 11 | 8.40e-01 | -3.51e-02 | 0.950000 |
| VXPX CARGO TARGETING TO CILIUM | 19 | 7.91e-01 | -3.51e-02 | 0.931000 |
| RHOQ GTPASE CYCLE | 57 | 6.47e-01 | 3.51e-02 | 0.870000 |
| TRANSCRIPTIONAL REGULATION BY RUNX3 | 92 | 5.68e-01 | -3.45e-02 | 0.827000 |
| METABOLISM OF STEROIDS | 112 | 5.30e-01 | -3.44e-02 | 0.807000 |
| CELLULAR RESPONSES TO EXTERNAL STIMULI | 600 | 1.55e-01 | -3.42e-02 | 0.461000 |
| RHO GTPASES ACTIVATE FORMINS | 118 | 5.25e-01 | -3.39e-02 | 0.804000 |
| CELL CELL JUNCTION ORGANIZATION | 51 | 6.76e-01 | -3.38e-02 | 0.879000 |
| FORMATION OF TC NER PRE INCISION COMPLEX | 53 | 6.70e-01 | -3.38e-02 | 0.879000 |
| RHO GTPASES ACTIVATE PAKS | 21 | 7.89e-01 | -3.37e-02 | 0.931000 |
| ARACHIDONIC ACID METABOLISM | 39 | 7.17e-01 | 3.35e-02 | 0.895000 |
| MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | 15 | 8.25e-01 | -3.30e-02 | 0.947000 |
| TRANSLATION OF SARS COV 2 STRUCTURAL PROTEINS | 44 | 7.06e-01 | 3.29e-02 | 0.893000 |
| GENE SILENCING BY RNA | 83 | 6.11e-01 | 3.24e-02 | 0.845000 |
| VESICLE MEDIATED TRANSPORT | 605 | 1.77e-01 | 3.23e-02 | 0.482000 |
| FATTY ACID METABOLISM | 145 | 5.04e-01 | -3.22e-02 | 0.787000 |
| METABOLISM OF STEROID HORMONES | 20 | 8.03e-01 | -3.22e-02 | 0.935000 |
| SIGNALING BY WNT IN CANCER | 30 | 7.61e-01 | 3.20e-02 | 0.912000 |
| COBALAMIN CBL VITAMIN B12 TRANSPORT AND METABOLISM | 13 | 8.43e-01 | 3.18e-02 | 0.950000 |
| G ALPHA Z SIGNALLING EVENTS | 45 | 7.13e-01 | -3.17e-02 | 0.895000 |
| SURFACTANT METABOLISM | 17 | 8.21e-01 | 3.16e-02 | 0.947000 |
| DISEASES OF IMMUNE SYSTEM | 24 | 7.89e-01 | 3.15e-02 | 0.931000 |
| TRANSCRIPTIONAL ACTIVATION OF MITOCHONDRIAL BIOGENESIS | 54 | 6.89e-01 | 3.15e-02 | 0.884000 |
| METABOLISM OF LIPIDS | 610 | 1.86e-01 | 3.15e-02 | 0.493000 |
| NICOTINATE METABOLISM | 24 | 7.91e-01 | 3.13e-02 | 0.931000 |
| BASIGIN INTERACTIONS | 23 | 7.97e-01 | 3.09e-02 | 0.931000 |
| TRANSMISSION ACROSS CHEMICAL SYNAPSES | 238 | 4.14e-01 | 3.08e-02 | 0.726000 |
| BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | 76 | 6.43e-01 | 3.08e-02 | 0.869000 |
| MEMBRANE TRAFFICKING | 576 | 2.15e-01 | 3.03e-02 | 0.528000 |
| ADORA2B MEDIATED ANTI INFLAMMATORY CYTOKINES PRODUCTION | 85 | 6.30e-01 | 3.02e-02 | 0.860000 |
| FGFR2 ALTERNATIVE SPLICING | 25 | 7.95e-01 | 3.00e-02 | 0.931000 |
| PHOSPHOLIPASE C MEDIATED CASCADE FGFR2 | 11 | 8.64e-01 | -2.99e-02 | 0.959000 |
| SIGNALING BY TYPE 1 INSULIN LIKE GROWTH FACTOR 1 RECEPTOR IGF1R | 41 | 7.46e-01 | -2.93e-02 | 0.902000 |
| TP53 REGULATES TRANSCRIPTION OF DNA REPAIR GENES | 61 | 6.93e-01 | 2.92e-02 | 0.889000 |
| FORMATION OF SENESCENCE ASSOCIATED HETEROCHROMATIN FOCI SAHF | 13 | 8.57e-01 | -2.88e-02 | 0.955000 |
| MRNA CAPPING | 29 | 7.89e-01 | -2.87e-02 | 0.931000 |
| PLATELET ACTIVATION SIGNALING AND AGGREGATION | 223 | 4.64e-01 | 2.85e-02 | 0.766000 |
| NUCLEOTIDE LIKE PURINERGIC RECEPTORS | 13 | 8.60e-01 | -2.82e-02 | 0.957000 |
| REGULATION OF KIT SIGNALING | 16 | 8.45e-01 | -2.82e-02 | 0.950000 |
| RAB GEFS EXCHANGE GTP FOR GDP ON RABS | 88 | 6.50e-01 | -2.80e-02 | 0.871000 |
| CARGO CONCENTRATION IN THE ER | 30 | 7.92e-01 | 2.78e-02 | 0.931000 |
| NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | 12 | 8.69e-01 | 2.75e-02 | 0.962000 |
| ANCHORING OF THE BASAL BODY TO THE PLASMA MEMBRANE | 96 | 6.43e-01 | 2.74e-02 | 0.869000 |
| RNA POLYMERASE I PROMOTER ESCAPE | 47 | 7.45e-01 | -2.74e-02 | 0.902000 |
| CYTOSOLIC SULFONATION OF SMALL MOLECULES | 15 | 8.55e-01 | 2.73e-02 | 0.954000 |
| JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | 22 | 8.25e-01 | -2.73e-02 | 0.947000 |
| COOPERATION OF PREFOLDIN AND TRIC CCT IN ACTIN AND TUBULIN FOLDING | 26 | 8.11e-01 | 2.71e-02 | 0.942000 |
| GAP FILLING DNA REPAIR SYNTHESIS AND LIGATION IN GG NER | 25 | 8.16e-01 | -2.69e-02 | 0.945000 |
| RNA POLYMERASE III CHAIN ELONGATION | 18 | 8.46e-01 | -2.65e-02 | 0.950000 |
| HOMOLOGY DIRECTED REPAIR | 108 | 6.36e-01 | -2.63e-02 | 0.865000 |
| RNA POLYMERASE I TRANSCRIPTION | 67 | 7.12e-01 | 2.61e-02 | 0.895000 |
| B WICH COMPLEX POSITIVELY REGULATES RRNA EXPRESSION | 47 | 7.58e-01 | 2.60e-02 | 0.911000 |
| BASE EXCISION REPAIR | 57 | 7.36e-01 | 2.58e-02 | 0.900000 |
| LOSS OF FUNCTION OF MECP2 IN RETT SYNDROME | 13 | 8.73e-01 | -2.56e-02 | 0.962000 |
| TOLL LIKE RECEPTOR CASCADES | 138 | 6.06e-01 | -2.55e-02 | 0.841000 |
| REGULATION OF TP53 EXPRESSION AND DEGRADATION | 35 | 7.95e-01 | -2.54e-02 | 0.931000 |
| TRANSPORT OF MATURE TRANSCRIPT TO CYTOPLASM | 79 | 7.02e-01 | -2.49e-02 | 0.893000 |
| METABOLIC DISORDERS OF BIOLOGICAL OXIDATION ENZYMES | 20 | 8.49e-01 | 2.47e-02 | 0.950000 |
| TRANSCRIPTIONAL REGULATION BY TP53 | 342 | 4.35e-01 | -2.46e-02 | 0.743000 |
| REGULATION OF SIGNALING BY CBL | 22 | 8.42e-01 | -2.46e-02 | 0.950000 |
| THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | 27 | 8.26e-01 | -2.45e-02 | 0.947000 |
| ACTIVATION OF GENE EXPRESSION BY SREBF SREBP | 43 | 7.83e-01 | 2.43e-02 | 0.930000 |
| GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTEGRINS | 12 | 8.85e-01 | 2.40e-02 | 0.965000 |
| BASE EXCISION REPAIR AP SITE FORMATION | 29 | 8.25e-01 | 2.38e-02 | 0.947000 |
| SIGNALING BY WNT | 268 | 5.04e-01 | -2.37e-02 | 0.787000 |
| NRIF SIGNALS CELL DEATH FROM THE NUCLEUS | 17 | 8.67e-01 | 2.36e-02 | 0.961000 |
| CLASS A 1 RHODOPSIN LIKE RECEPTORS | 166 | 6.01e-01 | 2.35e-02 | 0.838000 |
| STRIATED MUSCLE CONTRACTION | 28 | 8.30e-01 | 2.34e-02 | 0.947000 |
| ADRENALINE NORADRENALINE INHIBITS INSULIN SECRETION | 26 | 8.37e-01 | 2.33e-02 | 0.948000 |
| RND1 GTPASE CYCLE | 37 | 8.10e-01 | -2.29e-02 | 0.941000 |
| RAF ACTIVATION | 34 | 8.18e-01 | -2.28e-02 | 0.946000 |
| POLO LIKE KINASE MEDIATED EVENTS | 14 | 8.84e-01 | -2.26e-02 | 0.965000 |
| BIOLOGICAL OXIDATIONS | 122 | 6.67e-01 | -2.26e-02 | 0.879000 |
| REGULATION OF INSULIN SECRETION | 71 | 7.45e-01 | 2.24e-02 | 0.902000 |
| SCAVENGING BY CLASS A RECEPTORS | 13 | 8.90e-01 | 2.22e-02 | 0.967000 |
| SIGNALING BY NUCLEAR RECEPTORS | 221 | 5.70e-01 | -2.22e-02 | 0.829000 |
| RAC2 GTPASE CYCLE | 86 | 7.23e-01 | -2.22e-02 | 0.895000 |
| UCH PROTEINASES | 90 | 7.18e-01 | -2.21e-02 | 0.895000 |
| DOWNSTREAM SIGNAL TRANSDUCTION | 29 | 8.38e-01 | 2.19e-02 | 0.948000 |
| EPIGENETIC REGULATION OF GENE EXPRESSION | 103 | 7.03e-01 | 2.18e-02 | 0.893000 |
| TOLL LIKE RECEPTOR 9 TLR9 CASCADE | 92 | 7.19e-01 | 2.17e-02 | 0.895000 |
| ENERGY DEPENDENT REGULATION OF MTOR BY LKB1 AMPK | 28 | 8.44e-01 | -2.15e-02 | 0.950000 |
| INTERLEUKIN 17 SIGNALING | 66 | 7.63e-01 | 2.15e-02 | 0.913000 |
| SARS COV INFECTIONS | 140 | 6.62e-01 | 2.14e-02 | 0.879000 |
| INTRACELLULAR SIGNALING BY SECOND MESSENGERS | 280 | 5.47e-01 | 2.10e-02 | 0.811000 |
| ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | 38 | 8.23e-01 | -2.10e-02 | 0.947000 |
| RA BIOSYNTHESIS PATHWAY | 14 | 8.92e-01 | -2.09e-02 | 0.969000 |
| CD28 DEPENDENT PI3K AKT SIGNALING | 20 | 8.72e-01 | 2.08e-02 | 0.962000 |
| DEFECTS IN COBALAMIN B12 METABOLISM | 12 | 9.01e-01 | -2.07e-02 | 0.975000 |
| REGULATION OF PLK1 ACTIVITY AT G2 M TRANSITION | 85 | 7.44e-01 | -2.05e-02 | 0.902000 |
| SIGNALING BY FGFR4 | 32 | 8.41e-01 | -2.05e-02 | 0.950000 |
| FERTILIZATION | 12 | 9.03e-01 | -2.04e-02 | 0.975000 |
| SENSORY PERCEPTION | 149 | 6.70e-01 | 2.02e-02 | 0.879000 |
| REGULATION OF GLUCOKINASE BY GLUCOKINASE REGULATORY PROTEIN | 30 | 8.48e-01 | 2.02e-02 | 0.950000 |
| RAC3 GTPASE CYCLE | 88 | 7.50e-01 | -1.97e-02 | 0.904000 |
| TP53 REGULATES TRANSCRIPTION OF CELL DEATH GENES | 37 | 8.37e-01 | -1.96e-02 | 0.948000 |
| TRANSPORT OF MATURE MRNAS DERIVED FROM INTRONLESS TRANSCRIPTS | 41 | 8.28e-01 | 1.96e-02 | 0.947000 |
| MITOCHONDRIAL PROTEIN IMPORT | 63 | 7.90e-01 | -1.94e-02 | 0.931000 |
| NEGATIVE REGULATION OF FGFR4 SIGNALING | 22 | 8.77e-01 | 1.91e-02 | 0.965000 |
| PTEN REGULATION | 134 | 7.04e-01 | -1.90e-02 | 0.893000 |
| LYSOSOME VESICLE BIOGENESIS | 32 | 8.53e-01 | -1.89e-02 | 0.953000 |
| POLYMERASE SWITCHING ON THE C STRAND OF THE TELOMERE | 25 | 8.71e-01 | -1.88e-02 | 0.962000 |
| G ALPHA Q SIGNALLING EVENTS | 146 | 6.97e-01 | -1.87e-02 | 0.891000 |
| CIRCADIAN CLOCK | 68 | 7.91e-01 | 1.86e-02 | 0.931000 |
| TRNA MODIFICATION IN THE NUCLEUS AND CYTOSOL | 43 | 8.34e-01 | 1.84e-02 | 0.948000 |
| NUCLEAR PORE COMPLEX NPC DISASSEMBLY | 32 | 8.57e-01 | 1.84e-02 | 0.955000 |
| SYNDECAN INTERACTIONS | 26 | 8.73e-01 | 1.81e-02 | 0.962000 |
| PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | 12 | 9.14e-01 | -1.81e-02 | 0.977000 |
| SARS COV 1 INFECTION | 48 | 8.33e-01 | -1.76e-02 | 0.948000 |
| SUMOYLATION OF CHROMATIN ORGANIZATION PROTEINS | 57 | 8.19e-01 | -1.75e-02 | 0.946000 |
| SEMA3A PAK DEPENDENT AXON REPULSION | 16 | 9.06e-01 | 1.71e-02 | 0.977000 |
| NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | 41 | 8.51e-01 | 1.70e-02 | 0.951000 |
| RUNX2 REGULATES OSTEOBLAST DIFFERENTIATION | 23 | 8.88e-01 | 1.69e-02 | 0.967000 |
| POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | 57 | 8.26e-01 | 1.68e-02 | 0.947000 |
| BUDDING AND MATURATION OF HIV VIRION | 27 | 8.80e-01 | -1.68e-02 | 0.965000 |
| TRAF6 MEDIATED IRF7 ACTIVATION | 15 | 9.11e-01 | -1.67e-02 | 0.977000 |
| SARS COV 2 INFECTION | 65 | 8.16e-01 | -1.67e-02 | 0.945000 |
| TP53 REGULATES TRANSCRIPTION OF CELL CYCLE GENES | 45 | 8.48e-01 | 1.65e-02 | 0.950000 |
| PEPTIDE LIGAND BINDING RECEPTORS | 96 | 7.80e-01 | -1.65e-02 | 0.929000 |
| TRANSCRIPTION COUPLED NUCLEOTIDE EXCISION REPAIR TC NER | 78 | 8.01e-01 | -1.65e-02 | 0.934000 |
| UPTAKE AND ACTIONS OF BACTERIAL TOXINS | 29 | 8.82e-01 | -1.59e-02 | 0.965000 |
| KSRP KHSRP BINDS AND DESTABILIZES MRNA | 16 | 9.12e-01 | 1.59e-02 | 0.977000 |
| CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | 90 | 7.94e-01 | -1.59e-02 | 0.931000 |
| RNA POLYMERASE III TRANSCRIPTION | 41 | 8.60e-01 | -1.59e-02 | 0.957000 |
| TOLL LIKE RECEPTOR TLR1 TLR2 CASCADE | 93 | 7.92e-01 | 1.58e-02 | 0.931000 |
| PIWI INTERACTING RNA PIRNA BIOGENESIS | 20 | 9.03e-01 | -1.57e-02 | 0.975000 |
| PKA MEDIATED PHOSPHORYLATION OF CREB | 19 | 9.06e-01 | -1.56e-02 | 0.977000 |
| VISUAL PHOTOTRANSDUCTION | 60 | 8.35e-01 | 1.55e-02 | 0.948000 |
| GLUTATHIONE CONJUGATION | 29 | 8.85e-01 | -1.55e-02 | 0.965000 |
| CYTOSOLIC TRNA AMINOACYLATION | 24 | 8.96e-01 | -1.54e-02 | 0.972000 |
| FLT3 SIGNALING | 37 | 8.72e-01 | -1.54e-02 | 0.962000 |
| EPHA MEDIATED GROWTH CONE COLLAPSE | 29 | 8.87e-01 | -1.52e-02 | 0.966000 |
| NUCLEOTIDE EXCISION REPAIR | 110 | 7.82e-01 | -1.52e-02 | 0.930000 |
| MITOCHONDRIAL FATTY ACID BETA OXIDATION | 33 | 8.81e-01 | -1.50e-02 | 0.965000 |
| DNA REPAIR | 292 | 6.61e-01 | -1.50e-02 | 0.878000 |
| NEF MEDIATES DOWN MODULATION OF CELL SURFACE RECEPTORS BY RECRUITING THEM TO CLATHRIN ADAPTERS | 19 | 9.11e-01 | -1.49e-02 | 0.977000 |
| UNWINDING OF DNA | 12 | 9.30e-01 | 1.47e-02 | 0.990000 |
| TRANSPORT OF THE SLBP DEPENDANT MATURE MRNA | 34 | 8.84e-01 | -1.45e-02 | 0.965000 |
| SLC TRANSPORTER DISORDERS | 74 | 8.30e-01 | -1.44e-02 | 0.947000 |
| GROWTH HORMONE RECEPTOR SIGNALING | 20 | 9.11e-01 | 1.44e-02 | 0.977000 |
| DISEASES OF SIGNAL TRANSDUCTION BY GROWTH FACTOR RECEPTORS AND SECOND MESSENGERS | 364 | 6.41e-01 | 1.43e-02 | 0.869000 |
| NUCLEAR ENVELOPE BREAKDOWN | 49 | 8.63e-01 | 1.42e-02 | 0.959000 |
| PRC2 METHYLATES HISTONES AND DNA | 29 | 8.96e-01 | -1.40e-02 | 0.972000 |
| SUMOYLATION OF UBIQUITINYLATION PROTEINS | 37 | 8.83e-01 | -1.40e-02 | 0.965000 |
| MYD88 INDEPENDENT TLR4 CASCADE | 94 | 8.29e-01 | -1.29e-02 | 0.947000 |
| RHO GTPASE EFFECTORS | 245 | 7.29e-01 | 1.29e-02 | 0.897000 |
| BILE ACID AND BILE SALT METABOLISM | 25 | 9.12e-01 | 1.27e-02 | 0.977000 |
| NUCLEAR IMPORT OF REV PROTEIN | 32 | 9.03e-01 | -1.25e-02 | 0.975000 |
| TRNA PROCESSING IN THE NUCLEUS | 56 | 8.74e-01 | -1.23e-02 | 0.962000 |
| PROTEIN FOLDING | 89 | 8.45e-01 | 1.20e-02 | 0.950000 |
| REGULATION OF FZD BY UBIQUITINATION | 19 | 9.29e-01 | -1.19e-02 | 0.989000 |
| SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | 11 | 9.50e-01 | -1.08e-02 | 0.996000 |
| TRANSLOCATION OF SLC2A4 GLUT4 TO THE PLASMA MEMBRANE | 63 | 8.84e-01 | -1.06e-02 | 0.965000 |
| POST TRANSLATIONAL PROTEIN MODIFICATION | 1216 | 5.41e-01 | -1.05e-02 | 0.811000 |
| P75NTR REGULATES AXONOGENESIS | 10 | 9.55e-01 | 1.02e-02 | 0.996000 |
| AMINO ACIDS REGULATE MTORC1 | 51 | 9.02e-01 | 9.96e-03 | 0.975000 |
| TCF DEPENDENT SIGNALING IN RESPONSE TO WNT | 177 | 8.20e-01 | -9.91e-03 | 0.947000 |
| SIGNALING BY FGFR2 IIIA TM | 19 | 9.41e-01 | 9.85e-03 | 0.995000 |
| CITRIC ACID CYCLE TCA CYCLE | 22 | 9.36e-01 | -9.82e-03 | 0.994000 |
| NEUROTRANSMITTER RECEPTORS AND POSTSYNAPTIC SIGNAL TRANSMISSION | 179 | 8.28e-01 | 9.40e-03 | 0.947000 |
| ENDOGENOUS STEROLS | 20 | 9.43e-01 | -9.29e-03 | 0.995000 |
| RETROGRADE TRANSPORT AT THE TRANS GOLGI NETWORK | 48 | 9.13e-01 | -9.10e-03 | 0.977000 |
| ATF4 ACTIVATES GENES IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS | 23 | 9.41e-01 | 8.97e-03 | 0.995000 |
| MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | 15 | 9.52e-01 | -8.92e-03 | 0.996000 |
| HS GAG BIOSYNTHESIS | 29 | 9.35e-01 | -8.71e-03 | 0.994000 |
| INTERLEUKIN 15 SIGNALING | 12 | 9.59e-01 | 8.63e-03 | 0.996000 |
| DUAL INCISION IN GG NER | 41 | 9.26e-01 | -8.34e-03 | 0.988000 |
| ALPHA PROTEIN KINASE 1 SIGNALING PATHWAY | 11 | 9.66e-01 | -7.42e-03 | 0.996000 |
| SUMOYLATION OF IMMUNE RESPONSE PROTEINS | 11 | 9.66e-01 | 7.37e-03 | 0.996000 |
| FGFR2 MUTANT RECEPTOR ACTIVATION | 26 | 9.49e-01 | -7.28e-03 | 0.996000 |
| RNA POLYMERASE III TRANSCRIPTION INITIATION FROM TYPE 1 PROMOTER | 28 | 9.47e-01 | 7.22e-03 | 0.996000 |
| ZINC INFLUX INTO CELLS BY THE SLC39 GENE FAMILY | 10 | 9.69e-01 | -7.15e-03 | 0.997000 |
| REGULATION OF TP53 ACTIVITY | 151 | 8.84e-01 | 6.91e-03 | 0.965000 |
| WNT LIGAND BIOGENESIS AND TRAFFICKING | 23 | 9.55e-01 | 6.78e-03 | 0.996000 |
| SIGNALING BY FGFR | 72 | 9.22e-01 | -6.66e-03 | 0.985000 |
| SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | 18 | 9.62e-01 | -6.41e-03 | 0.996000 |
| RECRUITMENT OF MITOTIC CENTROSOME PROTEINS AND COMPLEXES | 78 | 9.23e-01 | 6.32e-03 | 0.985000 |
| SIGNALING BY FGFR2 | 62 | 9.34e-01 | -6.12e-03 | 0.993000 |
| SMOOTH MUSCLE CONTRACTION | 33 | 9.52e-01 | -6.11e-03 | 0.996000 |
| ATF6 ATF6 ALPHA ACTIVATES CHAPERONES | 12 | 9.71e-01 | 6.03e-03 | 0.997000 |
| TELOMERE EXTENSION BY TELOMERASE | 22 | 9.61e-01 | 5.97e-03 | 0.996000 |
| MEIOTIC SYNAPSIS | 40 | 9.48e-01 | -5.93e-03 | 0.996000 |
| NOTCH4 ACTIVATION AND TRANSMISSION OF SIGNAL TO THE NUCLEUS | 12 | 9.73e-01 | 5.61e-03 | 0.997000 |
| DNA DOUBLE STRAND BREAK REPAIR | 137 | 9.12e-01 | -5.50e-03 | 0.977000 |
| VITAMIN B5 PANTOTHENATE METABOLISM | 14 | 9.74e-01 | -5.11e-03 | 0.997000 |
| SIGNALING BY FGFR3 | 35 | 9.59e-01 | 4.97e-03 | 0.996000 |
| INFECTION WITH MYCOBACTERIUM TUBERCULOSIS | 24 | 9.67e-01 | -4.81e-03 | 0.996000 |
| GABA B RECEPTOR ACTIVATION | 39 | 9.60e-01 | -4.68e-03 | 0.996000 |
| TICAM1 TRAF6 DEPENDENT INDUCTION OF TAK1 COMPLEX | 11 | 9.79e-01 | 4.67e-03 | 0.999000 |
| SPHINGOLIPID METABOLISM | 81 | 9.42e-01 | -4.65e-03 | 0.995000 |
| NEGATIVE REGULATION OF FGFR2 SIGNALING | 27 | 9.67e-01 | 4.63e-03 | 0.996000 |
| HEDGEHOG ON STATE | 83 | 9.42e-01 | 4.61e-03 | 0.995000 |
| ATF6 ATF6 ALPHA ACTIVATES CHAPERONE GENES | 10 | 9.80e-01 | -4.53e-03 | 0.999000 |
| MITOCHONDRIAL BIOGENESIS | 92 | 9.40e-01 | 4.51e-03 | 0.995000 |
| NEUROTRANSMITTER RELEASE CYCLE | 47 | 9.59e-01 | 4.35e-03 | 0.996000 |
| CASPASE ACTIVATION VIA EXTRINSIC APOPTOTIC SIGNALLING PATHWAY | 24 | 9.71e-01 | 4.30e-03 | 0.997000 |
| NEGATIVE EPIGENETIC REGULATION OF RRNA EXPRESSION | 65 | 9.54e-01 | -4.18e-03 | 0.996000 |
| MISCELLANEOUS TRANSPORT AND BINDING EVENTS | 20 | 9.74e-01 | 4.15e-03 | 0.997000 |
| ROS AND RNS PRODUCTION IN PHAGOCYTES | 28 | 9.70e-01 | 4.06e-03 | 0.997000 |
| RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | 107 | 9.43e-01 | -4.01e-03 | 0.995000 |
| NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR NLR SIGNALING PATHWAYS | 52 | 9.61e-01 | -3.92e-03 | 0.996000 |
| AURKA ACTIVATION BY TPX2 | 71 | 9.55e-01 | -3.86e-03 | 0.996000 |
| FORMATION OF RNA POL II ELONGATION COMPLEX | 57 | 9.64e-01 | 3.44e-03 | 0.996000 |
| DNA DOUBLE STRAND BREAK RESPONSE | 52 | 9.67e-01 | 3.37e-03 | 0.996000 |
| NEGATIVE REGULATION OF THE PI3K AKT NETWORK | 92 | 9.56e-01 | 3.32e-03 | 0.996000 |
| ESTROGEN DEPENDENT GENE EXPRESSION | 102 | 9.62e-01 | -2.75e-03 | 0.996000 |
| CILIUM ASSEMBLY | 190 | 9.51e-01 | -2.59e-03 | 0.996000 |
| CELLULAR RESPONSE TO HEAT STRESS | 96 | 9.66e-01 | 2.52e-03 | 0.996000 |
| TRANSCRIPTIONAL REGULATION BY THE AP 2 TFAP2 FAMILY OF TRANSCRIPTION FACTORS | 29 | 9.82e-01 | 2.38e-03 | 0.999000 |
| CONSTITUTIVE SIGNALING BY ABERRANT PI3K IN CANCER | 60 | 9.75e-01 | -2.38e-03 | 0.997000 |
| RESOLUTION OF ABASIC SITES AP SITES | 38 | 9.82e-01 | -2.17e-03 | 0.999000 |
| SIALIC ACID METABOLISM | 32 | 9.85e-01 | 1.87e-03 | 0.999000 |
| ACYL CHAIN REMODELLING OF PE | 16 | 9.91e-01 | -1.69e-03 | 0.999000 |
| CARGO RECOGNITION FOR CLATHRIN MEDIATED ENDOCYTOSIS | 90 | 9.79e-01 | -1.60e-03 | 0.999000 |
| SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | 31 | 9.88e-01 | -1.60e-03 | 0.999000 |
| TELOMERE MAINTENANCE | 78 | 9.81e-01 | -1.54e-03 | 0.999000 |
| DISEASES OF PROGRAMMED CELL DEATH | 54 | 9.87e-01 | 1.32e-03 | 0.999000 |
| CAMK IV MEDIATED PHOSPHORYLATION OF CREB | 10 | 9.95e-01 | 1.24e-03 | 0.999000 |
| G ALPHA I SIGNALLING EVENTS | 192 | 9.80e-01 | -1.04e-03 | 0.999000 |
| MET RECEPTOR RECYCLING | 10 | 9.96e-01 | 8.64e-04 | 0.999000 |
| ABERRANT REGULATION OF MITOTIC G1 S TRANSITION IN CANCER DUE TO RB1 DEFECTS | 17 | 9.95e-01 | 8.64e-04 | 0.999000 |
| PYRIMIDINE CATABOLISM | 10 | 9.97e-01 | 7.10e-04 | 0.999000 |
| PCP CE PATHWAY | 91 | 9.93e-01 | 5.61e-04 | 0.999000 |
| REGULATION OF CHOLESTEROL BIOSYNTHESIS BY SREBP SREBF | 56 | 9.96e-01 | -4.30e-04 | 0.999000 |
| MYOGENESIS | 25 | 9.97e-01 | 3.88e-04 | 0.999000 |
| ORGANELLE BIOGENESIS AND MAINTENANCE | 282 | 9.94e-01 | -2.66e-04 | 0.999000 |
| EXPORT OF VIRAL RIBONUCLEOPROTEINS FROM NUCLEUS | 31 | 9.98e-01 | 2.56e-04 | 0.999000 |
| REGULATION OF GLYCOLYSIS BY FRUCTOSE 2 6 BISPHOSPHATE METABOLISM | 10 | 9.99e-01 | 2.49e-04 | 0.999000 |
| TRANSLATION OF REPLICASE AND ASSEMBLY OF THE REPLICATION TRANSCRIPTION COMPLEX | 12 | 9.99e-01 | -2.47e-04 | 0.999000 |
| INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | 34 | 9.98e-01 | -1.92e-04 | 0.999000 |
| TRANSCRIPTIONAL REGULATION BY MECP2 | 60 | 9.98e-01 | -1.56e-04 | 0.999000 |
| RHOU GTPASE CYCLE | 33 | 9.99e-01 | 9.70e-05 | 0.999000 |
| TRNA PROCESSING | 105 | 9.99e-01 | -4.53e-05 | 0.999000 |
COHESIN LOADING ONTO CHROMATIN
| 164 | |
|---|---|
| set | COHESIN LOADING ONTO CHROMATIN |
| setSize | 10 |
| pANOVA | 0.00353 |
| s.dist | -0.533 |
| p.adjustANOVA | 0.0599 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Smc3 | -7975 |
| Rad21 | -7731 |
| Stag2 | -7576 |
| Pds5b | -6348 |
| Wapl | -5873 |
| Nipbl | -4859 |
| Stag1 | -4187 |
| Pds5a | -3294 |
| Smc1a | -3206 |
| Mau2 | 8684 |
| GeneID | Gene Rank |
|---|---|
| Smc3 | -7975 |
| Rad21 | -7731 |
| Stag2 | -7576 |
| Pds5b | -6348 |
| Wapl | -5873 |
| Nipbl | -4859 |
| Stag1 | -4187 |
| Pds5a | -3294 |
| Smc1a | -3206 |
| Mau2 | 8684 |
SYNTHESIS SECRETION AND INACTIVATION OF GLUCAGON LIKE PEPTIDE 1 GLP 1
| 1048 | |
|---|---|
| set | SYNTHESIS SECRETION AND INACTIVATION OF GLUCAGON LIKE PEPTIDE 1 GLP 1 |
| setSize | 12 |
| pANOVA | 0.0014 |
| s.dist | -0.533 |
| p.adjustANOVA | 0.0376 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Spcs2 | -8035 |
| Spcs3 | -7896 |
| Pcsk1 | -7280 |
| Dpp4 | -7096 |
| Spcs1 | -5610 |
| Sec11a | -3720 |
| Sec11c | -3701 |
| Tcf7l2 | -2896 |
| Ctnnb1 | -2304 |
| Pax6 | -1837 |
| Grp | -1325 |
| Gng13 | 885 |
| GeneID | Gene Rank |
|---|---|
| Spcs2 | -8035 |
| Spcs3 | -7896 |
| Pcsk1 | -7280 |
| Dpp4 | -7096 |
| Spcs1 | -5610 |
| Sec11a | -3720 |
| Sec11c | -3701 |
| Tcf7l2 | -2896 |
| Ctnnb1 | -2304 |
| Pax6 | -1837 |
| Grp | -1325 |
| Gng13 | 885 |
INCRETIN SYNTHESIS SECRETION AND INACTIVATION
| 438 | |
|---|---|
| set | INCRETIN SYNTHESIS SECRETION AND INACTIVATION |
| setSize | 13 |
| pANOVA | 0.00118 |
| s.dist | -0.52 |
| p.adjustANOVA | 0.0371 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Spcs2 | -8035 |
| Spcs3 | -7896 |
| Pcsk1 | -7280 |
| Dpp4 | -7096 |
| Spcs1 | -5610 |
| Sec11a | -3720 |
| Sec11c | -3701 |
| Tcf7l2 | -2896 |
| Isl1 | -2805 |
| Ctnnb1 | -2304 |
| Pax6 | -1837 |
| Grp | -1325 |
| Gng13 | 885 |
| GeneID | Gene Rank |
|---|---|
| Spcs2 | -8035 |
| Spcs3 | -7896 |
| Pcsk1 | -7280 |
| Dpp4 | -7096 |
| Spcs1 | -5610 |
| Sec11a | -3720 |
| Sec11c | -3701 |
| Tcf7l2 | -2896 |
| Isl1 | -2805 |
| Ctnnb1 | -2304 |
| Pax6 | -1837 |
| Grp | -1325 |
| Gng13 | 885 |
TERMINATION OF O GLYCAN BIOSYNTHESIS
| 1057 | |
|---|---|
| set | TERMINATION OF O GLYCAN BIOSYNTHESIS |
| setSize | 11 |
| pANOVA | 0.00328 |
| s.dist | 0.512 |
| p.adjustANOVA | 0.059 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| St3gal3 | 8670 |
| St6galnac2 | 8117 |
| St6galnac4 | 7920 |
| St3gal2 | 7108 |
| St3gal1 | 4068 |
| Muc6 | 4056 |
| Muc3a | 3708 |
| St6galnac3 | 3380 |
| Muc1 | 3351 |
| St3gal4 | 2155 |
| St6gal1 | -2025 |
| GeneID | Gene Rank |
|---|---|
| St3gal3 | 8670 |
| St6galnac2 | 8117 |
| St6galnac4 | 7920 |
| St3gal2 | 7108 |
| St3gal1 | 4068 |
| Muc6 | 4056 |
| Muc3a | 3708 |
| St6galnac3 | 3380 |
| Muc1 | 3351 |
| St3gal4 | 2155 |
| St6gal1 | -2025 |
POST CHAPERONIN TUBULIN FOLDING PATHWAY
| 725 | |
|---|---|
| set | POST CHAPERONIN TUBULIN FOLDING PATHWAY |
| setSize | 17 |
| pANOVA | 0.000265 |
| s.dist | 0.511 |
| p.adjustANOVA | 0.0174 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Tubb4a | 8426 |
| Tbcd | 8184 |
| Tubb2a | 7827 |
| Tubb3 | 7808 |
| Tubb4b | 7797 |
| Tuba1c | 7302 |
| Arl2 | 6821 |
| Tubb6 | 6795 |
| Tuba1b | 6068 |
| Tubb2b | 5525 |
| Tuba4a | 4512 |
| Tuba1a | 4381 |
| Tbcb | 3336 |
| Tbcc | 1422 |
| Tuba8 | 1029 |
| Tbce | -2728 |
| Tbca | -6636 |
| GeneID | Gene Rank |
|---|---|
| Tubb4a | 8426 |
| Tbcd | 8184 |
| Tubb2a | 7827 |
| Tubb3 | 7808 |
| Tubb4b | 7797 |
| Tuba1c | 7302 |
| Arl2 | 6821 |
| Tubb6 | 6795 |
| Tuba1b | 6068 |
| Tubb2b | 5525 |
| Tuba4a | 4512 |
| Tuba1a | 4381 |
| Tbcb | 3336 |
| Tbcc | 1422 |
| Tuba8 | 1029 |
| Tbce | -2728 |
| Tbca | -6636 |
CROSSLINKING OF COLLAGEN FIBRILS
| 191 | |
|---|---|
| set | CROSSLINKING OF COLLAGEN FIBRILS |
| setSize | 15 |
| pANOVA | 0.000938 |
| s.dist | 0.493 |
| p.adjustANOVA | 0.0371 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Loxl1 | 8319 |
| Loxl3 | 7717 |
| Pxdn | 7399 |
| Pcolce | 7369 |
| Col4a2 | 6243 |
| Col1a1 | 6218 |
| Col4a1 | 5628 |
| Bmp1 | 5233 |
| Tll2 | 4748 |
| Col4a5 | 4244 |
| Col4a3 | 3817 |
| Col1a2 | 2483 |
| Col4a4 | 2367 |
| Tll1 | -2487 |
| Loxl2 | -2802 |
| GeneID | Gene Rank |
|---|---|
| Loxl1 | 8319 |
| Loxl3 | 7717 |
| Pxdn | 7399 |
| Pcolce | 7369 |
| Col4a2 | 6243 |
| Col1a1 | 6218 |
| Col4a1 | 5628 |
| Bmp1 | 5233 |
| Tll2 | 4748 |
| Col4a5 | 4244 |
| Col4a3 | 3817 |
| Col1a2 | 2483 |
| Col4a4 | 2367 |
| Tll1 | -2487 |
| Loxl2 | -2802 |
PROCESSING AND ACTIVATION OF SUMO
| 737 | |
|---|---|
| set | PROCESSING AND ACTIVATION OF SUMO |
| setSize | 10 |
| pANOVA | 0.00822 |
| s.dist | -0.483 |
| p.adjustANOVA | 0.101 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Sumo1 | -7721 |
| Sumo2 | -7623 |
| Rwdd3 | -6507 |
| Ube2i | -5461 |
| Senp5 | -4326 |
| Senp2 | -3570 |
| Uba2 | -3145 |
| Sumo3 | -1650 |
| Sae1 | -1012 |
| Senp1 | 2877 |
| GeneID | Gene Rank |
|---|---|
| Sumo1 | -7721 |
| Sumo2 | -7623 |
| Rwdd3 | -6507 |
| Ube2i | -5461 |
| Senp5 | -4326 |
| Senp2 | -3570 |
| Uba2 | -3145 |
| Sumo3 | -1650 |
| Sae1 | -1012 |
| Senp1 | 2877 |
APOPTOSIS INDUCED DNA FRAGMENTATION
| 66 | |
|---|---|
| set | APOPTOSIS INDUCED DNA FRAGMENTATION |
| setSize | 10 |
| pANOVA | 0.00822 |
| s.dist | -0.483 |
| p.adjustANOVA | 0.101 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Hmgb1 | -8015 |
| H1f2 | -7875 |
| Kpna1 | -7625 |
| H1f0 | -7431 |
| Casp3 | -7246 |
| H1f4 | -5952 |
| Hmgb2 | -5383 |
| Kpnb1 | -1861 |
| Dffb | 6070 |
| Dffa | 7184 |
| GeneID | Gene Rank |
|---|---|
| Hmgb1 | -8015 |
| H1f2 | -7875 |
| Kpna1 | -7625 |
| H1f0 | -7431 |
| Casp3 | -7246 |
| H1f4 | -5952 |
| Hmgb2 | -5383 |
| Kpnb1 | -1861 |
| Dffb | 6070 |
| Dffa | 7184 |
ADENYLATE CYCLASE ACTIVATING PATHWAY
| 35 | |
|---|---|
| set | ADENYLATE CYCLASE ACTIVATING PATHWAY |
| setSize | 10 |
| pANOVA | 0.0106 |
| s.dist | 0.467 |
| p.adjustANOVA | 0.111 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Adcy6 | 7918 |
| Adcy4 | 7515 |
| Adcy5 | 7263 |
| Adcy1 | 6292 |
| Adcy3 | 6229 |
| Adcy9 | 3792 |
| Gnal | 2364 |
| Adcy2 | 1762 |
| Adcy7 | 502 |
| Adcy8 | -1560 |
| GeneID | Gene Rank |
|---|---|
| Adcy6 | 7918 |
| Adcy4 | 7515 |
| Adcy5 | 7263 |
| Adcy1 | 6292 |
| Adcy3 | 6229 |
| Adcy9 | 3792 |
| Gnal | 2364 |
| Adcy2 | 1762 |
| Adcy7 | 502 |
| Adcy8 | -1560 |
CYTOSOLIC IRON SULFUR CLUSTER ASSEMBLY
| 201 | |
|---|---|
| set | CYTOSOLIC IRON SULFUR CLUSTER ASSEMBLY |
| setSize | 13 |
| pANOVA | 0.00373 |
| s.dist | 0.465 |
| p.adjustANOVA | 0.0623 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Ercc2 | 8672 |
| Ndor1 | 8403 |
| Nubp1 | 7762 |
| Mms19 | 7727 |
| Ciao3 | 7622 |
| Pold1 | 6075 |
| Rtel1 | 5377 |
| Nubp2 | 5000 |
| Ciapin1 | 4423 |
| Ciao2b | 3942 |
| Ciao1 | 1954 |
| Brip1 | -4788 |
| Abcb7 | -7698 |
| GeneID | Gene Rank |
|---|---|
| Ercc2 | 8672 |
| Ndor1 | 8403 |
| Nubp1 | 7762 |
| Mms19 | 7727 |
| Ciao3 | 7622 |
| Pold1 | 6075 |
| Rtel1 | 5377 |
| Nubp2 | 5000 |
| Ciapin1 | 4423 |
| Ciao2b | 3942 |
| Ciao1 | 1954 |
| Brip1 | -4788 |
| Abcb7 | -7698 |
TRANSPORT OF CONNEXONS TO THE PLASMA MEMBRANE
| 1131 | |
|---|---|
| set | TRANSPORT OF CONNEXONS TO THE PLASMA MEMBRANE |
| setSize | 13 |
| pANOVA | 0.00442 |
| s.dist | 0.456 |
| p.adjustANOVA | 0.0671 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Tubb4a | 8426 |
| Tubb2a | 7827 |
| Tubb3 | 7808 |
| Tubb4b | 7797 |
| Tuba1c | 7302 |
| Tubb6 | 6795 |
| Tuba1b | 6068 |
| Tubb2b | 5525 |
| Tuba4a | 4512 |
| Tuba1a | 4381 |
| Tuba8 | 1029 |
| Gja1 | -6681 |
| Gjb2 | -7257 |
| GeneID | Gene Rank |
|---|---|
| Tubb4a | 8426 |
| Tubb2a | 7827 |
| Tubb3 | 7808 |
| Tubb4b | 7797 |
| Tuba1c | 7302 |
| Tubb6 | 6795 |
| Tuba1b | 6068 |
| Tubb2b | 5525 |
| Tuba4a | 4512 |
| Tuba1a | 4381 |
| Tuba8 | 1029 |
| Gja1 | -6681 |
| Gjb2 | -7257 |
SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN
| 1047 | |
|---|---|
| set | SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN |
| setSize | 12 |
| pANOVA | 0.00628 |
| s.dist | -0.456 |
| p.adjustANOVA | 0.0864 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Spcs2 | -8035 |
| Spcs3 | -7896 |
| Pla2g7 | -7315 |
| Pcsk1 | -7280 |
| Igf1 | -6925 |
| Bche | -6191 |
| Spcs1 | -5610 |
| Sec11a | -3720 |
| Sec11c | -3701 |
| Klf4 | 3048 |
| Crhr2 | 3261 |
| Ache | 7345 |
| GeneID | Gene Rank |
|---|---|
| Spcs2 | -8035 |
| Spcs3 | -7896 |
| Pla2g7 | -7315 |
| Pcsk1 | -7280 |
| Igf1 | -6925 |
| Bche | -6191 |
| Spcs1 | -5610 |
| Sec11a | -3720 |
| Sec11c | -3701 |
| Klf4 | 3048 |
| Crhr2 | 3261 |
| Ache | 7345 |
CD28 DEPENDENT VAV1 PATHWAY
| 125 | |
|---|---|
| set | CD28 DEPENDENT VAV1 PATHWAY |
| setSize | 11 |
| pANOVA | 0.0114 |
| s.dist | -0.441 |
| p.adjustANOVA | 0.112 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Cdc42 | -8103 |
| Pak3 | -7922 |
| Pak2 | -6948 |
| Pak1 | -6892 |
| Rac1 | -4971 |
| Cd86 | -3468 |
| Cd80 | -2956 |
| Grb2 | -1158 |
| Fyn | 1077 |
| Lck | 1386 |
| Vav1 | 1921 |
| GeneID | Gene Rank |
|---|---|
| Cdc42 | -8103 |
| Pak3 | -7922 |
| Pak2 | -6948 |
| Pak1 | -6892 |
| Rac1 | -4971 |
| Cd86 | -3468 |
| Cd80 | -2956 |
| Grb2 | -1158 |
| Fyn | 1077 |
| Lck | 1386 |
| Vav1 | 1921 |
ACTIVATION OF SMO
| 26 | |
|---|---|
| set | ACTIVATION OF SMO |
| setSize | 16 |
| pANOVA | 0.0028 |
| s.dist | 0.432 |
| p.adjustANOVA | 0.0556 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Arrb2 | 8418 |
| Evc2 | 8191 |
| Smo | 7824 |
| Grk2 | 7676 |
| Evc | 7384 |
| Gas8 | 7022 |
| Iqce | 6946 |
| Boc | 6790 |
| Gas1 | 6495 |
| Arrb1 | 4563 |
| Cdon | 2825 |
| Ptch1 | 1788 |
| Shh | -84 |
| Kif3a | -1376 |
| Efcab7 | -5253 |
| Csnk1a1 | -6640 |
| GeneID | Gene Rank |
|---|---|
| Arrb2 | 8418 |
| Evc2 | 8191 |
| Smo | 7824 |
| Grk2 | 7676 |
| Evc | 7384 |
| Gas8 | 7022 |
| Iqce | 6946 |
| Boc | 6790 |
| Gas1 | 6495 |
| Arrb1 | 4563 |
| Cdon | 2825 |
| Ptch1 | 1788 |
| Shh | -84 |
| Kif3a | -1376 |
| Efcab7 | -5253 |
| Csnk1a1 | -6640 |
MITOTIC TELOPHASE CYTOKINESIS
| 579 | |
|---|---|
| set | MITOTIC TELOPHASE CYTOKINESIS |
| setSize | 13 |
| pANOVA | 0.0112 |
| s.dist | -0.406 |
| p.adjustANOVA | 0.112 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Smc3 | -7975 |
| Rad21 | -7731 |
| Stag2 | -7576 |
| Pds5b | -6348 |
| Wapl | -5873 |
| Nipbl | -4859 |
| Stag1 | -4187 |
| Pds5a | -3294 |
| Smc1a | -3206 |
| Plk1 | -584 |
| Kif23 | -564 |
| Kif20a | 2338 |
| Mau2 | 8684 |
| GeneID | Gene Rank |
|---|---|
| Smc3 | -7975 |
| Rad21 | -7731 |
| Stag2 | -7576 |
| Pds5b | -6348 |
| Wapl | -5873 |
| Nipbl | -4859 |
| Stag1 | -4187 |
| Pds5a | -3294 |
| Smc1a | -3206 |
| Plk1 | -584 |
| Kif23 | -564 |
| Kif20a | 2338 |
| Mau2 | 8684 |
SYNTHESIS OF ACTIVE UBIQUITIN ROLES OF E1 AND E2 ENZYMES
| 1029 | |
|---|---|
| set | SYNTHESIS OF ACTIVE UBIQUITIN ROLES OF E1 AND E2 ENZYMES |
| setSize | 29 |
| pANOVA | 0.000173 |
| s.dist | -0.403 |
| p.adjustANOVA | 0.0145 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Ube2k | -8033 |
| Ube2e1 | -7991 |
| Ube2w | -7969 |
| Ube2q2 | -7842 |
| Ube2d1 | -7767 |
| Ube2b | -7710 |
| Ube2g1 | -7701 |
| Ube2e3 | -7465 |
| Ube2l3 | -7446 |
| Usp9x | -7190 |
| Ube2a | -7021 |
| Ube2d2a | -7010 |
| Uba6 | -6190 |
| Uchl3 | -5135 |
| Ube2r2 | -4376 |
| Rps27a | -4180 |
| Otulin | -3313 |
| Usp7 | -3157 |
| Ube2h | -3004 |
| Ube2t | -2663 |
| GeneID | Gene Rank |
|---|---|
| Ube2k | -8033 |
| Ube2e1 | -7991 |
| Ube2w | -7969 |
| Ube2q2 | -7842 |
| Ube2d1 | -7767 |
| Ube2b | -7710 |
| Ube2g1 | -7701 |
| Ube2e3 | -7465 |
| Ube2l3 | -7446 |
| Usp9x | -7190 |
| Ube2a | -7021 |
| Ube2d2a | -7010 |
| Uba6 | -6190 |
| Uchl3 | -5135 |
| Ube2r2 | -4376 |
| Rps27a | -4180 |
| Otulin | -3313 |
| Usp7 | -3157 |
| Ube2h | -3004 |
| Ube2t | -2663 |
| Ube2s | 515 |
| Uba52 | 1260 |
| Ube2z | 2330 |
| Cdc34 | 2968 |
| Uba1 | 3197 |
| Usp5 | 4890 |
| Ubc | 5007 |
| Ubb | 5655 |
| Ube2g2 | 6406 |
MET ACTIVATES RAP1 AND RAC1
| 537 | |
|---|---|
| set | MET ACTIVATES RAP1 AND RAC1 |
| setSize | 11 |
| pANOVA | 0.0226 |
| s.dist | -0.397 |
| p.adjustANOVA | 0.165 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Rap1a | -8158 |
| Rap1b | -7890 |
| Hgf | -5700 |
| Met | -5187 |
| Crk | -5173 |
| Rac1 | -4971 |
| Crkl | -4466 |
| Dock7 | -2596 |
| Grb2 | -1158 |
| Gab1 | 3019 |
| Rapgef1 | 8297 |
| GeneID | Gene Rank |
|---|---|
| Rap1a | -8158 |
| Rap1b | -7890 |
| Hgf | -5700 |
| Met | -5187 |
| Crk | -5173 |
| Rac1 | -4971 |
| Crkl | -4466 |
| Dock7 | -2596 |
| Grb2 | -1158 |
| Gab1 | 3019 |
| Rapgef1 | 8297 |
REPRESSION OF WNT TARGET GENES
| 826 | |
|---|---|
| set | REPRESSION OF WNT TARGET GENES |
| setSize | 14 |
| pANOVA | 0.0117 |
| s.dist | 0.389 |
| p.adjustANOVA | 0.114 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Axin2 | 7391 |
| Tle1 | 7269 |
| Ctbp2 | 6852 |
| Tle2 | 6484 |
| Ctbp1 | 6357 |
| Myc | 5785 |
| Tle5 | 5579 |
| Tcf7l1 | 5115 |
| Tle3 | 4841 |
| Hdac1 | 1596 |
| Tcf7 | -222 |
| Lef1 | -1906 |
| Tle4 | -2491 |
| Tcf7l2 | -2896 |
| GeneID | Gene Rank |
|---|---|
| Axin2 | 7391 |
| Tle1 | 7269 |
| Ctbp2 | 6852 |
| Tle2 | 6484 |
| Ctbp1 | 6357 |
| Myc | 5785 |
| Tle5 | 5579 |
| Tcf7l1 | 5115 |
| Tle3 | 4841 |
| Hdac1 | 1596 |
| Tcf7 | -222 |
| Lef1 | -1906 |
| Tle4 | -2491 |
| Tcf7l2 | -2896 |
CREB1 PHOSPHORYLATION THROUGH THE ACTIVATION OF ADENYLATE CYCLASE
| 187 | |
|---|---|
| set | CREB1 PHOSPHORYLATION THROUGH THE ACTIVATION OF ADENYLATE CYCLASE |
| setSize | 11 |
| pANOVA | 0.0267 |
| s.dist | -0.386 |
| p.adjustANOVA | 0.181 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Calm1 | -7820 |
| Prkacb | -7730 |
| Creb1 | -7577 |
| Prkar1a | -7404 |
| Prkar2b | -7026 |
| Prkx | -4930 |
| Prkar2a | -3055 |
| Adcy8 | -1560 |
| Prkar1b | 3391 |
| Prkaca | 4461 |
| Adcy1 | 6292 |
| GeneID | Gene Rank |
|---|---|
| Calm1 | -7820 |
| Prkacb | -7730 |
| Creb1 | -7577 |
| Prkar1a | -7404 |
| Prkar2b | -7026 |
| Prkx | -4930 |
| Prkar2a | -3055 |
| Adcy8 | -1560 |
| Prkar1b | 3391 |
| Prkaca | 4461 |
| Adcy1 | 6292 |
CHK1 CHK2 CDS1 MEDIATED INACTIVATION OF CYCLIN B CDK1 COMPLEX
| 146 | |
|---|---|
| set | CHK1 CHK2 CDS1 MEDIATED INACTIVATION OF CYCLIN B CDK1 COMPLEX |
| setSize | 10 |
| pANOVA | 0.0353 |
| s.dist | -0.384 |
| p.adjustANOVA | 0.219 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Ywhae | -7748 |
| Ywhab | -7697 |
| Ywhaz | -7567 |
| Ywhaq | -7059 |
| Chek2 | -4908 |
| Ywhah | -2677 |
| Chek1 | -2105 |
| Wee1 | -1047 |
| Ywhag | 4978 |
| Sfn | 5992 |
| GeneID | Gene Rank |
|---|---|
| Ywhae | -7748 |
| Ywhab | -7697 |
| Ywhaz | -7567 |
| Ywhaq | -7059 |
| Chek2 | -4908 |
| Ywhah | -2677 |
| Chek1 | -2105 |
| Wee1 | -1047 |
| Ywhag | 4978 |
| Sfn | 5992 |
CELLULAR HEXOSE TRANSPORT
| 136 | |
|---|---|
| set | CELLULAR HEXOSE TRANSPORT |
| setSize | 11 |
| pANOVA | 0.0292 |
| s.dist | 0.38 |
| p.adjustANOVA | 0.193 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Slc2a6 | 8711 |
| Slc2a8 | 8471 |
| Slc2a1 | 6710 |
| Slc50a1 | 6015 |
| Slc2a10 | 3503 |
| Slc45a3 | 2963 |
| Mfsd4b1 | 2673 |
| Slc2a4 | 1975 |
| Slc2a9 | 178 |
| Slc2a3 | -969 |
| Slc2a12 | -2020 |
| GeneID | Gene Rank |
|---|---|
| Slc2a6 | 8711 |
| Slc2a8 | 8471 |
| Slc2a1 | 6710 |
| Slc50a1 | 6015 |
| Slc2a10 | 3503 |
| Slc45a3 | 2963 |
| Mfsd4b1 | 2673 |
| Slc2a4 | 1975 |
| Slc2a9 | 178 |
| Slc2a3 | -969 |
| Slc2a12 | -2020 |
ACTIVATION OF RAC1
| 25 | |
|---|---|
| set | ACTIVATION OF RAC1 |
| setSize | 13 |
| pANOVA | 0.0182 |
| s.dist | -0.378 |
| p.adjustANOVA | 0.144 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Pak3 | -7922 |
| Pak5 | -7375 |
| Pak2 | -6948 |
| Pak1 | -6892 |
| Nck1 | -6619 |
| Slit2 | -5867 |
| Sos2 | -5570 |
| Sos1 | -5298 |
| Rac1 | -4971 |
| Robo1 | 1089 |
| Pak6 | 3641 |
| Nck2 | 6160 |
| Pak4 | 8451 |
| GeneID | Gene Rank |
|---|---|
| Pak3 | -7922 |
| Pak5 | -7375 |
| Pak2 | -6948 |
| Pak1 | -6892 |
| Nck1 | -6619 |
| Slit2 | -5867 |
| Sos2 | -5570 |
| Sos1 | -5298 |
| Rac1 | -4971 |
| Robo1 | 1089 |
| Pak6 | 3641 |
| Nck2 | 6160 |
| Pak4 | 8451 |
ACTIVATION OF AMPK DOWNSTREAM OF NMDARS
| 15 | |
|---|---|
| set | ACTIVATION OF AMPK DOWNSTREAM OF NMDARS |
| setSize | 20 |
| pANOVA | 0.00432 |
| s.dist | 0.369 |
| p.adjustANOVA | 0.0671 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Tubb4a | 8426 |
| Tubb2a | 7827 |
| Tubb3 | 7808 |
| Tubb4b | 7797 |
| Tuba1c | 7302 |
| Tubb6 | 6795 |
| Mapt | 6126 |
| Tuba1b | 6068 |
| Tubb2b | 5525 |
| Camkk2 | 4771 |
| Tuba4a | 4512 |
| Tuba1a | 4381 |
| Prkag1 | 3219 |
| Prkab1 | 2678 |
| Prkag2 | 2416 |
| Prkab2 | 1960 |
| Tuba8 | 1029 |
| Prkaa2 | -6371 |
| Prkaa1 | -6882 |
| Calm1 | -7820 |
| GeneID | Gene Rank |
|---|---|
| Tubb4a | 8426 |
| Tubb2a | 7827 |
| Tubb3 | 7808 |
| Tubb4b | 7797 |
| Tuba1c | 7302 |
| Tubb6 | 6795 |
| Mapt | 6126 |
| Tuba1b | 6068 |
| Tubb2b | 5525 |
| Camkk2 | 4771 |
| Tuba4a | 4512 |
| Tuba1a | 4381 |
| Prkag1 | 3219 |
| Prkab1 | 2678 |
| Prkag2 | 2416 |
| Prkab2 | 1960 |
| Tuba8 | 1029 |
| Prkaa2 | -6371 |
| Prkaa1 | -6882 |
| Calm1 | -7820 |
SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION
| 910 | |
|---|---|
| set | SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION |
| setSize | 14 |
| pANOVA | 0.0181 |
| s.dist | 0.365 |
| p.adjustANOVA | 0.144 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Tln1 | 8369 |
| Plxna3 | 8125 |
| Fes | 7854 |
| Pip5k1c | 7499 |
| Plxna1 | 7478 |
| Plxna4 | 4651 |
| Rras | 4494 |
| Nrp1 | 3828 |
| Plxna2 | 2464 |
| Farp2 | 1725 |
| Fyn | 1077 |
| Rnd1 | 146 |
| Rac1 | -4971 |
| Sema3a | -5883 |
| GeneID | Gene Rank |
|---|---|
| Tln1 | 8369 |
| Plxna3 | 8125 |
| Fes | 7854 |
| Pip5k1c | 7499 |
| Plxna1 | 7478 |
| Plxna4 | 4651 |
| Rras | 4494 |
| Nrp1 | 3828 |
| Plxna2 | 2464 |
| Farp2 | 1725 |
| Fyn | 1077 |
| Rnd1 | 146 |
| Rac1 | -4971 |
| Sema3a | -5883 |
SYNAPTIC ADHESION LIKE MOLECULES
| 1027 | |
|---|---|
| set | SYNAPTIC ADHESION LIKE MOLECULES |
| setSize | 21 |
| pANOVA | 0.00409 |
| s.dist | 0.362 |
| p.adjustANOVA | 0.0655 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Grin2c | 8593 |
| Ptprs | 8558 |
| Grin1 | 8455 |
| Lrfn4 | 8314 |
| Lrfn1 | 8214 |
| Grin2d | 8087 |
| Ptprf | 7604 |
| Lrfn3 | 7511 |
| Lrfn2 | 7292 |
| Flot2 | 7222 |
| Dlg4 | 6504 |
| Flot1 | 4933 |
| Gria1 | 3701 |
| Dlg3 | 2900 |
| Grin2b | 1090 |
| Grin2a | 994 |
| Ptprd | -3424 |
| Gria4 | -6481 |
| Rtn3 | -6487 |
| Gria3 | -6672 |
| GeneID | Gene Rank |
|---|---|
| Grin2c | 8593 |
| Ptprs | 8558 |
| Grin1 | 8455 |
| Lrfn4 | 8314 |
| Lrfn1 | 8214 |
| Grin2d | 8087 |
| Ptprf | 7604 |
| Lrfn3 | 7511 |
| Lrfn2 | 7292 |
| Flot2 | 7222 |
| Dlg4 | 6504 |
| Flot1 | 4933 |
| Gria1 | 3701 |
| Dlg3 | 2900 |
| Grin2b | 1090 |
| Grin2a | 994 |
| Ptprd | -3424 |
| Gria4 | -6481 |
| Rtn3 | -6487 |
| Gria3 | -6672 |
| Dlg1 | -7155 |
ASSEMBLY AND CELL SURFACE PRESENTATION OF NMDA RECEPTORS
| 74 | |
|---|---|
| set | ASSEMBLY AND CELL SURFACE PRESENTATION OF NMDA RECEPTORS |
| setSize | 35 |
| pANOVA | 0.000282 |
| s.dist | 0.355 |
| p.adjustANOVA | 0.0174 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Grin2c | 8593 |
| Grin1 | 8455 |
| Tubb4a | 8426 |
| Grin2d | 8087 |
| Tubb2a | 7827 |
| Tubb3 | 7808 |
| Tubb4b | 7797 |
| Lin7b | 7432 |
| Camk2b | 7337 |
| Tuba1c | 7302 |
| Actn2 | 7146 |
| Tubb6 | 6795 |
| Dlg4 | 6504 |
| Kif17 | 6124 |
| Tuba1b | 6068 |
| Camk2a | 6018 |
| Tubb2b | 5525 |
| Apba1 | 4876 |
| Tuba4a | 4512 |
| Tuba1a | 4381 |
| GeneID | Gene Rank |
|---|---|
| Grin2c | 8593 |
| Grin1 | 8455 |
| Tubb4a | 8426 |
| Grin2d | 8087 |
| Tubb2a | 7827 |
| Tubb3 | 7808 |
| Tubb4b | 7797 |
| Lin7b | 7432 |
| Camk2b | 7337 |
| Tuba1c | 7302 |
| Actn2 | 7146 |
| Tubb6 | 6795 |
| Dlg4 | 6504 |
| Kif17 | 6124 |
| Tuba1b | 6068 |
| Camk2a | 6018 |
| Tubb2b | 5525 |
| Apba1 | 4876 |
| Tuba4a | 4512 |
| Tuba1a | 4381 |
| Nefl | 3455 |
| Dlg3 | 2900 |
| Camk2g | 1604 |
| Grin2b | 1090 |
| Tuba8 | 1029 |
| Grin2a | 994 |
| Nbea | 511 |
| Lrrc7 | -100 |
| Lin7a | -1366 |
| Dlg2 | -1832 |
| Grin3a | -2172 |
| Cask | -6477 |
| Dlg1 | -7155 |
| Camk2d | -7443 |
| Lin7c | -8023 |
FOXO MEDIATED TRANSCRIPTION OF CELL DEATH GENES
| 339 | |
|---|---|
| set | FOXO MEDIATED TRANSCRIPTION OF CELL DEATH GENES |
| setSize | 15 |
| pANOVA | 0.0187 |
| s.dist | 0.351 |
| p.adjustANOVA | 0.147 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Crebbp | 7899 |
| Stk11 | 7364 |
| Nfyc | 7279 |
| Ddit3 | 7121 |
| Bcl6 | 6400 |
| Foxo4 | 5873 |
| Nfya | 4396 |
| Bbc3 | 3848 |
| Ep300 | 3623 |
| Foxo3 | 1752 |
| Pink1 | 1707 |
| Cited2 | -209 |
| Bcl2l11 | -592 |
| Foxo1 | -730 |
| Nfyb | -7310 |
| GeneID | Gene Rank |
|---|---|
| Crebbp | 7899 |
| Stk11 | 7364 |
| Nfyc | 7279 |
| Ddit3 | 7121 |
| Bcl6 | 6400 |
| Foxo4 | 5873 |
| Nfya | 4396 |
| Bbc3 | 3848 |
| Ep300 | 3623 |
| Foxo3 | 1752 |
| Pink1 | 1707 |
| Cited2 | -209 |
| Bcl2l11 | -592 |
| Foxo1 | -730 |
| Nfyb | -7310 |
NRAGE SIGNALS DEATH THROUGH JNK
| 644 | |
|---|---|
| set | NRAGE SIGNALS DEATH THROUGH JNK |
| setSize | 55 |
| pANOVA | 8.3e-06 |
| s.dist | 0.347 |
| p.adjustANOVA | 0.00203 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Arhgef4 | 8389 |
| Plekhg5 | 8269 |
| Arhgef5 | 8152 |
| Arhgef10 | 8077 |
| Plekhg2 | 8068 |
| Arhgef10l | 7986 |
| Prex1 | 7978 |
| Arhgef18 | 7897 |
| Arhgef17 | 7876 |
| Fgd1 | 7825 |
| Arhgef2 | 7575 |
| Arhgef40 | 7503 |
| Arhgef11 | 7382 |
| Arhgef1 | 7381 |
| Vav2 | 7349 |
| Mcf2l | 7328 |
| Arhgef7 | 7299 |
| Arhgef19 | 7277 |
| Abr | 7028 |
| Obscn | 7000 |
| GeneID | Gene Rank |
|---|---|
| Arhgef4 | 8389 |
| Plekhg5 | 8269 |
| Arhgef5 | 8152 |
| Arhgef10 | 8077 |
| Plekhg2 | 8068 |
| Arhgef10l | 7986 |
| Prex1 | 7978 |
| Arhgef18 | 7897 |
| Arhgef17 | 7876 |
| Fgd1 | 7825 |
| Arhgef2 | 7575 |
| Arhgef40 | 7503 |
| Arhgef11 | 7382 |
| Arhgef1 | 7381 |
| Vav2 | 7349 |
| Mcf2l | 7328 |
| Arhgef7 | 7299 |
| Arhgef19 | 7277 |
| Abr | 7028 |
| Obscn | 7000 |
| Bad | 6794 |
| Kalrn | 6581 |
| Akap13 | 5878 |
| Fgd3 | 5765 |
| Trio | 5419 |
| Itsn1 | 5046 |
| Fgd2 | 4975 |
| Ngf | 4741 |
| Rasgrf2 | 4405 |
| Arhgef33 | 4147 |
| Maged1 | 3608 |
| Arhgef15 | 3369 |
| Arhgef6 | 3352 |
| Arhgef16 | 3105 |
| Tiam1 | 2573 |
| Arhgef12 | 2168 |
| Vav1 | 1921 |
| Ngef | 1301 |
| Aatf | 824 |
| Arhgef26 | 447 |
| Arhgef37 | 377 |
| Bcl2l11 | -592 |
| Tiam2 | -863 |
| Ngfr | -1288 |
| Gna13 | -1942 |
| Arhgef3 | -2877 |
| Arhgef9 | -3542 |
| Vav3 | -3612 |
| Net1 | -3835 |
| Rac1 | -4971 |
| Sos1 | -5298 |
| Sos2 | -5570 |
| Mcf2 | -6037 |
| Fgd4 | -6754 |
| Mapk8 | -7602 |
SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS
| 1046 | |
|---|---|
| set | SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS |
| setSize | 20 |
| pANOVA | 0.00728 |
| s.dist | -0.347 |
| p.adjustANOVA | 0.098 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Acsl4 | -8101 |
| Acsl3 | -8077 |
| Elovl4 | -7452 |
| Hsd17b12 | -7247 |
| Hacd3 | -7168 |
| Elovl7 | -7035 |
| Elovl5 | -6104 |
| Acsl5 | -5532 |
| Elovl2 | -5409 |
| Hacd1 | -5151 |
| Hacd2 | -3847 |
| Hacd4 | -3353 |
| Acsl1 | -2953 |
| Acsl6 | -2702 |
| Elovl6 | -947 |
| Acsf3 | 489 |
| Tecr | 4241 |
| Acsbg1 | 7133 |
| Elovl1 | 7465 |
| Slc27a3 | 8499 |
| GeneID | Gene Rank |
|---|---|
| Acsl4 | -8101 |
| Acsl3 | -8077 |
| Elovl4 | -7452 |
| Hsd17b12 | -7247 |
| Hacd3 | -7168 |
| Elovl7 | -7035 |
| Elovl5 | -6104 |
| Acsl5 | -5532 |
| Elovl2 | -5409 |
| Hacd1 | -5151 |
| Hacd2 | -3847 |
| Hacd4 | -3353 |
| Acsl1 | -2953 |
| Acsl6 | -2702 |
| Elovl6 | -947 |
| Acsf3 | 489 |
| Tecr | 4241 |
| Acsbg1 | 7133 |
| Elovl1 | 7465 |
| Slc27a3 | 8499 |
A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS
| 1 | |
|---|---|
| set | A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS |
| setSize | 26 |
| pANOVA | 0.00232 |
| s.dist | 0.345 |
| p.adjustANOVA | 0.0497 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| B3gat1 | 8150 |
| Bcan | 7924 |
| Xylt2 | 7494 |
| Hspg2 | 7484 |
| Agrn | 7422 |
| B3galt6 | 7400 |
| Gpc1 | 7370 |
| Gpc4 | 7127 |
| Cspg4 | 6486 |
| B3gat3 | 6049 |
| Ncan | 5816 |
| Sdc3 | 5762 |
| Bgn | 5436 |
| Gpc2 | 4209 |
| Sdc4 | 3495 |
| B4galt7 | 3220 |
| Gpc6 | 2499 |
| Cspg5 | 1965 |
| B3gat2 | 1194 |
| Vcan | 694 |
| GeneID | Gene Rank |
|---|---|
| B3gat1 | 8150 |
| Bcan | 7924 |
| Xylt2 | 7494 |
| Hspg2 | 7484 |
| Agrn | 7422 |
| B3galt6 | 7400 |
| Gpc1 | 7370 |
| Gpc4 | 7127 |
| Cspg4 | 6486 |
| B3gat3 | 6049 |
| Ncan | 5816 |
| Sdc3 | 5762 |
| Bgn | 5436 |
| Gpc2 | 4209 |
| Sdc4 | 3495 |
| B4galt7 | 3220 |
| Gpc6 | 2499 |
| Cspg5 | 1965 |
| B3gat2 | 1194 |
| Vcan | 694 |
| Sdc1 | -1455 |
| Gpc3 | -2330 |
| Xylt1 | -2808 |
| Gpc5 | -4617 |
| Dcn | -5719 |
| Sdc2 | -7629 |
MATURATION OF NUCLEOPROTEIN
| 529 | |
|---|---|
| set | MATURATION OF NUCLEOPROTEIN |
| setSize | 10 |
| pANOVA | 0.0599 |
| s.dist | -0.344 |
| p.adjustANOVA | 0.288 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Sumo1 | -7721 |
| Ube2i | -5461 |
| Gsk3b | -5344 |
| Parp14 | -4901 |
| Parp9 | -4764 |
| Parp10 | -1986 |
| Parp4 | -1382 |
| Parp16 | 649 |
| Parp6 | 1819 |
| Parp8 | 2704 |
| GeneID | Gene Rank |
|---|---|
| Sumo1 | -7721 |
| Ube2i | -5461 |
| Gsk3b | -5344 |
| Parp14 | -4901 |
| Parp9 | -4764 |
| Parp10 | -1986 |
| Parp4 | -1382 |
| Parp16 | 649 |
| Parp6 | 1819 |
| Parp8 | 2704 |
EARLY PHASE OF HIV LIFE CYCLE
| 274 | |
|---|---|
| set | EARLY PHASE OF HIV LIFE CYCLE |
| setSize | 13 |
| pANOVA | 0.0338 |
| s.dist | -0.34 |
| p.adjustANOVA | 0.214 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Psip1 | -7883 |
| Kpna1 | -7625 |
| Xrcc5 | -7481 |
| Xrcc4 | -6723 |
| Lig4 | -5846 |
| Ccr5 | -5696 |
| Ppia | -4904 |
| Xrcc6 | -2303 |
| Fen1 | -376 |
| Banf1 | 1779 |
| Cxcr4 | 2237 |
| Lig1 | 4073 |
| Hmga1 | 6846 |
| GeneID | Gene Rank |
|---|---|
| Psip1 | -7883 |
| Kpna1 | -7625 |
| Xrcc5 | -7481 |
| Xrcc4 | -6723 |
| Lig4 | -5846 |
| Ccr5 | -5696 |
| Ppia | -4904 |
| Xrcc6 | -2303 |
| Fen1 | -376 |
| Banf1 | 1779 |
| Cxcr4 | 2237 |
| Lig1 | 4073 |
| Hmga1 | 6846 |
SIGNALING BY FGFR4 IN DISEASE
| 953 | |
|---|---|
| set | SIGNALING BY FGFR4 IN DISEASE |
| setSize | 10 |
| pANOVA | 0.0656 |
| s.dist | -0.336 |
| p.adjustANOVA | 0.306 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Kras | -8145 |
| Nras | -7416 |
| Pik3ca | -7221 |
| Pik3r1 | -6335 |
| Frs2 | -5382 |
| Sos1 | -5298 |
| Grb2 | -1158 |
| Gab1 | 3019 |
| Hras | 4086 |
| Plcg1 | 8089 |
| GeneID | Gene Rank |
|---|---|
| Kras | -8145 |
| Nras | -7416 |
| Pik3ca | -7221 |
| Pik3r1 | -6335 |
| Frs2 | -5382 |
| Sos1 | -5298 |
| Grb2 | -1158 |
| Gab1 | 3019 |
| Hras | 4086 |
| Plcg1 | 8089 |
PRE NOTCH PROCESSING IN GOLGI
| 733 | |
|---|---|
| set | PRE NOTCH PROCESSING IN GOLGI |
| setSize | 18 |
| pANOVA | 0.0139 |
| s.dist | 0.335 |
| p.adjustANOVA | 0.128 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| St3gal3 | 8670 |
| Lfng | 8472 |
| Furin | 8438 |
| Notch3 | 8325 |
| Notch1 | 8206 |
| Rfng | 8033 |
| Notch4 | 7812 |
| Notch2 | 6960 |
| B4galt1 | 6162 |
| Atp2a3 | 4830 |
| Atp2a1 | 4134 |
| St3gal4 | 2155 |
| Mfng | 659 |
| Sel1l | -2323 |
| Atp2a2 | -3230 |
| Tmed2 | -6842 |
| Rab6a | -6963 |
| St3gal6 | -7783 |
| GeneID | Gene Rank |
|---|---|
| St3gal3 | 8670 |
| Lfng | 8472 |
| Furin | 8438 |
| Notch3 | 8325 |
| Notch1 | 8206 |
| Rfng | 8033 |
| Notch4 | 7812 |
| Notch2 | 6960 |
| B4galt1 | 6162 |
| Atp2a3 | 4830 |
| Atp2a1 | 4134 |
| St3gal4 | 2155 |
| Mfng | 659 |
| Sel1l | -2323 |
| Atp2a2 | -3230 |
| Tmed2 | -6842 |
| Rab6a | -6963 |
| St3gal6 | -7783 |
SIGNALING BY FGFR3 FUSIONS IN CANCER
| 951 | |
|---|---|
| set | SIGNALING BY FGFR3 FUSIONS IN CANCER |
| setSize | 10 |
| pANOVA | 0.0699 |
| s.dist | -0.331 |
| p.adjustANOVA | 0.31 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Kras | -8145 |
| Nras | -7416 |
| Pik3ca | -7221 |
| Pik3r1 | -6335 |
| Frs2 | -5382 |
| Sos1 | -5298 |
| Grb2 | -1158 |
| Gab1 | 3019 |
| Hras | 4086 |
| Fgfr3 | 8528 |
| GeneID | Gene Rank |
|---|---|
| Kras | -8145 |
| Nras | -7416 |
| Pik3ca | -7221 |
| Pik3r1 | -6335 |
| Frs2 | -5382 |
| Sos1 | -5298 |
| Grb2 | -1158 |
| Gab1 | 3019 |
| Hras | 4086 |
| Fgfr3 | 8528 |
E2F MEDIATED REGULATION OF DNA REPLICATION
| 272 | |
|---|---|
| set | E2F MEDIATED REGULATION OF DNA REPLICATION |
| setSize | 19 |
| pANOVA | 0.0137 |
| s.dist | -0.327 |
| p.adjustANOVA | 0.128 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Orc2 | -7525 |
| Orc4 | -7512 |
| Rb1 | -7076 |
| Orc5 | -7050 |
| Ppp2cb | -6716 |
| Orc3 | -6566 |
| Ppp2ca | -6103 |
| Orc6 | -6082 |
| Prim2 | -5680 |
| Prim1 | -3038 |
| Ppp2r1b | -2845 |
| Tfdp2 | -1912 |
| Pola1 | -1352 |
| Mcm8 | -1037 |
| E2f1 | 1562 |
| Tfdp1 | 3785 |
| Ppp2r1a | 4452 |
| Pola2 | 5123 |
| Ppp2r3d | 8204 |
| GeneID | Gene Rank |
|---|---|
| Orc2 | -7525 |
| Orc4 | -7512 |
| Rb1 | -7076 |
| Orc5 | -7050 |
| Ppp2cb | -6716 |
| Orc3 | -6566 |
| Ppp2ca | -6103 |
| Orc6 | -6082 |
| Prim2 | -5680 |
| Prim1 | -3038 |
| Ppp2r1b | -2845 |
| Tfdp2 | -1912 |
| Pola1 | -1352 |
| Mcm8 | -1037 |
| E2f1 | 1562 |
| Tfdp1 | 3785 |
| Ppp2r1a | 4452 |
| Pola2 | 5123 |
| Ppp2r3d | 8204 |
COLLAGEN BIOSYNTHESIS AND MODIFYING ENZYMES
| 165 | |
|---|---|
| set | COLLAGEN BIOSYNTHESIS AND MODIFYING ENZYMES |
| setSize | 62 |
| pANOVA | 9.27e-06 |
| s.dist | 0.326 |
| p.adjustANOVA | 0.00203 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Plod3 | 8519 |
| Serpinh1 | 8200 |
| Plod1 | 7472 |
| Pcolce | 7369 |
| Colgalt1 | 7237 |
| P3h1 | 7211 |
| Adamts14 | 7158 |
| P3h3 | 7135 |
| Col9a3 | 6401 |
| Col4a2 | 6243 |
| Col1a1 | 6218 |
| P3h2 | 6188 |
| P4ha2 | 6129 |
| Col18a1 | 5921 |
| Col26a1 | 5835 |
| Col27a1 | 5750 |
| Col4a1 | 5628 |
| Col11a2 | 5366 |
| Bmp1 | 5233 |
| Col13a1 | 5068 |
| GeneID | Gene Rank |
|---|---|
| Plod3 | 8519 |
| Serpinh1 | 8200 |
| Plod1 | 7472 |
| Pcolce | 7369 |
| Colgalt1 | 7237 |
| P3h1 | 7211 |
| Adamts14 | 7158 |
| P3h3 | 7135 |
| Col9a3 | 6401 |
| Col4a2 | 6243 |
| Col1a1 | 6218 |
| P3h2 | 6188 |
| P4ha2 | 6129 |
| Col18a1 | 5921 |
| Col26a1 | 5835 |
| Col27a1 | 5750 |
| Col4a1 | 5628 |
| Col11a2 | 5366 |
| Bmp1 | 5233 |
| Col13a1 | 5068 |
| Tll2 | 4748 |
| Ppib | 4723 |
| Col2a1 | 4670 |
| Col4a5 | 4244 |
| Col12a1 | 4239 |
| Col8a2 | 4121 |
| Crtap | 4108 |
| P4ha3 | 4011 |
| Col4a3 | 3817 |
| Col20a1 | 3742 |
| Col16a1 | 3722 |
| Col11a1 | 3187 |
| Col6a3 | 3166 |
| Col7a1 | 2998 |
| Adamts3 | 2781 |
| Col1a2 | 2483 |
| Col4a4 | 2367 |
| Col22a1 | 2244 |
| Col15a1 | 2147 |
| Col9a2 | 2103 |
| Adamts2 | 1999 |
| Col19a1 | 1941 |
| Col6a5 | 1503 |
| Col5a2 | 1387 |
| Col5a3 | 1113 |
| Col6a1 | 1100 |
| Col8a1 | 964 |
| Col5a1 | 429 |
| Pcolce2 | -94 |
| Col6a2 | -508 |
| Col6a6 | -570 |
| P4hb | -602 |
| Col23a1 | -927 |
| P4ha1 | -1043 |
| Col24a1 | -1374 |
| Col9a1 | -1542 |
| Col25a1 | -1602 |
| Colgalt2 | -1860 |
| Col14a1 | -1865 |
| Tll1 | -2487 |
| Col3a1 | -3831 |
| Plod2 | -5533 |
SYNTHESIS OF LEUKOTRIENES LT AND EOXINS EX
| 1035 | |
|---|---|
| set | SYNTHESIS OF LEUKOTRIENES LT AND EOXINS EX |
| setSize | 12 |
| pANOVA | 0.0523 |
| s.dist | 0.324 |
| p.adjustANOVA | 0.278 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Mapkapk2 | 6591 |
| Cyp4f14 | 6035 |
| Ltc4s | 5961 |
| Abcc1 | 5855 |
| Ggt5 | 5054 |
| Cyp4f15 | 3833 |
| Alox5ap | 3477 |
| Alox5 | 1484 |
| Ggt1 | 1439 |
| Cyp4f16 | 1016 |
| Ptgr1 | -2289 |
| Lta4h | -2469 |
| GeneID | Gene Rank |
|---|---|
| Mapkapk2 | 6591 |
| Cyp4f14 | 6035 |
| Ltc4s | 5961 |
| Abcc1 | 5855 |
| Ggt5 | 5054 |
| Cyp4f15 | 3833 |
| Alox5ap | 3477 |
| Alox5 | 1484 |
| Ggt1 | 1439 |
| Cyp4f16 | 1016 |
| Ptgr1 | -2289 |
| Lta4h | -2469 |
CARBOXYTERMINAL POST TRANSLATIONAL MODIFICATIONS OF TUBULIN
| 112 | |
|---|---|
| set | CARBOXYTERMINAL POST TRANSLATIONAL MODIFICATIONS OF TUBULIN |
| setSize | 35 |
| pANOVA | 0.000983 |
| s.dist | 0.322 |
| p.adjustANOVA | 0.0371 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Tubb4a | 8426 |
| Tpgs1 | 7987 |
| Tubb2a | 7827 |
| Tubb3 | 7808 |
| Tubb4b | 7797 |
| Ttll11 | 7542 |
| Tuba1c | 7302 |
| Ttll3 | 7130 |
| Ttll12 | 6965 |
| Tubb6 | 6795 |
| Agbl5 | 6653 |
| Tuba1b | 6068 |
| Ttll8 | 5681 |
| Ttll5 | 5549 |
| Ttll1 | 5548 |
| Vash1 | 5529 |
| Tubb2b | 5525 |
| Ttll4 | 5094 |
| Tuba4a | 4512 |
| Ttll9 | 4387 |
| GeneID | Gene Rank |
|---|---|
| Tubb4a | 8426 |
| Tpgs1 | 7987 |
| Tubb2a | 7827 |
| Tubb3 | 7808 |
| Tubb4b | 7797 |
| Ttll11 | 7542 |
| Tuba1c | 7302 |
| Ttll3 | 7130 |
| Ttll12 | 6965 |
| Tubb6 | 6795 |
| Agbl5 | 6653 |
| Tuba1b | 6068 |
| Ttll8 | 5681 |
| Ttll5 | 5549 |
| Ttll1 | 5548 |
| Vash1 | 5529 |
| Tubb2b | 5525 |
| Ttll4 | 5094 |
| Tuba4a | 4512 |
| Ttll9 | 4387 |
| Tuba1a | 4381 |
| Ttl | 3394 |
| Agbl2 | 1901 |
| Ttll13 | 1856 |
| Ttll6 | 1213 |
| Tuba8 | 1029 |
| Nicn1 | -1701 |
| Svbp | -2542 |
| Agtpbp1 | -2942 |
| Lrrc49 | -3371 |
| Agbl4 | -4441 |
| Vash2 | -5030 |
| Tpgs2 | -5646 |
| Agbl3 | -6881 |
| Ttll7 | -7006 |
SEALING OF THE NUCLEAR ENVELOPE NE BY ESCRT III
| 906 | |
|---|---|
| set | SEALING OF THE NUCLEAR ENVELOPE NE BY ESCRT III |
| setSize | 23 |
| pANOVA | 0.00759 |
| s.dist | 0.322 |
| p.adjustANOVA | 0.0986 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Lemd2 | 8553 |
| Tubb4a | 8426 |
| Tubb2a | 7827 |
| Tubb3 | 7808 |
| Tubb4b | 7797 |
| Tuba1c | 7302 |
| Tubb6 | 6795 |
| Tuba1b | 6068 |
| Cc2d1b | 5969 |
| Tubb2b | 5525 |
| Chmp4b | 4930 |
| Tuba4a | 4512 |
| Chmp6 | 4395 |
| Tuba1a | 4381 |
| Chmp7 | 2981 |
| Tuba8 | 1029 |
| Chmp4c | 76 |
| Ist1 | -208 |
| Chmp2a | -791 |
| Vps4a | -4072 |
| GeneID | Gene Rank |
|---|---|
| Lemd2 | 8553 |
| Tubb4a | 8426 |
| Tubb2a | 7827 |
| Tubb3 | 7808 |
| Tubb4b | 7797 |
| Tuba1c | 7302 |
| Tubb6 | 6795 |
| Tuba1b | 6068 |
| Cc2d1b | 5969 |
| Tubb2b | 5525 |
| Chmp4b | 4930 |
| Tuba4a | 4512 |
| Chmp6 | 4395 |
| Tuba1a | 4381 |
| Chmp7 | 2981 |
| Tuba8 | 1029 |
| Chmp4c | 76 |
| Ist1 | -208 |
| Chmp2a | -791 |
| Vps4a | -4072 |
| Chmp3 | -6145 |
| Chmp2b | -6778 |
| Spast | -7828 |
NOTCH4 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION
| 641 | |
|---|---|
| set | NOTCH4 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION |
| setSize | 20 |
| pANOVA | 0.013 |
| s.dist | 0.321 |
| p.adjustANOVA | 0.121 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Notch1 | 8206 |
| Crebbp | 7899 |
| Notch4 | 7812 |
| Notch2 | 6960 |
| Kat2a | 6302 |
| Hes5 | 5449 |
| Flt4 | 5339 |
| Smad3 | 5298 |
| Maml3 | 5073 |
| Maml1 | 4946 |
| Hes1 | 4487 |
| Ep300 | 3623 |
| Mamld1 | 2254 |
| Maml2 | 1087 |
| Acta2 | 926 |
| Hey1 | -424 |
| Rbpj | -1287 |
| Hey2 | -2060 |
| Kat2b | -5160 |
| Snw1 | -7225 |
| GeneID | Gene Rank |
|---|---|
| Notch1 | 8206 |
| Crebbp | 7899 |
| Notch4 | 7812 |
| Notch2 | 6960 |
| Kat2a | 6302 |
| Hes5 | 5449 |
| Flt4 | 5339 |
| Smad3 | 5298 |
| Maml3 | 5073 |
| Maml1 | 4946 |
| Hes1 | 4487 |
| Ep300 | 3623 |
| Mamld1 | 2254 |
| Maml2 | 1087 |
| Acta2 | 926 |
| Hey1 | -424 |
| Rbpj | -1287 |
| Hey2 | -2060 |
| Kat2b | -5160 |
| Snw1 | -7225 |
CRMPS IN SEMA3A SIGNALING
| 189 | |
|---|---|
| set | CRMPS IN SEMA3A SIGNALING |
| setSize | 16 |
| pANOVA | 0.0266 |
| s.dist | 0.32 |
| p.adjustANOVA | 0.181 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Dpysl4 | 8303 |
| Plxna3 | 8125 |
| Fes | 7854 |
| Dpysl5 | 7679 |
| Plxna1 | 7478 |
| Crmp1 | 7168 |
| Cdk5 | 6446 |
| Plxna4 | 4651 |
| Nrp1 | 3828 |
| Plxna2 | 2464 |
| Fyn | 1077 |
| Dpysl2 | -162 |
| Cdk5r1 | -2886 |
| Dpysl3 | -3273 |
| Gsk3b | -5344 |
| Sema3a | -5883 |
| GeneID | Gene Rank |
|---|---|
| Dpysl4 | 8303 |
| Plxna3 | 8125 |
| Fes | 7854 |
| Dpysl5 | 7679 |
| Plxna1 | 7478 |
| Crmp1 | 7168 |
| Cdk5 | 6446 |
| Plxna4 | 4651 |
| Nrp1 | 3828 |
| Plxna2 | 2464 |
| Fyn | 1077 |
| Dpysl2 | -162 |
| Cdk5r1 | -2886 |
| Dpysl3 | -3273 |
| Gsk3b | -5344 |
| Sema3a | -5883 |
ADP SIGNALLING THROUGH P2Y PURINOCEPTOR 12
| 40 | |
|---|---|
| set | ADP SIGNALLING THROUGH P2Y PURINOCEPTOR 12 |
| setSize | 19 |
| pANOVA | 0.0172 |
| s.dist | -0.316 |
| p.adjustANOVA | 0.143 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Gng2 | -7364 |
| P2ry12 | -7235 |
| Gnai3 | -6940 |
| Gng12 | -6675 |
| Gnai1 | -6664 |
| Gnb4 | -5923 |
| Gng11 | -5748 |
| Gng10 | -5647 |
| Gnb1 | -5213 |
| Gng5 | -4130 |
| Gng4 | -2590 |
| Gng3 | -1019 |
| Gngt2 | 30 |
| Gng8 | 857 |
| Gng13 | 885 |
| Gnb5 | 1614 |
| Gng7 | 4537 |
| Gnai2 | 4799 |
| Gnb2 | 6805 |
| GeneID | Gene Rank |
|---|---|
| Gng2 | -7364 |
| P2ry12 | -7235 |
| Gnai3 | -6940 |
| Gng12 | -6675 |
| Gnai1 | -6664 |
| Gnb4 | -5923 |
| Gng11 | -5748 |
| Gng10 | -5647 |
| Gnb1 | -5213 |
| Gng5 | -4130 |
| Gng4 | -2590 |
| Gng3 | -1019 |
| Gngt2 | 30 |
| Gng8 | 857 |
| Gng13 | 885 |
| Gnb5 | 1614 |
| Gng7 | 4537 |
| Gnai2 | 4799 |
| Gnb2 | 6805 |
NCAM1 INTERACTIONS
| 597 | |
|---|---|
| set | NCAM1 INTERACTIONS |
| setSize | 40 |
| pANOVA | 0.000639 |
| s.dist | 0.312 |
| p.adjustANOVA | 0.0312 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Cacna1h | 8637 |
| Agrn | 7422 |
| Cacnb3 | 7338 |
| Nrtn | 7283 |
| Cacna1i | 6696 |
| Cacnb1 | 6624 |
| Col9a3 | 6401 |
| Col4a2 | 6243 |
| Cacna1d | 6208 |
| Cacna1g | 5824 |
| Ncan | 5816 |
| Cntn2 | 5812 |
| Cacna1c | 5646 |
| Col4a1 | 5628 |
| Gfra4 | 5465 |
| Col2a1 | 4670 |
| St8sia2 | 4418 |
| Col4a5 | 4244 |
| Col4a3 | 3817 |
| Gfra1 | 3238 |
| GeneID | Gene Rank |
|---|---|
| Cacna1h | 8637 |
| Agrn | 7422 |
| Cacnb3 | 7338 |
| Nrtn | 7283 |
| Cacna1i | 6696 |
| Cacnb1 | 6624 |
| Col9a3 | 6401 |
| Col4a2 | 6243 |
| Cacna1d | 6208 |
| Cacna1g | 5824 |
| Ncan | 5816 |
| Cntn2 | 5812 |
| Cacna1c | 5646 |
| Col4a1 | 5628 |
| Gfra4 | 5465 |
| Col2a1 | 4670 |
| St8sia2 | 4418 |
| Col4a5 | 4244 |
| Col4a3 | 3817 |
| Gfra1 | 3238 |
| Col6a3 | 3166 |
| Ncam1 | 3080 |
| Artn | 2834 |
| Col4a4 | 2367 |
| Gfra2 | 2134 |
| Col9a2 | 2103 |
| Cacna1s | 1911 |
| Col6a5 | 1503 |
| Col5a2 | 1387 |
| Col5a3 | 1113 |
| Col6a1 | 1100 |
| Col5a1 | 429 |
| Cacnb2 | 65 |
| Col6a2 | -508 |
| Col6a6 | -570 |
| Col9a1 | -1542 |
| Prnp | -3210 |
| Col3a1 | -3831 |
| St8sia4 | -7191 |
| Cacnb4 | -7877 |
PEXOPHAGY
| 690 | |
|---|---|
| set | PEXOPHAGY |
| setSize | 11 |
| pANOVA | 0.0802 |
| s.dist | 0.305 |
| p.adjustANOVA | 0.333 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Usp30 | 7412 |
| Pex5 | 7015 |
| Epas1 | 5775 |
| Ubb | 5655 |
| Ubc | 5007 |
| Map1lc3b | 4910 |
| Sqstm1 | 1772 |
| Uba52 | 1260 |
| Atm | -1121 |
| Nbr1 | -2275 |
| Rps27a | -4180 |
| GeneID | Gene Rank |
|---|---|
| Usp30 | 7412 |
| Pex5 | 7015 |
| Epas1 | 5775 |
| Ubb | 5655 |
| Ubc | 5007 |
| Map1lc3b | 4910 |
| Sqstm1 | 1772 |
| Uba52 | 1260 |
| Atm | -1121 |
| Nbr1 | -2275 |
| Rps27a | -4180 |
REGULATION OF TP53 ACTIVITY THROUGH ASSOCIATION WITH CO FACTORS
| 822 | |
|---|---|
| set | REGULATION OF TP53 ACTIVITY THROUGH ASSOCIATION WITH CO FACTORS |
| setSize | 13 |
| pANOVA | 0.0575 |
| s.dist | 0.304 |
| p.adjustANOVA | 0.286 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Banp | 8273 |
| Ppp1r13b | 7980 |
| Trp73 | 7470 |
| Akt1 | 7002 |
| Ppp1r13l | 6778 |
| Zfp385a | 6521 |
| Trp53 | 5412 |
| Akt2 | 2310 |
| Pou4f1 | -1631 |
| Akt3 | -1938 |
| Trp53bp2 | -2940 |
| Trp63 | -3963 |
| Phf20 | -4408 |
| GeneID | Gene Rank |
|---|---|
| Banp | 8273 |
| Ppp1r13b | 7980 |
| Trp73 | 7470 |
| Akt1 | 7002 |
| Ppp1r13l | 6778 |
| Zfp385a | 6521 |
| Trp53 | 5412 |
| Akt2 | 2310 |
| Pou4f1 | -1631 |
| Akt3 | -1938 |
| Trp53bp2 | -2940 |
| Trp63 | -3963 |
| Phf20 | -4408 |
INSULIN PROCESSING
| 452 | |
|---|---|
| set | INSULIN PROCESSING |
| setSize | 24 |
| pANOVA | 0.0099 |
| s.dist | -0.304 |
| p.adjustANOVA | 0.109 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Exoc5 | -8010 |
| Pcsk1 | -7280 |
| Exoc6 | -7180 |
| Kif5b | -6789 |
| Ero1a | -6533 |
| Exoc2 | -6109 |
| Kif5c | -5854 |
| Ero1b | -5811 |
| Slc30a5 | -5549 |
| Cpe | -5245 |
| Exoc3 | -4703 |
| Myo5a | -3776 |
| Slc30a7 | -3659 |
| Vamp2 | -2508 |
| Pcsk2 | -1769 |
| Exoc1 | -1445 |
| Slc30a6 | 345 |
| Stx1a | 2182 |
| Exoc4 | 2219 |
| Kif5a | 2288 |
| GeneID | Gene Rank |
|---|---|
| Exoc5 | -8010 |
| Pcsk1 | -7280 |
| Exoc6 | -7180 |
| Kif5b | -6789 |
| Ero1a | -6533 |
| Exoc2 | -6109 |
| Kif5c | -5854 |
| Ero1b | -5811 |
| Slc30a5 | -5549 |
| Cpe | -5245 |
| Exoc3 | -4703 |
| Myo5a | -3776 |
| Slc30a7 | -3659 |
| Vamp2 | -2508 |
| Pcsk2 | -1769 |
| Exoc1 | -1445 |
| Slc30a6 | 345 |
| Stx1a | 2182 |
| Exoc4 | 2219 |
| Kif5a | 2288 |
| Exoc8 | 2444 |
| Rab27a | 3706 |
| Myrip | 6423 |
| Exoc7 | 7331 |
PRESYNAPTIC DEPOLARIZATION AND CALCIUM CHANNEL OPENING
| 735 | |
|---|---|
| set | PRESYNAPTIC DEPOLARIZATION AND CALCIUM CHANNEL OPENING |
| setSize | 11 |
| pANOVA | 0.0823 |
| s.dist | 0.303 |
| p.adjustANOVA | 0.337 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Cacna1a | 7945 |
| Cacnb3 | 7338 |
| Cacng4 | 6639 |
| Cacnb1 | 6624 |
| Cacna1b | 6418 |
| Cacna2d2 | 2588 |
| Cacna1e | 1062 |
| Cacng2 | 315 |
| Cacnb2 | 65 |
| Cacna2d3 | -77 |
| Cacnb4 | -7877 |
| GeneID | Gene Rank |
|---|---|
| Cacna1a | 7945 |
| Cacnb3 | 7338 |
| Cacng4 | 6639 |
| Cacnb1 | 6624 |
| Cacna1b | 6418 |
| Cacna2d2 | 2588 |
| Cacna1e | 1062 |
| Cacng2 | 315 |
| Cacnb2 | 65 |
| Cacna2d3 | -77 |
| Cacnb4 | -7877 |
G BETA GAMMA SIGNALLING THROUGH CDC42
| 351 | |
|---|---|
| set | G BETA GAMMA SIGNALLING THROUGH CDC42 |
| setSize | 18 |
| pANOVA | 0.0263 |
| s.dist | -0.303 |
| p.adjustANOVA | 0.181 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Cdc42 | -8103 |
| Gng2 | -7364 |
| Pak1 | -6892 |
| Gng12 | -6675 |
| Gnb4 | -5923 |
| Gng11 | -5748 |
| Gng10 | -5647 |
| Gnb1 | -5213 |
| Gng5 | -4130 |
| Gng4 | -2590 |
| Gng3 | -1019 |
| Gngt2 | 30 |
| Gng8 | 857 |
| Gng13 | 885 |
| Gnb5 | 1614 |
| Arhgef6 | 3352 |
| Gng7 | 4537 |
| Gnb2 | 6805 |
| GeneID | Gene Rank |
|---|---|
| Cdc42 | -8103 |
| Gng2 | -7364 |
| Pak1 | -6892 |
| Gng12 | -6675 |
| Gnb4 | -5923 |
| Gng11 | -5748 |
| Gng10 | -5647 |
| Gnb1 | -5213 |
| Gng5 | -4130 |
| Gng4 | -2590 |
| Gng3 | -1019 |
| Gngt2 | 30 |
| Gng8 | 857 |
| Gng13 | 885 |
| Gnb5 | 1614 |
| Arhgef6 | 3352 |
| Gng7 | 4537 |
| Gnb2 | 6805 |
NF KB IS ACTIVATED AND SIGNALS SURVIVAL
| 624 | |
|---|---|
| set | NF KB IS ACTIVATED AND SIGNALS SURVIVAL |
| setSize | 13 |
| pANOVA | 0.0591 |
| s.dist | 0.302 |
| p.adjustANOVA | 0.288 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Ikbkb | 7710 |
| Rela | 7692 |
| Irak1 | 6187 |
| Ubb | 5655 |
| Ubc | 5007 |
| Ngf | 4741 |
| Nfkb1 | 4060 |
| Sqstm1 | 1772 |
| Uba52 | 1260 |
| Nfkbia | -111 |
| Ngfr | -1288 |
| Traf6 | -1853 |
| Rps27a | -4180 |
| GeneID | Gene Rank |
|---|---|
| Ikbkb | 7710 |
| Rela | 7692 |
| Irak1 | 6187 |
| Ubb | 5655 |
| Ubc | 5007 |
| Ngf | 4741 |
| Nfkb1 | 4060 |
| Sqstm1 | 1772 |
| Uba52 | 1260 |
| Nfkbia | -111 |
| Ngfr | -1288 |
| Traf6 | -1853 |
| Rps27a | -4180 |
Here is the session info with all the versions of packages used.
sessionInfo()
## R version 4.3.1 (2023-06-16)
## Platform: x86_64-pc-linux-gnu (64-bit)
## Running under: Ubuntu 22.04.3 LTS
##
## Matrix products: default
## BLAS: /usr/lib/x86_64-linux-gnu/openblas-pthread/libblas.so.3
## LAPACK: /usr/lib/x86_64-linux-gnu/openblas-pthread/libopenblasp-r0.3.20.so; LAPACK version 3.10.0
##
## locale:
## [1] LC_CTYPE=en_AU.UTF-8 LC_NUMERIC=C
## [3] LC_TIME=en_AU.UTF-8 LC_COLLATE=en_AU.UTF-8
## [5] LC_MONETARY=en_AU.UTF-8 LC_MESSAGES=en_AU.UTF-8
## [7] LC_PAPER=en_AU.UTF-8 LC_NAME=C
## [9] LC_ADDRESS=C LC_TELEPHONE=C
## [11] LC_MEASUREMENT=en_AU.UTF-8 LC_IDENTIFICATION=C
##
## time zone: /usr/share/zoneinfo/Australia/Melbourne
## tzcode source: system (glibc)
##
## attached base packages:
## [1] stats4 stats graphics grDevices utils datasets methods
## [8] base
##
## other attached packages:
## [1] GGally_2.1.2 gtools_3.9.4
## [3] echarts4r_0.4.5 beeswarm_0.4.0
## [5] pkgload_1.3.2.1 vioplot_0.4.0
## [7] sm_2.2-5.7.1 kableExtra_1.3.4
## [9] topconfects_1.16.0 limma_3.56.2
## [11] eulerr_7.0.0 mitch_1.12.0
## [13] MASS_7.3-60 fgsea_1.26.0
## [15] gplots_3.1.3 DESeq2_1.40.2
## [17] SummarizedExperiment_1.30.2 Biobase_2.60.0
## [19] MatrixGenerics_1.12.3 matrixStats_1.0.0
## [21] GenomicRanges_1.52.0 GenomeInfoDb_1.36.2
## [23] IRanges_2.34.1 S4Vectors_0.38.1
## [25] BiocGenerics_0.46.0 reshape2_1.4.4
## [27] lubridate_1.9.2 forcats_1.0.0
## [29] stringr_1.5.0 dplyr_1.1.2
## [31] purrr_1.0.2 readr_2.1.4
## [33] tidyr_1.3.0 tibble_3.2.1
## [35] ggplot2_3.4.3 tidyverse_2.0.0
## [37] zoo_1.8-12
##
## loaded via a namespace (and not attached):
## [1] bitops_1.0-7 gridExtra_2.3 rlang_1.1.1
## [4] magrittr_2.0.3 compiler_4.3.1 polylabelr_0.2.0
## [7] systemfonts_1.0.4 vctrs_0.6.3 rvest_1.0.3
## [10] pkgconfig_2.0.3 crayon_1.5.2 fastmap_1.1.1
## [13] XVector_0.40.0 ellipsis_0.3.2 labeling_0.4.2
## [16] caTools_1.18.2 utf8_1.2.3 promises_1.2.1
## [19] rmarkdown_2.24 tzdb_0.4.0 xfun_0.40
## [22] zlibbioc_1.46.0 cachem_1.0.8 jsonlite_1.8.7
## [25] highr_0.10 later_1.3.1 DelayedArray_0.26.7
## [28] reshape_0.8.9 BiocParallel_1.34.2 parallel_4.3.1
## [31] R6_2.5.1 bslib_0.5.1 stringi_1.7.12
## [34] RColorBrewer_1.1-3 jquerylib_0.1.4 assertthat_0.2.1
## [37] Rcpp_1.0.11 knitr_1.43 httpuv_1.6.11
## [40] Matrix_1.6-1 timechange_0.2.0 tidyselect_1.2.0
## [43] rstudioapi_0.15.0 abind_1.4-5 yaml_2.3.7
## [46] codetools_0.2-19 lattice_0.21-8 plyr_1.8.8
## [49] shiny_1.7.5 withr_2.5.0 evaluate_0.21
## [52] polyclip_1.10-4 xml2_1.3.5 pillar_1.9.0
## [55] KernSmooth_2.23-22 generics_0.1.3 RCurl_1.98-1.12
## [58] hms_1.1.3 munsell_0.5.0 scales_1.2.1
## [61] xtable_1.8-4 glue_1.6.2 tools_4.3.1
## [64] data.table_1.14.8 webshot_0.5.5 locfit_1.5-9.8
## [67] fastmatch_1.1-4 cowplot_1.1.1 grid_4.3.1
## [70] colorspace_2.1-0 GenomeInfoDbData_1.2.10 cli_3.6.1
## [73] fansi_1.0.4 viridisLite_0.4.2 S4Arrays_1.0.5
## [76] svglite_2.1.1 gtable_0.3.4 sass_0.4.7
## [79] digest_0.6.33 farver_2.1.1 htmlwidgets_1.6.2
## [82] htmltools_0.5.6 lifecycle_1.0.3 httr_1.4.7
## [85] mime_0.12
END of report